## Sheet1
Question ID:
qCountry

details_normalized:
{'Question ID': 'qCountry', 'Question Label': 'S0 - In which country are you currently practicing? ', 'question_type': 'QuotaField', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'qCountry', 'answers': [{'Answer Code': '12', 'Answer Label': 'France'}, {'Answer Code': '7', 'Answer Label': 'Germany'}, {'Answer Code': '2057', 'Answer Label': 'United Kingdom'}, {'Answer Code': '16', 'Answer Label': 'Italy'}, {'Answer Code': '1046', 'Answer Label': 'Brazil'}, {'Answer Code': '98', 'Answer Label': 'Other'}], 'question_attributes': {'ReferencedEntityId': '2753912961'}}

---

Question ID:
FRAE

details_normalized:
{'Question ID': 'FRAE', 'Question Label': 'FRAE - Afin d’assurer la conformité avec la réglementation liée à la pharmacovigilance nous (Société d’études de marché) sommes obligés de transmettre à notre client (le Sponsor de l’étude) toute information concernant des événements indésirables et/ou situations particulières* et/ou plaintes relatives au produit se produisant pendant cette enquête, et cela même si vous l’avez déjà rapporté directement à la société ou aux autorités compétentes. Il va de soi que lors de la remontée des événements indésirables et/ou plaintes relatives au produit tout information sera traitée de façon confidentielle.  Si cela se produit, la remontée au sponsor de ces évènements sera effectuée par nous avec deux niveaux d’implication possibles pour vous :  Vous consentez à renoncer à la confidentialité du Code de conduite des études de marché spécifiquement. Par conséquent :   Vous acceptez d’être contacté par le département de pharmacovigilance de notre client uniquement et exclusivement pour la documentation et le suivi du/des cas rapporté(s). Toute autre information recueillie dans le cadre de cette étude restera confidentielle. Votre nom sera mentionné en tant que rapporteur du/des cas, la documentation et le suivi du/des cas rapporté(s) s’effectuera, si besoin, directement entre vous et le sponsor.   Vous ne consentez pas à renoncer à la confidentialité du Code de conduite des études de marché spécifiquement en ce qui concerne des effets indésirables et/ou plaintes relatives au produit. Par conséquent : Vous acceptez d’être contacté exclusivement par nous (Société d’études de marché). Seul votre profession (pour les professionnels de santé) sera mentionnée comme rapporteur du/des cas, la documentation et le suivi du/des cas rapporté(s) s’effectuera, si besoin, directement entre vous et nous.    ', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('12')"], 'conditions': [], 'Variable ID': 'FRAE', 'answers': [{'Answer Code': '1', 'Answer Label': 'J’accepte de lever mon anonymat auprès du sponsor'}, {'Answer Code': '2', 'Answer Label': 'Je n’accepte pas de lever mon anonymat auprès du sponsor'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5860'}}

---

Question ID:
DAAE

details_normalized:
{'Question ID': 'DAAE', 'Question Label': 'DAAE - Um die Einhaltung der Pharmakovigilanzbestimmungen zu gewährleisten, sind wir (das Marktforschungsinstitut) verpflichtet, unserem Kunden (dem Auftraggeber der Marktforschungsstudie) Einzelheiten über unerwünschte Ereignisse, spezielle Situationen und/oder Produktbeschwerden zu melden, die während der Marktforschung erwähnt werden, auch wenn diese dem Unternehmen oder den Zulassungsbehörden bereits gemeldet wurden.  Sollte dies der Fall sein, wird die Meldung über solche Ereignisse an den Auftraggeber folgendermaßen durchgeführt:  Sie akzeptieren nur von uns (dem Marktforschungsinstitut) kontaktiert zu werden Nur Ihre Berufskategorie/Fachrichtung wird als meldende Person genannt, weitere Unterlagen und Folgemaßnahmen zu der/den Meldung(en) werden bei Bedarf nur zwischen Ihnen und uns bearbeitet  Sind Sie einverstanden, auf dieser Basis fortzufahren? ', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('7')"], 'conditions': ["f('DAAE').any('2') //screen DAAE"], 'Variable ID': 'DAAE', 'answers': [{'Answer Code': '1', 'Answer Label': 'Ja'}, {'Answer Code': '2', 'Answer Label': 'Nein'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5861'}}

---

Question ID:
UKAE

details_normalized:
{'Question ID': 'UKAE', 'Question Label': 'UKAE - To ensure compliance with regulations on Pharmacovigilance, we (the Market Research Agency) are obliged to report to our client (the sponsor of the Market Research Survey) details of adverse events and/or product complaints that are mentioned during market research, even if already reported to the company or the regulatory authorities.  Should this occur, the reporting of such events to the sponsor will be performed by us with two different possible levels of your involvement:  You accept to waive the confidentiality of contact details granted to you under the Market Research Code of Conduct  You accept to be contacted by the Pharmacovigilance Department of our client for the express and sole purpose of documentation and follow-up of such report(s), all other information that you provided us with in the context of this study remaining confidential. Your name will be mentioned as reporter of the case, further documentation and follow-up of the report(s) will be processed directly between you and the sponsor if needed   You do not accept to waive the confidentiality of contact details granted to you under the Market Research Code of Conduct You accept to be contacted only by us (the Market Research Agency). Only your professional category will be mentioned as reporter of the case, further documentation and follow-up of the report(s) will be processed only between you and us if needed  If you agree to waive confidentiality towards the sponsor, your name and contact details will be forwarded to the sponsor for the express and sole purpose of documentation and follow-up of adverse events and/or product complaints report(s), as described above. ', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('2057')"], 'conditions': [], 'Variable ID': 'UKAE', 'answers': [{'Answer Code': '3', 'Answer Label': 'I agree to waive confidentiality towards the sponsor'}, {'Answer Code': '4', 'Answer Label': 'I do not agree to waive confidentiality towards the sponsor'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5866'}}

---

Question ID:
ITAE

details_normalized:
{'Question ID': 'ITAE', 'Question Label': "ITAE - Per garantire la conformità alle normative sulla Farmacovigilanza, noi (l'Agenzia di Ricerche di Mercato) siamo obbligati a riferire al nostro cliente (lo sponsor della Ricerca di Mercato) i dettagli degli eventi avversi e/o dei reclami relativi ai prodotti che vengono menzionati durante le ricerche di mercato, anche se già segnalati all’azienda o alle Autorità Regolatorie.  In tal caso, la segnalazione di tali eventi allo sponsor sarà effettuata da noi con due diversi livelli di coinvolgimento possibili:  Lei accetta di rinunciare alla riservatezza dei dati di contatto a lei concessa ai sensi del Codice di Condotta per le ricerche di mercato  Accetta di essere contattato dal Dipartimento di Farmacovigilanza del nostro cliente per il solo ed esplicito scopo di documentare e assicurare il follow-up di tali segnalazioni; tutte le altre informazioni che ci ha fornito nel contesto di questo studio rimangono confidenziali. Il suo nome sarà menzionato come segnalatore, ulteriore documentazione e follow-up del caso saranno trattati direttamente tra lei e lo sponsor, se necessario;   Lei non accetta di rinunciare alla riservatezza dei dati di contatto che le è stata concessa ai sensi del Codice di Condotta per le ricerche di mercato Accetta di essere contattato solo da noi (l'Agenzia di Ricerche di Mercato). Solo la sua categoria professionale sarà menzionata come segnalatore, ulteriore documentazione e il follow-up del caso saranno trattati solo tra lei e noi, se necessario.  Se lei accetta di rinunciare alla riservatezza nei confronti dello sponsor, il suo nome e i suoi dati di contatto saranno inoltrati allo sponsor per il solo ed esplicito scopo di documentare e assicurare il follow-up di eventi avversi e/o reclami relativi ai prodotti, come descritto sopra.", 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('16')"], 'conditions': [], 'Variable ID': 'ITAE', 'answers': [{'Answer Code': '5', 'Answer Label': 'Accetto di rinunciare alla riservatezza nei confronti dello sponsor'}, {'Answer Code': '6', 'Answer Label': 'Non accetto di rinunciare alla riservatezza nei confronti dello sponsor'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5868'}}

---

Question ID:
BRAE

details_normalized:
{'Question ID': 'BRAE', 'Question Label': 'BRAE - Para garantir a conformidade com as regulamentações de Farmacovigilância, nós (the Market Research Agency/ Agência de Pesquisa de Mercado) somos obrigados a transmitir ao nosso cliente (o patrocinador da Pesquisa de Mercado) detalhes de eventos adversos e/ou reclamação de produtos que são mencionados durante pesquisas de mercado, mesmo que já reportados à empresa ou às autoridades regulatórias.  Caso isto ocorra, o relato destes eventos ao patrocinador será realizado por nós com dois níveis possíveis de seu envolvimento:  Você aceita renunciar à confidencialidade dos detalhes de contato concedida a você sob o Código de Conduta de Pesquisa de Mercado  Você aceita ser contatado pelo Departamento de Farmacovigilância de nosso cliente com o propósito expresso e exclusivo de documentação e acompanhamento deste(s) relato(s) e todas as demais informações que você forneceu no contexto deste estudo permanecerão confidenciais. Seu nome será mencionado como relator do caso. Documentação adicional e acompanhamento do(s) relato(s) serão processados diretamente entre você e o patrocinador, se necessário.   Você não aceita renunciar à confidencialidade dos detalhes de contato concedida a você sob o Código de Conduta de Pesquisa de Mercado Você aceita ser contatado somente por nós (the Market Research Agency/ Agência de Pesquisa de Mercado). Apenas a sua categoria profissional será mencionada como relatora do caso. Documentação adicional e acompanhamento do(s) relato(s) serão processados somente entre você e nós, se necessário.  Se você concordar em renunciar à confidencialidade com relação ao patrocinador, o seu nome e detalhes de contato serão encaminhados ao patrocinador com o propósito expresso e exclusivo de acompanhamento de relato(s) de eventos adversos e/ou reclamação de produtos, conforme descrito acima.  ', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('1046')"], 'conditions': [], 'Variable ID': 'BRAE', 'answers': [{'Answer Code': '7', 'Answer Label': 'Eu concordo em renunciar à confidencialidade com relação ao patrocinador'}, {'Answer Code': '8', 'Answer Label': 'Eu não concordo em renunciar à confidencialidade com relação ao patrocinador'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5870'}}

---

Question ID:
S0d

details_normalized:
{'Question ID': 'S0d', 'Question Label': 'S0d - Would you be willing for the local market research agency to re-contact you within 3 months for any follow-up that is deemed relevant for this research?  ', 'question_type': 'Single', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': [], 'Variable ID': 'S0d', 'answers': [{'Answer Code': '1', 'Answer Label': 'Willing to be contacted by the local market agency contact within 3 months for such purposes'}, {'Answer Code': '2', 'Answer Label': 'Unwilling to be contacted by the local market agency contact within 3 months for such purposes '}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5874'}}

---

Question ID:
SPECIALTY

details_normalized:
{'Question ID': 'SPECIALTY', 'Question Label': 'S1 - Which of the following best describes your primary medical specialty?', 'question_type': 'Single', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': ["f('SPECIALTY').any('99') //screen SPECIALITY"], 'Variable ID': 'SPECIALTY', 'answers': [{'Answer Code': '1', 'Answer Label': 'Oncologist'}, {'Answer Code': '2', 'Answer Label': 'Gastroenterologist'}, {'Answer Code': '3', 'Answer Label': 'Hepatologist'}, {'Answer Code': '99', 'Answer Label': "^isFR()?'Other':'Other specialty'^", 'answer_attributes': {'KeepPosition': 'true'}}], 'question_attributes': {'ValidationCode': 'checkOS()', 'PrecodeMask': 'MaskS1()', 'AutoCheckOther': 'true', 'EntityId': '967'}}

---

Question ID:
S2

details_normalized:
{'Question ID': 'S2', 'Question Label': 'S2 - For how many years have you been practicing in your current specialty?', 'question_type': 'Multi', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': ["f('S2')['1']<3 || f('S2')['1']>35 //soft-screen S2"], 'Variable ID': 'S2_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'S2_1 (S2 - For how many years have you been practicing in your current specialty?)'}], 'question_attributes': {'Numeric': 'true', 'LowerLimit': '1', 'EntityId': '5876', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '80'}}

---

Question ID:
S3aFR

details_normalized:
{'Question ID': 'S3aFR', 'Question Label': 'S3aFR - Which of the following best describes your practice setting (the setting where you spend 50% or more of your professional time)?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('12')"], 'conditions': [], 'Variable ID': 'S3aFR', 'answers': [{'Answer Code': '1', 'Answer Label': 'CHU/CHR '}, {'Answer Code': '4', 'Answer Label': 'CLCC/CRLC/CAC'}, {'Answer Code': '2', 'Answer Label': 'CH/CHG '}, {'Answer Code': '3', 'Answer Label': 'Hôpital privé / Clinique privée '}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5883'}}

---

Question ID:
HidS3aFR

details_normalized:
{'Question ID': 'HidS3aFR', 'Question Label': 'HidS3aFR - Quota S3a: FR', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HidS3aFR', 'answers': [{'Answer Code': '1', 'Answer Label': 'CHU/CHR + CLCC/CRLC/ CAC'}, {'Answer Code': '2', 'Answer Label': 'CH/CHG '}, {'Answer Code': '3', 'Answer Label': 'Hôpital privé / Clinique privée '}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '5884'}}

---

Question ID:
S3aDE

details_normalized:
{'Question ID': 'S3aDE', 'Question Label': 'S3aDE - Which of the following best describes your practice setting (the setting where you spend 50% or more of your professional time)?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('7')"], 'conditions': [], 'Variable ID': 'S3aDE', 'answers': [{'Answer Code': '1', 'Answer Label': 'University hospital '}, {'Answer Code': '2', 'Answer Label': 'Non- university teaching hospital '}, {'Answer Code': '4', 'Answer Label': 'Non-university hospital (without teaching)'}, {'Answer Code': '3', 'Answer Label': 'Private office and/or MVZ '}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5888'}}

---

Question ID:
HidS3aDE

details_normalized:
{'Question ID': 'HidS3aDE', 'Question Label': 'HidS3aDE - Quota S3a: DE', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HidS3aDE', 'answers': [{'Answer Code': '1', 'Answer Label': 'University hospital'}, {'Answer Code': '2', 'Answer Label': 'Non- university teaching hospital + Non-university hospital (without teaching)'}, {'Answer Code': '3', 'Answer Label': 'Private office and/or MVZ '}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '5890'}}

---

Question ID:
S3aIT

details_normalized:
{'Question ID': 'S3aIT', 'Question Label': 'S3aIT - Which of the following best describes your practice setting (the setting where you spend 50% or more of your professional time)?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('16')"], 'conditions': [], 'Variable ID': 'S3aIT', 'answers': [{'Answer Code': '1', 'Answer Label': 'Università / ospedale universitario'}, {'Answer Code': '2', 'Answer Label': 'Centro oncologico/ centro tumori'}, {'Answer Code': '3', 'Answer Label': 'Ospedale pubblico non universitario'}, {'Answer Code': '4', 'Answer Label': 'Ospedali locali / presidi di zona'}, {'Answer Code': '5', 'Answer Label': 'Ospedali specializzati'}, {'Answer Code': '6', 'Answer Label': 'Clinica/Ospedale privata/o'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5894'}}

---

Question ID:
HidS3aIT

details_normalized:
{'Question ID': 'HidS3aIT', 'Question Label': 'HidS3aIT - Quota S3a: IT', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HidS3aIT', 'answers': [{'Answer Code': '1', 'Answer Label': 'Università / ospedale universitario + Centro oncologico/ centro tumori'}, {'Answer Code': '2', 'Answer Label': 'Ospedale pubblico non universitario + Ospedali locali / presidi di zona + Ospedali specializzati + Clinica/Ospedale privata/o'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '5896'}}

---

Question ID:
S3axBR

details_normalized:
{'Question ID': 'S3axBR', 'question_type': 'QuotaField', 'entry_conditions': [], 'conditions': [], 'Question Label': 'S3axBR - Which of the following best describes your practice setting (the setting where you spend 50% or more of your professional time)?', 'question_attributes': {'ReferencedEntityId': '5901'}, 'sub_questions': [{'Variable ID': 'S3axBR', 'answers': [{'Answer Code': '1', 'Answer Label': 'Private office'}, {'Answer Code': '2', 'Answer Label': 'University hospital '}, {'Answer Code': '3', 'Answer Label': 'Cancer centre'}, {'Answer Code': '4', 'Answer Label': 'General / non-university public hospital'}, {'Answer Code': '5', 'Answer Label': 'Private hospital /clinic'}, {'Answer Code': '6', 'Answer Label': 'Other (specify)'}]}, {'Variable ID': 'S3axBR_6_other', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}]}

---

Question ID:
S3auk

details_normalized:
{'Question ID': 'S3auk', 'question_type': 'Multi', 'entry_conditions': ["f('qCountry').any('2057')"], 'conditions': [], 'Question Label': 'S3auk - What percentage of your time seeing patients is spent in the following practice setting?', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'InputSuffix': '%', 'EntityId': '5903', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'RequireCheck(CurrentForm())', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'MultiSumEqual': '100', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'S3auk_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Private setting (S3auk - What percentage of your time seeing patients is spent in the following practice setting?)'}]}, {'Variable ID': 'S3auk_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Public setting (S3auk - What percentage of your time seeing patients is spent in the following practice setting?)'}]}]}

---

Question ID:
S3aBR

details_normalized:
{'Question ID': 'S3aBR', 'Question Label': 'S3aBR - What percentage of your time, if any, do you spend in private practice (private office or private hospital or private clinic)?', 'question_type': 'Multi', 'entry_conditions': ["f('qCountry').any('1046')"], 'conditions': ["f('S3aBR')['1']<50 //soft-screen S3aBR"], 'Variable ID': 'S3aBR_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'S3aBR_1 (S3aBR - What percentage of your time, if any, do you spend in private practice (private office or private hospital or private clinic)?)'}], 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'InputSuffix': '%', 'EntityId': '5910', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'Precision': '3'}}

---

Question ID:
S3b

details_normalized:
{'Question ID': 'S3b', 'Question Label': 'S3b - Which of the following corresponds to your title/position in the hospital you work at?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('7') && f('S3aDE').none('3')"], 'conditions': ["f('S3b').any('4') //screen S3b"], 'Variable ID': 'S3b', 'answers': [{'Answer Code': '1', 'Answer Label': 'Chief senior specialist '}, {'Answer Code': '2', 'Answer Label': 'Senior specialist '}, {'Answer Code': '3', 'Answer Label': 'Fully qualified specialist '}, {'Answer Code': '4', 'Answer Label': 'Junior level position '}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5916'}}

---

Question ID:
S4

details_normalized:
{'Question ID': 'S4', 'Question Label': 'S4 - Approximately what percentage of your time do you spend in a clinical setting engaging in direct patient care, as opposed to non-clinical research, teaching or administration?', 'question_type': 'Multi', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': [], 'Variable ID': 'S4_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'S4_1 (S4 - Approximately what percentage of your time do you spend in a clinical setting engaging in direct patient care, as opposed to non-clinical research, teaching or administration?)'}], 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'InputSuffix': '%', 'EntityId': '5920', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'Precision': '3'}}

---

Question ID:
S5

details_normalized:
{'Question ID': 'S5', 'Question Label': 'S5 - Which of the following statements best reflects the role you play in Cholangiocarcinoma (CCA)?', 'question_type': 'Single', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': ["f('S5').any('3') //screen S5"], 'Variable ID': 'S5', 'answers': [{'Answer Code': '1', 'Answer Label': 'I am the main decision maker for the systemic treatment of CCA'}, {'Answer Code': '2', 'Answer Label': 'I am actively involved in the decision making of the systemic treatment of CCA as part of a Multidisciplinary Tumor Board'}, {'Answer Code': '3', 'Answer Label': 'I am not involved in the decision making for the systemic treatment of CCA'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5926'}}

---

Question ID:
S6a

details_normalized:
{'Question ID': 'S6a', 'Question Label': 'S6a - Approximately how many adult patients (aged 18+) with cholangiocarcinoma (CCA) are currently under your care and seen in consultation?  Please report the number of unique individuals, counting each one only once and not the number of visits/ virtual appointments made or number of treatment lines the patient may be on.', 'question_type': 'Multi', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': ["f('S6a')['1']==0 //screen S6a"], 'Variable ID': 'S6a_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'S6a_1 (S6a - Approximately how many adult patients (aged 18+) with cholangiocarcinoma (CCA) are currently under your care and seen in consultation?  Please report the number of unique individuals, counting each one only once and not the number of visits/ virtual appointments made or number of treatment lines the patient may be on.)'}], 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '5930', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'if ( !QuestionErrors() )\n{\n\n\tif ( GetNum("S6a_1") > 100 && !f(\'hFlag\')[\'S6a\'].toBoolean() && !isDynTerm() )\n\t{\n\t\n\t\tf(\'hFlag\')[\'S6a\'].set(\'1\');\n\t\terrorMsg(\'S6a\');\n\t\n\t}\n\n}', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}}

---

Question ID:
S6b

details_normalized:
{'Question ID': 'S6b', 'question_type': 'Multi', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': [], 'Question Label': 'S6b - # of CCA patients who are:', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '5941', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "RequireCheck(CurrentForm());\nCompareNum('S6b', '=', f('S6a')['1'].toNumber(), 'defaults');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'S6b_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Resectable or localized CCA patients  (S6b - # of CCA patients who are:)'}]}, {'Variable ID': 'S6b_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Nonresectable or metastatic CCA patients  (S6b - # of CCA patients who are:)'}]}]}

---

Question ID:
S6c

details_normalized:
{'Question ID': 'S6c', 'question_type': 'Multi', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': [], 'Question Label': 'S6c - # of CCA nonresectable / metastatic patients who are:', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '5951', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "RequireCheck(CurrentForm());\nCompareNum('S6c', '=', f('S6b')['2'].toNumber(), 'defaults');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'S6c_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Enrolled in a clinical trial (S6c - # of CCA nonresectable / metastatic patients who are:)'}]}, {'Variable ID': 'S6c_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Receiving CCA treatment as part of an early access program or compassionate use program (S6c - # of CCA nonresectable / metastatic patients who are:)'}]}, {'Variable ID': 'S6c_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'Neither (S6c - # of CCA nonresectable / metastatic patients who are:)'}]}]}

---

Question ID:
S6d

details_normalized:
{'Question ID': 'S6d', 'question_type': 'Multi', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': [], 'Question Label': 'S6d - # of CCA nonresectable / metastatic patients who have:', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '5954', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "RequireCheck(CurrentForm());\nCompareNum('S6d', '=', f('S6b')['2'].toNumber(), 'defaults');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'S6d_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Intrahepatic tumours (iCCA) (S6d - # of CCA nonresectable / metastatic patients who have:)'}]}, {'Variable ID': 'S6d_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Extrahepatic tumours (eCCA) (S6d - # of CCA nonresectable / metastatic patients who have:)'}]}]}

---

Question ID:
S6e

details_normalized:
{'Question ID': 'S6e', 'question_type': 'Multi', 'entry_conditions': ['GetNum("S6d_1") > 0'], 'conditions': [], 'Question Label': 'S6e - # of iCCA patients who are:', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '5966', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "RequireCheck(CurrentForm());\nCompareNum('S6e', '=', f('S6d')['1'].toNumber(), 'defaults');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'S6e_1', 'answers': [{'Answer Code': '1', 'Answer Label': '...treated with 1st line active systemic treatment (S6e - # of iCCA patients who are: )'}]}, {'Variable ID': 'S6e_2', 'answers': [{'Answer Code': '2', 'Answer Label': '...treated with 2nd line active systemic treatment (S6e - # of iCCA patients who are: )'}]}, {'Variable ID': 'S6e_3', 'answers': [{'Answer Code': '3', 'Answer Label': '...treated with 3rd line or later active systemic treatment (S6e - # of iCCA patients who are: )'}]}, {'Variable ID': 'S6e_4', 'answers': [{'Answer Code': '4', 'Answer Label': '...receiving BSC / palliative care as only treatment / care (S6e - # of iCCA patients who are: )'}]}, {'Variable ID': 'S6e_5', 'answers': [{'Answer Code': '5', 'Answer Label': '&hellip;. not treated / lost sight of patient (S6e - # of iCCA patients who are: )'}]}]}

---

Question ID:
HVAR6

details_normalized:
{'Question ID': 'HVAR6', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Question Label': 'HVAR6 - Monitor in field to determine # eligible to complete PRFs (i.e. with iCCA 2L or later patients)', 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'EntityId': '5972', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'Precision': '4'}, 'sub_questions': [{'Variable ID': 'HVAR6_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Not receiving active treatment = SUM CODES 4+5 (HVAR6 - Monitor in field to determine # eligible to complete PRFs (i.e. with iCCA 2L or later patients))'}]}, {'Variable ID': 'HVAR6_3', 'answers': [{'Answer Code': '3', 'Answer Label': '2L+ iCCA = SUM CODES 2-4 (HVAR6 - Monitor in field to determine # eligible to complete PRFs (i.e. with iCCA 2L or later patients))'}]}]}

---

Question ID:
S7

details_normalized:
{'Question ID': 'S7', 'Question Label': 'S7 - Are you or any members of your household or immediate family employed or affiliated, directly or indirectly by a pharmaceutical company, market research company of healthcare manufacturer?', 'question_type': 'Single', 'entry_conditions': ["f('qSurveyType').none('2') //SCREENER"], 'conditions': ["f('S7').any('1') //screen S7"], 'Variable ID': 'S7', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5960'}}

---

Question ID:
S8FR

details_normalized:
{'Question ID': 'S8FR', 'Question Label': 'S8FR - In which region do you practice?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('12')"], 'conditions': [], 'Variable ID': 'S8FR', 'answers': [{'Answer Code': '1', 'Answer Label': 'Ile-De-France '}, {'Answer Code': '2', 'Answer Label': 'Hauts de France '}, {'Answer Code': '3', 'Answer Label': 'Grand Est '}, {'Answer Code': '4', 'Answer Label': 'Normandie '}, {'Answer Code': '5', 'Answer Label': 'Bretagne '}, {'Answer Code': '6', 'Answer Label': 'Pays de la Loire'}, {'Answer Code': '7', 'Answer Label': 'Centre – Val de Loire'}, {'Answer Code': '8', 'Answer Label': 'Bourgogne – Franche-Comté'}, {'Answer Code': '9', 'Answer Label': 'Nouvelle Aquitaine '}, {'Answer Code': '10', 'Answer Label': 'Auvergne – Rhône-Alpes '}, {'Answer Code': '11', 'Answer Label': 'Occitanie '}, {'Answer Code': '12', 'Answer Label': 'Provence-Alpes-Côte d’Azur'}, {'Answer Code': '13', 'Answer Label': 'Corse'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5978'}}

---

Question ID:
HS8FR

details_normalized:
{'Question ID': 'HS8FR', 'Question Label': 'HS8FR - S8: REGION-FR', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HS8FR', 'answers': [{'Answer Code': '1', 'Answer Label': 'Paris IDF'}, {'Answer Code': '2', 'Answer Label': 'Nord'}, {'Answer Code': '3', 'Answer Label': 'Ouest'}, {'Answer Code': '4', 'Answer Label': 'Nord-Est'}, {'Answer Code': '5', 'Answer Label': 'Centre'}, {'Answer Code': '6', 'Answer Label': 'Centre-Est'}, {'Answer Code': '7', 'Answer Label': 'Sud-Est'}, {'Answer Code': '8', 'Answer Label': 'Sud-Ouest'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '5979'}}

---

Question ID:
S8DE

details_normalized:
{'Question ID': 'S8DE', 'Question Label': 'S8DE - In which region do you practice?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('7')"], 'conditions': [], 'Variable ID': 'S8DE', 'answers': [{'Answer Code': '41', 'Answer Label': 'Baden-Württemberg'}, {'Answer Code': '42', 'Answer Label': 'Bayern'}, {'Answer Code': '43', 'Answer Label': 'Berlin'}, {'Answer Code': '44', 'Answer Label': 'Brandenburg'}, {'Answer Code': '45', 'Answer Label': 'Bremen'}, {'Answer Code': '46', 'Answer Label': 'Hamburg'}, {'Answer Code': '47', 'Answer Label': ' Hessen'}, {'Answer Code': '48', 'Answer Label': 'Niedersachsen'}, {'Answer Code': '49', 'Answer Label': 'Mecklenburg-Vorpommern'}, {'Answer Code': '50', 'Answer Label': 'Nordrhein-Westfalen'}, {'Answer Code': '51', 'Answer Label': ' Rheinland-Pfalz'}, {'Answer Code': '52', 'Answer Label': 'Saarland'}, {'Answer Code': '53', 'Answer Label': 'Sachsen'}, {'Answer Code': '54', 'Answer Label': 'Sachsen-Anhalt'}, {'Answer Code': '55', 'Answer Label': 'Schleswig-Holstein'}, {'Answer Code': '56', 'Answer Label': 'Thüringen'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5983'}}

---

Question ID:
HS8DE

details_normalized:
{'Question ID': 'HS8DE', 'Question Label': 'HS8DE - S8: REGION-DE', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HS8DE', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gebiet I (Bremen, Hamburg, Niedersachsen, Schleswig-Holstein)'}, {'Answer Code': '2', 'Answer Label': 'Gebiet II & IIIa (Nordrhein-Westfalen, Hessen, Saarland, Rheinland-Pfalz)'}, {'Answer Code': '3', 'Answer Label': 'Gebiet IIIb & IV (Baden-Württemberg, Bayern)'}, {'Answer Code': '4', 'Answer Label': 'Gebiet V, VI & VII (Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt, Sachsen, Thüringen)'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '5985'}}

---

Question ID:
S8UK

details_normalized:
{'Question ID': 'S8UK', 'Question Label': 'S8UK - In which region do you practice?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('2057')"], 'conditions': [], 'Variable ID': 'S8UK', 'answers': [{'Answer Code': '1', 'Answer Label': 'Scotland'}, {'Answer Code': '2', 'Answer Label': 'Northern Ireland'}, {'Answer Code': '3', 'Answer Label': 'Wales'}, {'Answer Code': '4', 'Answer Label': 'Northeast'}, {'Answer Code': '5', 'Answer Label': 'Northwest'}, {'Answer Code': '6', 'Answer Label': 'Yorkshire '}, {'Answer Code': '7', 'Answer Label': 'West Midlands'}, {'Answer Code': '8', 'Answer Label': 'East Midlands '}, {'Answer Code': '9', 'Answer Label': 'South East'}, {'Answer Code': '10', 'Answer Label': 'South West'}, {'Answer Code': '11', 'Answer Label': 'London'}, {'Answer Code': '12', 'Answer Label': 'East of England'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5989'}}

---

Question ID:
S8BR

details_normalized:
{'Question ID': 'S8BR', 'Question Label': 'S8BR - In which region do you practice?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('1046')"], 'conditions': [], 'Variable ID': 'S8BR', 'answers': [{'Answer Code': '1', 'Answer Label': 'São Paulo (Capital)'}, {'Answer Code': '2', 'Answer Label': 'Rio de Janeiro (Capital)'}, {'Answer Code': '3', 'Answer Label': 'Ribeirão Preto'}, {'Answer Code': '4', 'Answer Label': 'Salvador'}, {'Answer Code': '5', 'Answer Label': 'Porto Alegre'}, {'Answer Code': '6', 'Answer Label': 'Belo Horizonte'}, {'Answer Code': '7', 'Answer Label': 'Brasília'}, {'Answer Code': '8', 'Answer Label': 'Recife'}, {'Answer Code': '9', 'Answer Label': 'Campinas'}, {'Answer Code': '10', 'Answer Label': 'Curitiba'}, {'Answer Code': '11', 'Answer Label': 'Central-West Region: Federal District, Goiás, Mato Grosso, Mato Grosso do Sul.'}, {'Answer Code': '12', 'Answer Label': 'Northeast Region: Alagoas, Bahia, Ceará, Maranhão, Paraíba, Pernambuco, Piauí, Rio Grande do Norte, Sergipe.'}, {'Answer Code': '13', 'Answer Label': 'North Region: Acre, Amapá, Amazonas, Pará, Rondônia, Roraima, Tocantins.'}, {'Answer Code': '14', 'Answer Label': 'Southeast Region: Espírito Santo, Minas Gerais'}, {'Answer Code': '15', 'Answer Label': 'South Region: Paraná, Santa Catarina, Rio Grande do Sul'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '5995'}}

---

Question ID:
HS8BR

details_normalized:
{'Question ID': 'HS8BR', 'Question Label': 'HS8BR - S8: REGION-BR', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HS8BR', 'answers': [{'Answer Code': '1', 'Answer Label': 'São Paulo (Capital)'}, {'Answer Code': '2', 'Answer Label': 'Rio de Janeiro (Capital)'}, {'Answer Code': '3', 'Answer Label': 'Ribeirão Preto, Salvador, Porto Alegre, Belo Horizonte, Brasília, Recife, Campinas, Curitiba'}, {'Answer Code': '11', 'Answer Label': 'Central-West Region: Federal District, Goiás, Mato Grosso, Mato Grosso do Sul.'}, {'Answer Code': '12', 'Answer Label': 'Northeast Region: Alagoas, Bahia, Ceará, Maranhão, Paraíba, Pernambuco, Piauí, Rio Grande do Norte, Sergipe.'}, {'Answer Code': '13', 'Answer Label': 'North Region: Acre, Amapá, Amazonas, Pará, Rondônia, Roraima, Tocantins.'}, {'Answer Code': '14', 'Answer Label': 'Southeast Region: Espírito Santo, Minas Gerais'}, {'Answer Code': '15', 'Answer Label': 'South Region: Paraná, Santa Catarina, Rio Grande do Sul'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '6001'}}

---

Question ID:
S8IT

details_normalized:
{'Question ID': 'S8IT', 'Question Label': 'S8IT - In which region do you practice?', 'question_type': 'Single', 'entry_conditions': ["f('qCountry').any('16')"], 'conditions': [], 'Variable ID': 'S8IT', 'answers': [{'Answer Code': '1', 'Answer Label': 'Nord Oest  '}, {'Answer Code': '2', 'Answer Label': 'Nord Est'}, {'Answer Code': '3', 'Answer Label': 'Centro '}, {'Answer Code': '4', 'Answer Label': 'Sud '}, {'Answer Code': '5', 'Answer Label': 'Isole '}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6004'}}

---

Question ID:
HS9

details_normalized:
{'Question ID': 'HS9', 'Question Label': "HS9 - Qualifies...  Recode as 'Qualified' if S5 = 1 or code 2 and qualifies at S6e  Recode as 'Not qualified' if S5= 3 or does not qualify at S6", 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HS9', 'answers': [{'Answer Code': '1', 'Answer Label': 'Qualified'}, {'Answer Code': '2', 'Answer Label': 'Not qualified'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '6010'}}

---

Question ID:
A1a

details_normalized:
{'Question ID': 'A1a', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Question Label': 'A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind?', 'question_attributes': {'OpenText': 'true', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'ValidationCode': 'RequireCheck(CurrentForm());\n\nif ( !QuestionErrors() )\n{\n   //CheckOpenLengthMultiOE(CurrentForm(),5,0,"chars");\n   CheckMultiOpen();\n}', 'EntityId': '6021'}, 'sub_questions': [{'Variable ID': 'A1a_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'A1a_1 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'A1a_2 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'A1a_3 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'A1a_4 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_5', 'answers': [{'Answer Code': '5', 'Answer Label': 'A1a_5 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_6', 'answers': [{'Answer Code': '6', 'Answer Label': 'A1a_6 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_7', 'answers': [{'Answer Code': '7', 'Answer Label': 'A1a_7 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_8', 'answers': [{'Answer Code': '8', 'Answer Label': 'A1a_8 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_9', 'answers': [{'Answer Code': '9', 'Answer Label': 'A1a_9 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_10', 'answers': [{'Answer Code': '10', 'Answer Label': 'A1a_10 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_11', 'answers': [{'Answer Code': '11', 'Answer Label': 'A1a_11 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_12', 'answers': [{'Answer Code': '12', 'Answer Label': 'A1a_12 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_13', 'answers': [{'Answer Code': '13', 'Answer Label': 'A1a_13 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_14', 'answers': [{'Answer Code': '14', 'Answer Label': 'A1a_14 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}, {'Variable ID': 'A1a_15', 'answers': [{'Answer Code': '15', 'Answer Label': 'A1a_15 (A1a - When you think of products used to treat patients with nonresectable/metastatic CCA, what products come to mind? )'}]}]}

---

Question ID:
A1b

details_normalized:
{'Question ID': 'A1b', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Question Label': 'A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?', 'question_attributes': {'OpenText': 'true', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'ValidationCode': 'CheckDK(\'A1b\',\'A1bDK\');\n\nif ( !QuestionErrors() && f(\'A1b\').size() > 0 )\n{\n   //CheckOpenLengthMultiOE(CurrentForm(),5,0,"chars");\n   CheckMultiOpen();\n}', 'EntityId': '6024'}, 'sub_questions': [{'Variable ID': 'A1b_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'A1b_1 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'A1b_2 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'A1b_3 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'A1b_4 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_5', 'answers': [{'Answer Code': '5', 'Answer Label': 'A1b_5 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_6', 'answers': [{'Answer Code': '6', 'Answer Label': 'A1b_6 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_7', 'answers': [{'Answer Code': '7', 'Answer Label': 'A1b_7 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_8', 'answers': [{'Answer Code': '8', 'Answer Label': 'A1b_8 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_9', 'answers': [{'Answer Code': '9', 'Answer Label': 'A1b_9 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_10', 'answers': [{'Answer Code': '10', 'Answer Label': 'A1b_10 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_11', 'answers': [{'Answer Code': '11', 'Answer Label': 'A1b_11 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_12', 'answers': [{'Answer Code': '12', 'Answer Label': 'A1b_12 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_13', 'answers': [{'Answer Code': '13', 'Answer Label': 'A1b_13 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_14', 'answers': [{'Answer Code': '14', 'Answer Label': 'A1b_14 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}, {'Variable ID': 'A1b_15', 'answers': [{'Answer Code': '15', 'Answer Label': 'A1b_15 (A1b - Which mutations/fusions/rearrangements are you aware of that may potentially influence treatment decisions for nonresectable/metastatic CCA patients, today or in a near future?)'}]}]}

---

Question ID:
A1bDK

details_normalized:
{'Question ID': 'A1bDK', 'Question Label': 'I’m not aware of any mutations/fusions/rearrangements may potentially influence treatment decisions for CCA patients (A1bDK)', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'A1bDK_99', 'answers': [{'Answer Code': '99', 'Answer Label': ''}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6025'}}

---

Question ID:
A1c

details_normalized:
{'Question ID': 'A1c', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Question Label': 'A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?', 'question_attributes': {'OpenText': 'true', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'ValidationCode': 'RequireCheck(CurrentForm());\n\nif ( !QuestionErrors() )\n{\n  // CheckOpenLengthMultiOE(CurrentForm(),5,0,"chars");\n   CheckMultiOpen();\n}', 'EntityId': '6026'}, 'sub_questions': [{'Variable ID': 'A1c_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'A1c_1 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'A1c_2 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'A1c_3 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'A1c_4 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_5', 'answers': [{'Answer Code': '5', 'Answer Label': 'A1c_5 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_6', 'answers': [{'Answer Code': '6', 'Answer Label': 'A1c_6 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_7', 'answers': [{'Answer Code': '7', 'Answer Label': 'A1c_7 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_8', 'answers': [{'Answer Code': '8', 'Answer Label': 'A1c_8 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_9', 'answers': [{'Answer Code': '9', 'Answer Label': 'A1c_9 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_10', 'answers': [{'Answer Code': '10', 'Answer Label': 'A1c_10 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_11', 'answers': [{'Answer Code': '11', 'Answer Label': 'A1c_11 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_12', 'answers': [{'Answer Code': '12', 'Answer Label': 'A1c_12 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_13', 'answers': [{'Answer Code': '13', 'Answer Label': 'A1c_13 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_14', 'answers': [{'Answer Code': '14', 'Answer Label': 'A1c_14 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}, {'Variable ID': 'A1c_15', 'answers': [{'Answer Code': '15', 'Answer Label': 'A1c_15 (A1c - Next, please think of therapies intended to target specific mutations/alterations for nonresectable/metastatic CCA patients. What products come to mind?  )'}]}]}

---

Question ID:
A2a

details_normalized:
{'Question ID': 'A2a', 'question_type': 'Grid', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'NotRequired': 'true', 'PrecodeMask': "isBR() ? a('A2a').diff(set('3')):a('A2a')", 'AnswerlistOrder': 'Randomize', 'Carousel': 'false', 'Disabled': 'true', 'EntityId': '6028'}, 'sub_questions': [{'Variable ID': 'A2a_1', 'Question Label': 'Keytruda&reg; (pembrolizumab) (A2a - How familiar are you with each of the following as a treatment for nonresectable/metastatic CCA?  When answering, please consider the products listed below in all possible scenarios, including when used as a standalone treatment or in combination with other treatments. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Never heard of it'}, {'Answer Code': '2', 'Answer Label': 'Heard of it, but don’t know anything about it'}, {'Answer Code': '3', 'Answer Label': 'Familiar with it, but not yet planning to use'}, {'Answer Code': '4', 'Answer Label': 'Planning to use, but have not yet had opportunity'}, {'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future'}, {'Answer Code': '7', 'Answer Label': 'My use of the product/ regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/ regimen regularly, but I am now using the product/ regimen less and less'}]}, {'Variable ID': 'A2a_2', 'Question Label': 'Pemazyre&reg; (pemigatinib) (A2a - How familiar are you with each of the following as a treatment for nonresectable/metastatic CCA?  When answering, please consider the products listed below in all possible scenarios, including when used as a standalone treatment or in combination with other treatments. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Never heard of it'}, {'Answer Code': '2', 'Answer Label': 'Heard of it, but don’t know anything about it'}, {'Answer Code': '3', 'Answer Label': 'Familiar with it, but not yet planning to use'}, {'Answer Code': '4', 'Answer Label': 'Planning to use, but have not yet had opportunity'}, {'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future'}, {'Answer Code': '7', 'Answer Label': 'My use of the product/ regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/ regimen regularly, but I am now using the product/ regimen less and less'}]}, {'Variable ID': 'A2a_3', 'Question Label': 'Lytgobi&reg; (futibatinib) (A2a - How familiar are you with each of the following as a treatment for nonresectable/metastatic CCA?  When answering, please consider the products listed below in all possible scenarios, including when used as a standalone treatment or in combination with other treatments. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Never heard of it'}, {'Answer Code': '2', 'Answer Label': 'Heard of it, but don’t know anything about it'}, {'Answer Code': '3', 'Answer Label': 'Familiar with it, but not yet planning to use'}, {'Answer Code': '4', 'Answer Label': 'Planning to use, but have not yet had opportunity'}, {'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future'}, {'Answer Code': '7', 'Answer Label': 'My use of the product/ regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/ regimen regularly, but I am now using the product/ regimen less and less'}]}, {'Variable ID': 'A2a_6', 'Question Label': 'Tibsovo&reg; (ivosidenib) (A2a - How familiar are you with each of the following as a treatment for nonresectable/metastatic CCA?  When answering, please consider the products listed below in all possible scenarios, including when used as a standalone treatment or in combination with other treatments. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Never heard of it'}, {'Answer Code': '2', 'Answer Label': 'Heard of it, but don’t know anything about it'}, {'Answer Code': '3', 'Answer Label': 'Familiar with it, but not yet planning to use'}, {'Answer Code': '4', 'Answer Label': 'Planning to use, but have not yet had opportunity'}, {'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future'}, {'Answer Code': '7', 'Answer Label': 'My use of the product/ regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/ regimen regularly, but I am now using the product/ regimen less and less'}]}, {'Variable ID': 'A2a_7', 'Question Label': 'Imfinzi&reg; (durvalumab) (A2a - How familiar are you with each of the following as a treatment for nonresectable/metastatic CCA?  When answering, please consider the products listed below in all possible scenarios, including when used as a standalone treatment or in combination with other treatments. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Never heard of it'}, {'Answer Code': '2', 'Answer Label': 'Heard of it, but don’t know anything about it'}, {'Answer Code': '3', 'Answer Label': 'Familiar with it, but not yet planning to use'}, {'Answer Code': '4', 'Answer Label': 'Planning to use, but have not yet had opportunity'}, {'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future'}, {'Answer Code': '7', 'Answer Label': 'My use of the product/ regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/ regimen regularly, but I am now using the product/ regimen less and less'}]}]}

---

Question ID:
HA2a_1

details_normalized:
{'Question ID': 'HA2a_1', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6030'}, 'sub_questions': [{'Variable ID': 'HA2a_1_1', 'Question Label': 'Non-users A2a = 1, 2, 3, 4 (Keytruda&reg; (pembrolizumab) - Keytruda&reg; (pembrolizumab))', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_1_2', 'Question Label': 'Past users / Irresolute A2a = 5, 6, 9 (Keytruda&reg; (pembrolizumab) - Keytruda&reg; (pembrolizumab))', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_1_5', 'Question Label': 'Past users A2a = 5 (Keytruda&reg; (pembrolizumab) - Keytruda&reg; (pembrolizumab))', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_1_6', 'Question Label': 'Irresolute A2a = 6,9 (Keytruda&reg; (pembrolizumab) - Keytruda&reg; (pembrolizumab))', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_1_3', 'Question Label': 'Current users A2a = 7, 8 (Keytruda&reg; (pembrolizumab) - Keytruda&reg; (pembrolizumab))', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_1_4', 'Question Label': 'Unaware A2a=1 (Keytruda&reg; (pembrolizumab) - Keytruda&reg; (pembrolizumab))', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}]}

---

Question ID:
HA2a_2

details_normalized:
{'Question ID': 'HA2a_2', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6031'}, 'sub_questions': [{'Variable ID': 'HA2a_2_1', 'Question Label': 'Non-users A2a = 1, 2, 3, 4 (Pemazyre&reg; (pemigatinib) - Pemazyre&reg; (pemigatinib))', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_2_2', 'Question Label': 'Past users / Irresolute A2a = 5, 6, 9 (Pemazyre&reg; (pemigatinib) - Pemazyre&reg; (pemigatinib))', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_2_5', 'Question Label': 'Past users A2a = 5 (Pemazyre&reg; (pemigatinib) - Pemazyre&reg; (pemigatinib))', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_2_6', 'Question Label': 'Irresolute A2a = 6,9 (Pemazyre&reg; (pemigatinib) - Pemazyre&reg; (pemigatinib))', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_2_3', 'Question Label': 'Current users A2a = 7, 8 (Pemazyre&reg; (pemigatinib) - Pemazyre&reg; (pemigatinib))', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_2_4', 'Question Label': 'Unaware A2a=1 (Pemazyre&reg; (pemigatinib) - Pemazyre&reg; (pemigatinib))', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}]}

---

Question ID:
HA2a_3

details_normalized:
{'Question ID': 'HA2a_3', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6032'}, 'sub_questions': [{'Variable ID': 'HA2a_3_1', 'Question Label': 'Non-users A2a = 1, 2, 3, 4 (Lytgobi&reg; (futibatinib) - Lytgobi&reg; (futibatinib))', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_3_2', 'Question Label': 'Past users / Irresolute A2a = 5, 6, 9 (Lytgobi&reg; (futibatinib) - Lytgobi&reg; (futibatinib))', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_3_5', 'Question Label': 'Past users A2a = 5 (Lytgobi&reg; (futibatinib) - Lytgobi&reg; (futibatinib))', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_3_6', 'Question Label': 'Irresolute A2a = 6,9 (Lytgobi&reg; (futibatinib) - Lytgobi&reg; (futibatinib))', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_3_3', 'Question Label': 'Current users A2a = 7, 8 (Lytgobi&reg; (futibatinib) - Lytgobi&reg; (futibatinib))', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_3_4', 'Question Label': 'Unaware A2a=1 (Lytgobi&reg; (futibatinib) - Lytgobi&reg; (futibatinib))', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}]}

---

Question ID:
HA2a_6

details_normalized:
{'Question ID': 'HA2a_6', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6033'}, 'sub_questions': [{'Variable ID': 'HA2a_6_1', 'Question Label': 'Non-users A2a = 1, 2, 3, 4 (Tibsovo&reg; (ivosidenib) - Tibsovo&reg; (ivosidenib))', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_6_2', 'Question Label': 'Past users / Irresolute A2a = 5, 6, 9 (Tibsovo&reg; (ivosidenib) - Tibsovo&reg; (ivosidenib))', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_6_5', 'Question Label': 'Past users A2a = 5 (Tibsovo&reg; (ivosidenib) - Tibsovo&reg; (ivosidenib))', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_6_6', 'Question Label': 'Irresolute A2a = 6,9 (Tibsovo&reg; (ivosidenib) - Tibsovo&reg; (ivosidenib))', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_6_3', 'Question Label': 'Current users A2a = 7, 8 (Tibsovo&reg; (ivosidenib) - Tibsovo&reg; (ivosidenib))', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_6_4', 'Question Label': 'Unaware A2a=1 (Tibsovo&reg; (ivosidenib) - Tibsovo&reg; (ivosidenib))', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}]}

---

Question ID:
HA2a_7

details_normalized:
{'Question ID': 'HA2a_7', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6034'}, 'sub_questions': [{'Variable ID': 'HA2a_7_1', 'Question Label': 'Non-users A2a = 1, 2, 3, 4 (Imfinzi&reg; (durvalumab) - Imfinzi&reg; (durvalumab))', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_7_2', 'Question Label': 'Past users / Irresolute A2a = 5, 6, 9 (Imfinzi&reg; (durvalumab) - Imfinzi&reg; (durvalumab))', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_7_5', 'Question Label': 'Past users A2a = 5 (Imfinzi&reg; (durvalumab) - Imfinzi&reg; (durvalumab))', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_7_6', 'Question Label': 'Irresolute A2a = 6,9 (Imfinzi&reg; (durvalumab) - Imfinzi&reg; (durvalumab))', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_7_3', 'Question Label': 'Current users A2a = 7, 8 (Imfinzi&reg; (durvalumab) - Imfinzi&reg; (durvalumab))', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'HA2a_7_4', 'Question Label': 'Unaware A2a=1 (Imfinzi&reg; (durvalumab) - Imfinzi&reg; (durvalumab))', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}]}

---

Question ID:
B4x1

details_normalized:
{'Question ID': 'B4x1', 'question_type': 'Multi', 'entry_conditions': ["GetNum('HVAR6_1') > 0"], 'conditions': [], 'Question Label': "B4x1 - Patients currently in 2L : ^GetNum('S6e_2')^", 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6043', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CompareNum3D('B4x1', '<=', GetNum('S6e_2'), 'rows')\n\nif (!QuestionErrors()) \n{\n   if ((Sum(GetNum('B4x1_1'), GetNum('B4x2_1'), GetNum('B4x3_1')) == 0 && f('hB4soft').none('1')) || ((Sum(GetNum('B4x1_1'), GetNum('B4x2_1'), GetNum('B4x3_1'))) < GetNum('HVAR6_1')) && f('hB4soft').none('1'))\n{\n      f('hB4soft')['1'].set(1)\n   errorMsg('B4')\n}\n}", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'GetNum("S6e_2") > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B4x1_1', 'answers': [{'Answer Code': '1', 'Answer Label': "IDH1 (B4x1 - Patients currently in 2L : ^GetNum('S6e_2')^)"}]}, {'Variable ID': 'B4x1_2', 'answers': [{'Answer Code': '2', 'Answer Label': "FGFR2 (B4x1 - Patients currently in 2L : ^GetNum('S6e_2')^)"}]}]}

---

Question ID:
B4x2

details_normalized:
{'Question ID': 'B4x2', 'question_type': 'Multi', 'entry_conditions': ["GetNum('HVAR6_1') > 0"], 'conditions': [], 'Question Label': "B4x2 - Patients currently in 3L or later : ^GetNum('S6e_3')^", 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6044', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CompareNum3D('B4x2', '<=', GetNum('S6e_3'), 'rows')", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'GetNum("S6e_3") > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B4x2_1', 'answers': [{'Answer Code': '1', 'Answer Label': "IDH1 (B4x2 - Patients currently in 3L or later : ^GetNum('S6e_3')^)"}]}, {'Variable ID': 'B4x2_2', 'answers': [{'Answer Code': '2', 'Answer Label': "FGFR2 (B4x2 - Patients currently in 3L or later : ^GetNum('S6e_3')^)"}]}]}

---

Question ID:
B4x3

details_normalized:
{'Question ID': 'B4x3', 'question_type': 'Multi', 'entry_conditions': ["GetNum('HVAR6_1') > 0"], 'conditions': [], 'Question Label': "B4x3 - Patients currently in BSC or not treated : ^Sum(GetNum('S6e_4'),GetNum('S6e_5'))^", 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6045', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CompareNum3D('B4x3', '<=',Sum(GetNum('S6e_4'),GetNum('S6e_5')),'rows')", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'Sum(GetNum("S6e_4"),GetNum("S6e_5")) > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B4x3_1', 'answers': [{'Answer Code': '1', 'Answer Label': "IDH1 (B4x3 - Patients currently in BSC or not treated : ^Sum(GetNum('S6e_4'),GetNum('S6e_5'))^)"}]}, {'Variable ID': 'B4x3_2', 'answers': [{'Answer Code': '2', 'Answer Label': "FGFR2 (B4x3 - Patients currently in BSC or not treated : ^Sum(GetNum('S6e_4'),GetNum('S6e_5'))^)"}]}]}

---

Question ID:
B4xTot

details_normalized:
{'Question ID': 'B4xTot', 'question_type': 'Multi', 'entry_conditions': ["GetNum('HVAR6_1') > 0"], 'conditions': [], 'Question Label': "B4xTot - Total : ^Sum(GetNum('S6e_2'),GetNum('S6e_3'),GetNum('S6e_4'),GetNum('S6e_5'))^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6046', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B4xTot_1', 'answers': [{'Answer Code': '1', 'Answer Label': "IDH1 (B4xTot - Total : ^Sum(GetNum('S6e_2'),GetNum('S6e_3'),GetNum('S6e_4'),GetNum('S6e_5'))^)"}]}, {'Variable ID': 'B4xTot_2', 'answers': [{'Answer Code': '2', 'Answer Label': "FGFR2 (B4xTot - Total : ^Sum(GetNum('S6e_2'),GetNum('S6e_3'),GetNum('S6e_4'),GetNum('S6e_5'))^)"}]}]}

---

Question ID:
HVAR1

details_normalized:
{'Question ID': 'HVAR1', 'Question Label': 'HVAR1 - [SHOWN FOR TESTING PURPOSES ONLY]', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HVAR1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'iCCA PATIENTS NOT TESTED FOR IDH1 IN 2 or 3Lor currently not treated (HVAR1 - [SHOWN FOR TESTING PURPOSES ONLY])'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'EntityId': '6149', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}}

---

Question ID:
HVAR2

details_normalized:
{'Question ID': 'HVAR2', 'Question Label': 'HVAR2 - [SHOWN FOR TESTING PURPOSES ONLY]', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HVAR2_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'iCCA PATIENTS NOT TESTED FOR FGFR2 IN 2 or 3L or currently not treated (HVAR2 - [SHOWN FOR TESTING PURPOSES ONLY])'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6150', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}}

---

Question ID:
HVAR3

details_normalized:
{'Question ID': 'HVAR3', 'Question Label': 'HVAR3 - [SHOWN FOR TESTING PURPOSES ONLY]', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HVAR3_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Total patients in 2+3L+ tested for IDH1  (HVAR3 - [SHOWN FOR TESTING PURPOSES ONLY])'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6151', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}}

---

Question ID:
HVAR4

details_normalized:
{'Question ID': 'HVAR4', 'Question Label': 'HVAR4 - [SHOWN FOR TESTING PURPOSES ONLY]', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HVAR4_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Total patients in 2+3L+ tested for FGFR2 (HVAR4 - [SHOWN FOR TESTING PURPOSES ONLY])'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6152', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}}

---

Question ID:
HVAR5

details_normalized:
{'Question ID': 'HVAR5', 'Question Label': 'HVAR5 - [SHOWN FOR TESTING PURPOSES ONLY]', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HVAR5_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Total patients in 2L+ tested for IDH1 or FGFR2 (HVAR5 - [SHOWN FOR TESTING PURPOSES ONLY])'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6153', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}}

---

Question ID:
hB1bx1

details_normalized:
{'Question ID': 'hB1bx1', 'question_type': 'Multi', 'entry_conditions': ['MaskColsB1b().size() > 0'], 'conditions': [], 'Question Label': 'hB1bx1 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6054', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'ValidationCode': '/*if(!QuestionErrors())\n{\n    if( f(\'B1bx1\')[\'1\'].toBoolean() && GetNum(\'B1bx1_1\') >=0  && f(\'hSoftB1b\').none(\'1\'))\n{\n      f(\'hSoftB1b\')[\'1\'].set(1)\n      errorMsg("B1b")\n}\n}*/', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'MaskColsB1b().isect(set("1")).size() > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'hB1bx1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'IDH1 (hB1bx1 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration )'}]}, {'Variable ID': 'hB1bx1_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'FGFR2 (hB1bx1 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration )'}]}]}

---

Question ID:
B1bx1

details_normalized:
{'Question ID': 'B1bx1', 'question_type': 'Multi', 'entry_conditions': ['MaskColsB1b().size() > 0'], 'conditions': [], 'Question Label': 'B1bx1 - TESTED POSITIVE for this mutation/alteration', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6057', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "// CompareNumQues3D('B1bx1','<=','B4x1','B4x1')\n\nvalidateB1b('B4x1','B1bx1');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'MaskColsB1b().isect(set("1")).size() > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B1bx1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'IDH1 (B1bx1 - TESTED POSITIVE for this mutation/alteration  )'}]}, {'Variable ID': 'B1bx1_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'FGFR2 (B1bx1 - TESTED POSITIVE for this mutation/alteration  )'}]}]}

---

Question ID:
hB1bx2

details_normalized:
{'Question ID': 'hB1bx2', 'question_type': 'Multi', 'entry_conditions': ['MaskColsB1b().size() > 0'], 'conditions': [], 'Question Label': 'hB1bx2 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6058', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'MaskColsB1b().isect(set("2")).size() > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'hB1bx2_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'IDH1 (hB1bx2 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration )'}]}, {'Variable ID': 'hB1bx2_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'FGFR2 (hB1bx2 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration )'}]}]}

---

Question ID:
B1bx2

details_normalized:
{'Question ID': 'B1bx2', 'question_type': 'Multi', 'entry_conditions': ['MaskColsB1b().size() > 0'], 'conditions': [], 'Question Label': 'B1bx2 - TESTED POSITIVE for this mutation/alteration', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6076', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "// CompareNumQues3D('B1bx2', '<=', 'B4x2', 'B4x2')\n\nvalidateB1b('B4x2','B1bx2');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'MaskColsB1b().isect(set("2")).size() > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B1bx2_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'IDH1 (B1bx2 - TESTED POSITIVE for this mutation/alteration)'}]}, {'Variable ID': 'B1bx2_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'FGFR2 (B1bx2 - TESTED POSITIVE for this mutation/alteration)'}]}]}

---

Question ID:
hB1bx3

details_normalized:
{'Question ID': 'hB1bx3', 'question_type': 'Multi', 'entry_conditions': ['MaskColsB1b().size() > 0'], 'conditions': [], 'Question Label': 'hB1bx3 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6078', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'MaskColsB1b().isect(set("3")).size() > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'hB1bx3_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'IDH1 (hB1bx3 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration )'}]}, {'Variable ID': 'hB1bx3_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'FGFR2 (hB1bx3 - REMINDER: NUMBER OF PATIENTS TESTED for this mutation/alteration )'}]}]}

---

Question ID:
B1bx3

details_normalized:
{'Question ID': 'B1bx3', 'question_type': 'Multi', 'entry_conditions': ['MaskColsB1b().size() > 0'], 'conditions': [], 'Question Label': 'B1bx3 - TESTED POSITIVE for this mutation/alteration', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6077', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "// CompareNumQues3D('B1bx3', '<=', 'B4x3', 'B4x3')\n\nvalidateB1b('B4x3','B1bx3');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'MaskColsB1b().isect(set("3")).size() > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B1bx3_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'IDH1 (B1bx3 - TESTED POSITIVE for this mutation/alteration  )'}]}, {'Variable ID': 'B1bx3_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'FGFR2 (B1bx3 - TESTED POSITIVE for this mutation/alteration  )'}]}]}

---

Question ID:
B10b2

details_normalized:
{'Question ID': 'B10b2', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'Ordered': 'true', 'EntityId': '6277', 'RankByClick': 'true', 'AnswerlistOrder': 'Randomize', 'MultiItemsSelectedMinimum': '1', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'SubHeaderOrder': 'Randomize', 'MultiItemsSelectedMaximum': '5', 'PrecodeMask': "f('S3aDE').any('3') ? a('B10b2').diff(set('8')) :a('B10b2')"}, 'sub_questions': [{'Variable ID': 'B10b2_1_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '1', 'Answer Label': "Patient is too frail to receive any systemic therapy (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )", 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'B10b2_2_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '2', 'Answer Label': "Patient is not eligible for a targeted therapy due to reasons unrelated to fragility (contra-indications/comorbidities) (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )", 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'B10b2_4_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '4', 'Answer Label': "My treatment strategy does not necessitate IDH1 gene mutation testing (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )"}]}, {'Variable ID': 'B10b2_5_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '5', 'Answer Label': "Patient refuses to undergo a biopsy (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )"}]}, {'Variable ID': 'B10b2_7_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '7', 'Answer Label': "Test is too expensive / not reimbursed (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )"}]}, {'Variable ID': 'B10b2_8_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '8', 'Answer Label': "I do not have access to therapies targeting IDH1 gene mutation specifically in my setting  (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )"}]}, {'Variable ID': 'B10b2_9_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '9', 'Answer Label': "IDH1 gene mutation test is not available in my setting / not included in the molecular panel (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )"}]}, {'Variable ID': 'B10b2_10_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '10', 'Answer Label': "Available tissue was not sufficient (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )"}]}, {'Variable ID': 'B10b2_98_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '98', 'Answer Label': "Other (please specify) (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   )", 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'B10b2_98_other_1', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for IDH1 gene mutation.   Why were some of your iCCA patients not tested for IDH1 gene mutation   ", 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'B10b2_1_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '1', 'Answer Label': "Patient is too frail to receive any systemic therapy (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )", 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'B10b2_2_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '2', 'Answer Label': "Patient is not eligible for a targeted therapy due to reasons unrelated to fragility (contra-indications/comorbidities) (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )", 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'B10b2_4_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '4', 'Answer Label': "My treatment strategy does not necessitate FGFR2 gene mutation/alteration testing (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )"}]}, {'Variable ID': 'B10b2_5_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '5', 'Answer Label': "Patient refuses to undergo a biopsy (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )"}]}, {'Variable ID': 'B10b2_7_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '7', 'Answer Label': "Test is too expensive / not reimbursed (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )"}]}, {'Variable ID': 'B10b2_8_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '8', 'Answer Label': "I do not have access to therapies targeting FGFR2 gene mutation/alteration specifically in my setting  (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )"}]}, {'Variable ID': 'B10b2_9_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '9', 'Answer Label': "FGFR2 gene mutation/alteration test is not available in my setting / not included in the molecular panel (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )"}]}, {'Variable ID': 'B10b2_10_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '10', 'Answer Label': "Available tissue was not sufficient (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )"}]}, {'Variable ID': 'B10b2_98_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '98', 'Answer Label': "Other (please specify) (B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   )", 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'B10b2_98_other_2', 'Question Label': "B10b2 - You said that you did not test ^f('LoopB10b2').any('1')?GetNum('HVAR6_1') -Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1')):GetNum('HVAR6_1') - Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^ of your nonresectable/metastatic iCCA patients for FGFR2 gene mutation/alteration.   Why were some of your iCCA patients not tested for FGFR2 gene mutation/alteration   ", 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
B5G

details_normalized:
{'Question ID': 'B5G', 'Question Label': 'B5 - When molecular testing is performed, how often is it conducted at the following times…?    ', 'question_type': 'Grid3D', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'B5G_98_other', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}], 'question_attributes': {'MaxDiff': 'false', 'Transpose': 'false', 'AnswerTextPosition': 'Left', 'EntityId': '6110'}}

---

Question ID:
B5

details_normalized:
{'Question ID': 'B5', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Question Label': 'B5 - % of patients in which testing is conducted :', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'InputSuffix': '%', 'EntityId': '6112', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'RequireCheck3D(CurrentForm());\ncheckOS();', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'MultiSumEqual': '100', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B5_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Only at the time of diagnosis (B5 - % of patients in which testing is conducted :)'}]}, {'Variable ID': 'B5_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Only during 1st line (B5 - % of patients in which testing is conducted :)'}]}, {'Variable ID': 'B5_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'Only at progression of 1st line (B5 - % of patients in which testing is conducted :)'}]}, {'Variable ID': 'B5_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'Both at the time of diagnosis and at progression of 1st line  (this is % of patients who are tested more than once) (B5 - % of patients in which testing is conducted :)'}]}, {'Variable ID': 'B5_98', 'answers': [{'Answer Code': '98', 'Answer Label': 'Other (please specify) (B5 - % of patients in which testing is conducted :)'}]}]}

---

Question ID:
B6a

details_normalized:
{'Question ID': 'B6a', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Question Label': 'B6a - % of biopsies collected via:', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'InputSuffix': '%', 'EntityId': '6117', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'RequireCheck3D(CurrentForm());', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'MultiSumEqual': '100', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B6a_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Fine needle aspiration (B6a - % of biopsies collected via:)'}]}, {'Variable ID': 'B6a_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Core needle biopsy (B6a - % of biopsies collected via:)'}]}, {'Variable ID': 'B6a_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'Incisional biopsy (B6a - % of biopsies collected via:)'}]}, {'Variable ID': 'B6a_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'Liquid biopsy (B6a - % of biopsies collected via:)'}]}, {'Variable ID': 'B6a_98', 'answers': [{'Answer Code': '98', 'Answer Label': 'Other (B6a - % of biopsies collected via:)'}]}]}

---

Question ID:
B6b

details_normalized:
{'Question ID': 'B6b', 'Question Label': 'B6b - Which of the following statements best reflects your understanding of liquid biopsy for nonresectable/metastatic CCA today?', 'question_type': 'Single', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'B6b', 'answers': [{'Answer Code': '1', 'Answer Label': 'Approved by national competent authority, widely available and reimbursed'}, {'Answer Code': '2', 'Answer Label': 'Widely available but not approved by national competent authority / not reimbursed'}, {'Answer Code': '3', 'Answer Label': 'Not widely available, at least in my area'}, {'Answer Code': '4', 'Answer Label': 'Don’t know / Unsure ', 'answer_attributes': {'KeepPosition': 'true'}}], 'question_attributes': {'Randomize': 'true', 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'EntityId': '6108'}}

---

Question ID:
B7a

details_normalized:
{'Question ID': 'B7a', 'Question Label': 'B7a - How often are you able to get an appropriate sample (in terms of quantity and quality) in the initial biopsy to perform all desired molecular tests?  ', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'B7a_1', 'answers': [{'Answer Code': '1', 'Answer Label': '% of time to get appropriate tumour material to perform all desired molecular tests (B7a - How often are you able to get an appropriate sample (in terms of quantity and quality) in the initial biopsy to perform all desired molecular tests?  )'}], 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6111', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'Precision': '3'}}

---

Question ID:
B7b

details_normalized:
{'Question ID': 'B7b', 'question_type': 'Multi', 'entry_conditions': ["GetNum('B7a_1') < 100"], 'conditions': [], 'Question Label': 'B7b - % of time where would…', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'InputSuffix': '%', 'EntityId': '6114', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "RequireCheck3D('B7b')", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'MultiSumEqual': '100', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B7b_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Conduct liquid biopsy (B7b - % of time where would…)'}]}, {'Variable ID': 'B7b_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Conduct additional tissue biopsy (B7b - % of time where would…)'}]}, {'Variable ID': 'B7b_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'Not conduct any additional biopsy to support molecular tests (B7b - % of time where would…)'}]}]}

---

Question ID:
B7c

details_normalized:
{'Question ID': 'B7c', 'question_type': 'Multi', 'entry_conditions': ["GetNum('B7b_3') > 0"], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'AnswerRequiredType': 'Required', 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6121'}, 'sub_questions': [{'Variable ID': 'B7c_1', 'Question Label': 'Patient has poor health status / is too fragile (B7c - For what reason(s) do you not always conduct any additional tissue biopsy to support molecular tests if tumour material isn’t appropriate (in terms of quantity and quality). )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'B7c_2', 'Question Label': 'Logistical issues (cost, access or no reimbursement) (B7c - For what reason(s) do you not always conduct any additional tissue biopsy to support molecular tests if tumour material isn’t appropriate (in terms of quantity and quality). )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'B7c_3', 'Question Label': 'It is difficult to get additional sufficient tissue sample (B7c - For what reason(s) do you not always conduct any additional tissue biopsy to support molecular tests if tumour material isn’t appropriate (in terms of quantity and quality). )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'B7c_4', 'Question Label': 'It is no longer necessary to conduct any additional biopsy (B7c - For what reason(s) do you not always conduct any additional tissue biopsy to support molecular tests if tumour material isn’t appropriate (in terms of quantity and quality). )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'B7c_5', 'Question Label': 'Patient preference (B7c - For what reason(s) do you not always conduct any additional tissue biopsy to support molecular tests if tumour material isn’t appropriate (in terms of quantity and quality). )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'B7c_98', 'Question Label': 'Other (please specify) (B7c - For what reason(s) do you not always conduct any additional tissue biopsy to support molecular tests if tumour material isn’t appropriate (in terms of quantity and quality). )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'B7c_98_other', 'Question Label': 'B7c - For what reason(s) do you not always conduct any additional tissue biopsy to support molecular tests if tumour material isn’t appropriate (in terms of quantity and quality). ', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
B8

details_normalized:
{'Question ID': 'B8', 'question_type': 'Single', 'entry_conditions': ["( f('qCountry').any('16') || f('qCountry').any('1046') ) && (GetNum('B4x1_1') > 0 || GetNum('B4x2_1') > 0 || GetNum('B4x3_1') > 0 )"], 'conditions': [], 'Question Label': 'B8 - What lab do you use primarily for IDH1 molecular testing?', 'question_attributes': {'Randomize': 'true', 'PrecodeMask': "isBR() ? a(CurrentForm()) : a(CurrentForm()).diff(set('3'))", 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6124'}, 'sub_questions': [{'Variable ID': 'B8', 'answers': [{'Answer Code': '1', 'Answer Label': 'IDH1 mutation testing done in your hospital / setting '}, {'Answer Code': '2', 'Answer Label': 'IDH1 mutation testing done at external lab / hospital / centre'}, {'Answer Code': '3', 'Answer Label': 'Molecular test programs provided by the pharmaceutical industry '}, {'Answer Code': '98', 'Answer Label': 'Other (please specify) ', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'B8_98_other', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
B10bx1

details_normalized:
{'Question ID': 'B10bx1', 'question_type': 'Multi', 'entry_conditions': ["GreaterThan('B4x1', 0).size() > 0 || GreaterThan('B4x2', 0).size() > 0 || GreaterThan('B4x3', 0).size() > 0"], 'conditions': [], 'Question Label': "B10bx1 - IDH1 : ^Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1'))^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6205', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'CheckDK3D(\'B10bx1\', \'B10bDKx1\');\n//checkOS();\nif(!QuestionErrors() && f(\'B10bDKx1\').size() ==0)\n{\n    CompareNum3D(\'B10bx1\', \'<=\', Sum(GetNum("B4x1_1"), GetNum("B4x2_1"), GetNum("B4x3_1")), \'rows\')\n    CompareNum3D(\'B10bx1\',\'=\',Sum(GetNum("B4x1_1"),GetNum("B4x2_1"),GetNum("B4x3_1")),\'defaults\') \n}', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'Sum(GetNum("B4x1_1"),GetNum("B4x2_1"),GetNum("B4x3_1")) > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B10bx1_1', 'answers': [{'Answer Code': '1', 'Answer Label': "NGS panel only (B10bx1 - IDH1 : ^Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1'))^ )"}]}, {'Variable ID': 'B10bx1_2', 'answers': [{'Answer Code': '2', 'Answer Label': "Single gene PCR only (B10bx1 - IDH1 : ^Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1'))^ )"}]}, {'Variable ID': 'B10bx1_3', 'answers': [{'Answer Code': '3', 'Answer Label': "PCR panel only (B10bx1 - IDH1 : ^Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1'))^ )"}]}, {'Variable ID': 'B10bx1_4', 'answers': [{'Answer Code': '4', 'Answer Label': "Both NGS panel and PCR (single gene or panel) (B10bx1 - IDH1 : ^Sum(GetNum('B4x1_1'),GetNum('B4x2_1'),GetNum('B4x3_1'))^ )"}]}]}

---

Question ID:
B10bx2

details_normalized:
{'Question ID': 'B10bx2', 'question_type': 'Multi', 'entry_conditions': ["GreaterThan('B4x1', 0).size() > 0 || GreaterThan('B4x2', 0).size() > 0 || GreaterThan('B4x3', 0).size() > 0"], 'conditions': [], 'Question Label': "B10bx2 - FGFR2  : ^Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6206', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'CheckDK3D(\'B10bx2\', \'B10bDKx2\');\n//checkOS();\nif(!QuestionErrors() &&  f(\'B10bDKx2\').size() ==0)\n{\n    CompareNum3D(\'B10bx2\', \'<=\', Sum(GetNum("B4x1_2"), GetNum("B4x2_2"), GetNum("B4x3_2")), \'rows\')\n    CompareNum3D(\'B10bx2\',\'=\',Sum(GetNum("B4x1_2"),GetNum("B4x2_2"),GetNum("B4x3_2")),\'defaults\') \n}', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': 'Sum(GetNum("B4x1_2"),GetNum("B4x2_2"),GetNum("B4x3_2")) > 0', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'B10bx2_1', 'answers': [{'Answer Code': '1', 'Answer Label': "NGS panel only (B10bx2 - FGFR2  : ^Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^)"}]}, {'Variable ID': 'B10bx2_2', 'answers': [{'Answer Code': '2', 'Answer Label': "Single gene PCR only (B10bx2 - FGFR2  : ^Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^)"}]}, {'Variable ID': 'B10bx2_3', 'answers': [{'Answer Code': '3', 'Answer Label': "PCR panel only (B10bx2 - FGFR2  : ^Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^)"}]}, {'Variable ID': 'B10bx2_4', 'answers': [{'Answer Code': '4', 'Answer Label': "Both NGS panel and PCR (single gene or panel) (B10bx2 - FGFR2  : ^Sum(GetNum('B4x1_2'),GetNum('B4x2_2'),GetNum('B4x3_2'))^)"}]}]}

---

Question ID:
B10bDKx1

details_normalized:
{'Question ID': 'B10bDKx1', 'Question Label': 'I don’t know (B10bDKx1)', 'question_type': 'Multi', 'entry_conditions': ["GreaterThan('B4x1', 0).size() > 0 || GreaterThan('B4x2', 0).size() > 0 || GreaterThan('B4x3', 0).size() > 0"], 'conditions': [], 'Variable ID': 'B10bDKx1_99', 'answers': [{'Answer Code': '99', 'Answer Label': ''}], 'question_attributes': {'AnswerRequiredType': 'NotRequired', 'AutoCheckOther': 'true', 'ColumnMask': 'Sum(GetNum("B4x1_1"),GetNum("B4x2_1"),GetNum("B4x3_1")) > 0', 'EntityId': '6258'}}

---

Question ID:
B10bDKx2

details_normalized:
{'Question ID': 'B10bDKx2', 'Question Label': 'I don’t know (B10bDKx2)', 'question_type': 'Multi', 'entry_conditions': ["GreaterThan('B4x1', 0).size() > 0 || GreaterThan('B4x2', 0).size() > 0 || GreaterThan('B4x3', 0).size() > 0"], 'conditions': [], 'Variable ID': 'B10bDKx2_99', 'answers': [{'Answer Code': '99', 'Answer Label': ''}], 'question_attributes': {'AnswerRequiredType': 'NotRequired', 'AutoCheckOther': 'true', 'ColumnMask': 'Sum(GetNum("B4x1_2"), GetNum("B4x2_2"), GetNum("B4x3_2")) > 0', 'EntityId': '6259'}}

---

Question ID:
hC4order

details_normalized:
{'Question ID': 'hC4order', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Question Label': 'hC4order', 'question_attributes': {'Randomize': 'true', 'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6332', 'UpperLimitType': 'SmallerOrEqual', 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual'}, 'sub_questions': [{'Variable ID': 'hC4order_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine-based regimen (hC4order)'}]}, {'Variable ID': 'hC4order_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Other treatments  (hC4order)'}]}, {'Variable ID': 'hC4order_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'Clinical trial / other (hC4order)', 'answer_attributes': {'KeepPosition': 'true'}}]}]}

---

Question ID:
C4G

details_normalized:
{'Question ID': 'C4G', 'Question Label': "C4 - Amongst your ^GetNum('S6e_1')^ nonresectable/metastatic iCCA patients currently in 1L how many were initiated with the following systemic treatments?  See detailed patient definition ^tooltip(' here','ipd')^ Please note we’re interested in the treatment regimen prescribed at initiation (regimen could have been adjusted since initiation)", 'question_type': 'Grid3D', 'entry_conditions': ['GetNum("S6e_1") > 0'], 'conditions': [], 'Variable ID': 'C4G_98_other', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}], 'question_attributes': {'SubHeaderOrder': 'Alphabetic', 'MaxDiff': 'false', 'PrecodeMask': 'MaskC4()', 'Transpose': 'false', 'AnswerTextPosition': 'Left', 'EntityId': '6287'}}

---

Question ID:
C4

details_normalized:
{'Question ID': 'C4', 'question_type': 'Multi', 'entry_conditions': ['GetNum("S6e_1") > 0'], 'conditions': [], 'Question Label': 'C4 - Number of iCCA patients who received each treatment at initiation of 1st line', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6288', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'RequireCheck3D(CurrentForm());\nCompareNum3D(\'C4\',\'<=\',GetNum("S6e_1"),\'rows\') \nCompareNum3D(\'C4\',\'=\',GetNum("S6e_1"),\'defaults\') \ncheckOS();', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'C4_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Gemcitabine + cisplatin + durvalumab (Imfinzi®) (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'Gemcitabine  + cisplatin + Pembrolizumab (Keytruda®)  (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'Any other gemcitabine-based regimen  (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_5', 'answers': [{'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_6', 'answers': [{'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan) (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_7', 'answers': [{'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda®) / 5-FU mono (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_9', 'answers': [{'Answer Code': '9', 'Answer Label': 'Entrectinib (Rozlytrek®) (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_14', 'answers': [{'Answer Code': '14', 'Answer Label': 'Larotrectinib (Vitrakvi®)  (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_12', 'answers': [{'Answer Code': '12', 'Answer Label': 'Investigational drug (clinical trial) (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}, {'Variable ID': 'C4_98', 'answers': [{'Answer Code': '98', 'Answer Label': 'Any other approach (please specify)  (C4 - Number of iCCA patients who received each treatment at initiation of 1st line)'}]}]}

---

Question ID:
C5aG

details_normalized:
{'Question ID': 'C5aG', 'Question Label': "C5a - Now focusing on your nonresectable/metastatic CCA patients with intrahepatic tumours (iCCA) and with an IDH1 mutation who are currently in 2L^GetNum('B1bx2_1') > 0?' or 3L+':''^, how many are receiving the following treatments?  Please apply these definitions when answering the question:   A new line of treatment is a new and different treatment given when a patient progresses. If a drug is reintroduced after a treatment break, please do not consider this this a new line of treatment.   ", 'question_type': 'Grid3D', 'entry_conditions': ["GetNum('B1bx1_1') > 0 || GetNum('B1bx2_1') > 0"], 'conditions': [], 'Variable ID': 'C5aG_98_other', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}], 'question_attributes': {'MaxDiff': 'false', 'PrecodeMask': 'MaskC5a()', 'Transpose': 'false', 'AnswerTextPosition': 'Left', 'EntityId': '6311'}}

---

Question ID:
C5ax1

details_normalized:
{'Question ID': 'C5ax1', 'question_type': 'Multi', 'entry_conditions': ["GetNum('B1bx1_1') > 0 || GetNum('B1bx2_1') > 0"], 'conditions': [], 'Question Label': "C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6312', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'CompareNum3D(\'C5ax1\', \'<=\', GetNum("B1bx1_1"), \'rows\')\nCompareNum3D(\'C5ax1\', \'=\', GetNum("B1bx1_1"), \'defaults\')\ncheckOS();\n\nif (!QuestionErrors()) \n{\n\tif ((GetNum(\'C5ax1_10\')==0 && f(\'A2a\')[\'6\'].any(\'5\',\'6\',\'7\',\'8\',\'9\')) && f(\'hC5asoft\').none(\'1\'))\n{\n   f(\'hC5asoft\')[\'1\'].set(1)\n   //errorMsg(\'C5a\')\n}\n}', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': "GetNum('B1bx1_1') > 0", 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'C5ax1_1', 'answers': [{'Answer Code': '1', 'Answer Label': "Gemcitabine + cisplatin  (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_2', 'answers': [{'Answer Code': '2', 'Answer Label': "Gemcitabine + cisplatin + durvalumab (Imfinzi®)  (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_3', 'answers': [{'Answer Code': '3', 'Answer Label': "Gemcitabine + cisplatin + Pembrolizumab (Keytruda®)  (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_4', 'answers': [{'Answer Code': '4', 'Answer Label': "Any other gemcitabine-based regimen  (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_5', 'answers': [{'Answer Code': '5', 'Answer Label': "FOLFOX (5-FU, folinic acid, oxaliplatin) (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_6', 'answers': [{'Answer Code': '6', 'Answer Label': "FOLFIRI (5-FU, folinic acid, irinotecan) (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_7', 'answers': [{'Answer Code': '7', 'Answer Label': "Capecitabine (Xeloda®) / 5-FU mono (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_15', 'answers': [{'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda®) monotherapy ^isUK()?"(MSI-H patients)":""^ (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum(\'B1bx1_1\')^ )'}]}, {'Variable ID': 'C5ax1_10', 'answers': [{'Answer Code': '10', 'Answer Label': "Ivosidenib (Tibsovo®)  (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_12', 'answers': [{'Answer Code': '12', 'Answer Label': "Investigational drug (clinical trial)  (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}, {'Variable ID': 'C5ax1_98', 'answers': [{'Answer Code': '98', 'Answer Label': "Any other approach (please specify)  (C5ax1 - Number of mIDH1 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_1')^ )"}]}]}

---

Question ID:
C5ax2

details_normalized:
{'Question ID': 'C5ax2', 'question_type': 'Multi', 'entry_conditions': ["GetNum('B1bx1_1') > 0 || GetNum('B1bx2_1') > 0"], 'conditions': [], 'Question Label': "C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6313', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'CompareNum3D(\'C5ax2\', \'<=\', GetNum("B1bx2_1"), \'rows\')\nCompareNum3D(\'C5ax2\', \'=\', GetNum("B1bx2_1"), \'defaults\')\ncheckOS();\n\nif (!QuestionErrors()) \n{\n\tif ((GetNum(\'C5ax2_10\')==0 && f(\'A2a\')[\'6\'].any(\'7\',\'8\')) && f(\'hC5asoft\').none(\'1\'))\n{\n   f(\'hC5asoft\')[\'1\'].set(1)\n   errorMsg(\'C5a\')\n}\n}', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': "GetNum('B1bx2_1') > 0", 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'C5ax2_1', 'answers': [{'Answer Code': '1', 'Answer Label': "Gemcitabine + cisplatin  (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_2', 'answers': [{'Answer Code': '2', 'Answer Label': "Gemcitabine + cisplatin + durvalumab (Imfinzi®)  (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_3', 'answers': [{'Answer Code': '3', 'Answer Label': "Gemcitabine + cisplatin + Pembrolizumab (Keytruda®)  (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_4', 'answers': [{'Answer Code': '4', 'Answer Label': "Any other gemcitabine-based regimen  (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_5', 'answers': [{'Answer Code': '5', 'Answer Label': "FOLFOX (5-FU, folinic acid, oxaliplatin) (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_6', 'answers': [{'Answer Code': '6', 'Answer Label': "FOLFIRI (5-FU, folinic acid, irinotecan) (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_7', 'answers': [{'Answer Code': '7', 'Answer Label': "Capecitabine (Xeloda®) / 5-FU mono (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_15', 'answers': [{'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda®) monotherapy ^isUK()?"(MSI-H patients)":""^ (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum(\'B1bx2_1\')^ )'}]}, {'Variable ID': 'C5ax2_10', 'answers': [{'Answer Code': '10', 'Answer Label': "Ivosidenib (Tibsovo®)  (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_12', 'answers': [{'Answer Code': '12', 'Answer Label': "Investigational drug (clinical trial)  (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}, {'Variable ID': 'C5ax2_98', 'answers': [{'Answer Code': '98', 'Answer Label': "Any other approach (please specify)  (C5ax2 - Number of mIDH1 iCCA patients currently receiving each treatment in 3rd line + : ^GetNum('B1bx2_1')^ )"}]}]}

---

Question ID:
hC5asoft

details_normalized:
{'Question ID': 'hC5asoft', 'Question Label': ' (hC5asoft - [SHOWN FOR TESTING PURPOSES ONLY])', 'question_type': 'Multi', 'entry_conditions': ["GetNum('B1bx1_1') > 0 || GetNum('B1bx2_1') > 0"], 'conditions': [], 'Variable ID': 'hC5asoft_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}], 'question_attributes': {'AnswerRequiredType': 'NotRequired', 'VariableType': 'Hidden', 'AutoCheckOther': 'true', 'EntityId': '6337'}}

---

Question ID:
ER1

details_normalized:
{'Question ID': 'ER1', 'Question Label': 'ER1 - You previously answered that you have never used Ivosidenib (Tibsovo&reg;), but at least one of your patients is currently receiving / has received Ivosidenib (Tibsovo&reg;) in 2nd or later lines.   Please take the opportunity to review and amend your previous answers, if relevant.  ', 'question_type': 'Single', 'entry_conditions': ['Sum(GetNum("C5ax1_10"),GetNum("C5ax2_10")) > 0 && f(\'A2a\')[\'6\'].any(\'2\')'], 'conditions': [], 'Variable ID': 'ER1', 'answers': [{'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future '}, {'Answer Code': '7', 'Answer Label': 'My use of the product/regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/regimen regularly, but I am now using the product/regimen less and less'}], 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6360'}}

---

Question ID:
HidPreA2a

details_normalized:
{'Question ID': 'HidPreA2a', 'Question Label': 'HidPreA2a - Recode A2a response for Answer [Tibsovo® (ivosidenib) ]...', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HidPreA2a', 'answers': [{'Answer Code': '1', 'Answer Label': 'Never heard of it'}, {'Answer Code': '2', 'Answer Label': 'Heard of it, but don’t know anything about it'}, {'Answer Code': '3', 'Answer Label': 'Familiar with it, but not yet planning to use'}, {'Answer Code': '4', 'Answer Label': 'Planning to use, but have not yet had opportunity'}, {'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future'}, {'Answer Code': '7', 'Answer Label': 'My use of the product/ regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/ regimen regularly, but I am now using the product/ regimen less and less'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '6363'}}

---

Question ID:
HidNewA2a

details_normalized:
{'Question ID': 'HidNewA2a', 'Question Label': 'HidNewA2a - Recode A2a response for Answer [Tibsovo® (ivosidenib) ] with ER1...', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HidNewA2a', 'answers': [{'Answer Code': '1', 'Answer Label': 'Never heard of it'}, {'Answer Code': '2', 'Answer Label': 'Heard of it, but don’t know anything about it'}, {'Answer Code': '3', 'Answer Label': 'Familiar with it, but not yet planning to use'}, {'Answer Code': '4', 'Answer Label': 'Planning to use, but have not yet had opportunity'}, {'Answer Code': '5', 'Answer Label': 'I have tried it on a few patients, but I have not yet made up my mind about it'}, {'Answer Code': '6', 'Answer Label': 'I have tried it on a few patients, but I am not convinced, and I don’t plan using it often in the future'}, {'Answer Code': '7', 'Answer Label': 'My use of the product/ regimen is steadily increasing'}, {'Answer Code': '8', 'Answer Label': 'I use it regularly / I regard it as one of my standard therapies for the treatment of eligible CCA'}, {'Answer Code': '9', 'Answer Label': 'I did use the product/ regimen regularly, but I am now using the product/ regimen less and less'}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '6364'}}

---

Question ID:
C5bG

details_normalized:
{'Question ID': 'C5bG', 'Question Label': "C5b - Now, focusing on your nonresectable/metastatic CCA patients with intrahepatic tumours (iCCA) and with an FGFR2 mutation/alteration who are currently in 2nd line^GetNum('B1bx2_1') > 0?' or 3rd line+':''^, how many are receiving the following treatments?  Please apply these definitions when answering the question: A new line of treatment is a new and different treatment given when a patient progresses. If a drug is reintroduced after a treatment break, please do not consider this this a new line of treatment.  See detailed patient definition ^tooltip(' here','ipd')^   ", 'question_type': 'Grid3D', 'entry_conditions': ["GetNum('B1bx1_2') > 0 || GetNum('B1bx2_2') > 0"], 'conditions': [], 'Variable ID': 'C5bG_98_other', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}], 'question_attributes': {'MaxDiff': 'false', 'PrecodeMask': 'MaskC5()', 'Transpose': 'false', 'AnswerTextPosition': 'Left', 'EntityId': '6302'}}

---

Question ID:
C5bx1

details_normalized:
{'Question ID': 'C5bx1', 'question_type': 'Multi', 'entry_conditions': ["GetNum('B1bx1_2') > 0 || GetNum('B1bx2_2') > 0"], 'conditions': [], 'Question Label': "C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6303', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "checkOS();\nRequireCheck3D(CurrentForm());\nCompareNum3D('C5bx1','<=',GetNum('B1bx1_2'),'rows');\nCompareNum3D('C5bx1','=',GetNum('B1bx1_2'),'defaults')", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': "GetNum('B1bx1_2') > 0", 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'C5bx1_1', 'answers': [{'Answer Code': '1', 'Answer Label': "Gemcitabine + cisplatin (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_2', 'answers': [{'Answer Code': '2', 'Answer Label': "Gemcitabine + cisplatin + durvalumab (Imfinzi®) (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_3', 'answers': [{'Answer Code': '3', 'Answer Label': "Gemcitabine + cisplatin + Pembrolizumab (Keytruda®)  (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_4', 'answers': [{'Answer Code': '4', 'Answer Label': "Any other gemcitabine-based regimen  (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_5', 'answers': [{'Answer Code': '5', 'Answer Label': "FOLFOX (5-FU, folinic acid, oxaliplatin) (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_6', 'answers': [{'Answer Code': '6', 'Answer Label': "FOLFIRI (5-FU, folinic acid, irinotecan) (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_7', 'answers': [{'Answer Code': '7', 'Answer Label': "Capecitabine (Xeloda®) / 5-FU mono (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_8', 'answers': [{'Answer Code': '8', 'Answer Label': "Pemigatinib (Pemazyre®)  (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_11', 'answers': [{'Answer Code': '11', 'Answer Label': "Futibatinib (Lytgobi ®) (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_15', 'answers': [{'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda®) monotherapy ^isUK()?"(MSI-H patients)":""^ (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum(\'B1bx1_2\')^)'}]}, {'Variable ID': 'C5bx1_12', 'answers': [{'Answer Code': '12', 'Answer Label': "Investigational drug (clinical trial) (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}, {'Variable ID': 'C5bx1_98', 'answers': [{'Answer Code': '98', 'Answer Label': "Any other approach (please specify)  (C5bx1 - Number of mFGFR2 iCCA patients currently receiving each treatment in 2nd line : ^GetNum('B1bx1_2')^)"}]}]}

---

Question ID:
C5bx2

details_normalized:
{'Question ID': 'C5bx2', 'question_type': 'Multi', 'entry_conditions': ["GetNum('B1bx1_2') > 0 || GetNum('B1bx2_2') > 0"], 'conditions': [], 'Question Label': "C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6307', 'AutoSum': 'true', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "checkOS();\nRequireCheck3D(CurrentForm());\nCompareNum3D('C5bx2','<=',GetNum('B1bx2_2'),'rows');\nCompareNum3D('C5bx2','=',GetNum('B1bx2_2'),'defaults');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '998', 'ColumnMask': "GetNum('B1bx2_2') > 0", 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'C5bx2_1', 'answers': [{'Answer Code': '1', 'Answer Label': "Gemcitabine + cisplatin (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_2', 'answers': [{'Answer Code': '2', 'Answer Label': "Gemcitabine + cisplatin + durvalumab (Imfinzi®) (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_3', 'answers': [{'Answer Code': '3', 'Answer Label': "Gemcitabine + cisplatin + Pembrolizumab (Keytruda®)  (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_4', 'answers': [{'Answer Code': '4', 'Answer Label': "Any other gemcitabine-based regimen  (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_5', 'answers': [{'Answer Code': '5', 'Answer Label': "FOLFOX (5-FU, folinic acid, oxaliplatin) (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_6', 'answers': [{'Answer Code': '6', 'Answer Label': "FOLFIRI (5-FU, folinic acid, irinotecan) (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_7', 'answers': [{'Answer Code': '7', 'Answer Label': "Capecitabine (Xeloda®) / 5-FU mono (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_8', 'answers': [{'Answer Code': '8', 'Answer Label': "Pemigatinib (Pemazyre®)  (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_11', 'answers': [{'Answer Code': '11', 'Answer Label': "Futibatinib (Lytgobi ®) (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_15', 'answers': [{'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda®) monotherapy ^isUK()?"(MSI-H patients)":""^ (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum(\'B1bx2_2\')^)'}]}, {'Variable ID': 'C5bx2_12', 'answers': [{'Answer Code': '12', 'Answer Label': "Investigational drug (clinical trial) (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}, {'Variable ID': 'C5bx2_98', 'answers': [{'Answer Code': '98', 'Answer Label': "Any other approach (please specify)  (C5bx2 - Number of mFGFR2 iCCA patients currently receiving each treatment in 3rd line+ : ^GetNum('B1bx2_2')^)"}]}]}

---

Question ID:
C8x1

details_normalized:
{'Question ID': 'C8x1', 'Question Label': 'C8x1 - Patients with an IDH1 mutation ', 'question_type': 'Single', 'entry_conditions': ['MaskScaleC8().size() > 0'], 'conditions': [], 'Variable ID': 'C8x1', 'answers': [{'Answer Code': '1', 'Answer Label': 'The availability of gemcitabine + cisplatin + durvalumab (Imfinzi®) means that I will initiate targeted therapy later than I used to'}, {'Answer Code': '2', 'Answer Label': 'The availability of gemcitabine + cisplatin + durvalumab (Imfinzi®) means that I will initiate targeted therapy earlier than I used to'}, {'Answer Code': '3', 'Answer Label': 'The availability of gemcitabine + cisplatin + durvalumab (Imfinzi®) has no impact on when I would initiate targeted therapy'}], 'question_attributes': {'AutoCheckOther': 'true', 'ColumnMask': "GetNum('B1bx1_1') > 0 || GetNum('B1bx2_1') > 0 || GetNum('B1bx3_1') > 0", 'EntityId': '6339'}}

---

Question ID:
C8x2

details_normalized:
{'Question ID': 'C8x2', 'Question Label': 'C8x2 - Patients with an FGFR2 mutation/alteration', 'question_type': 'Single', 'entry_conditions': ['MaskScaleC8().size() > 0'], 'conditions': [], 'Variable ID': 'C8x2', 'answers': [{'Answer Code': '1', 'Answer Label': 'The availability of gemcitabine + cisplatin + durvalumab (Imfinzi®) means that I will initiate targeted therapy later than I used to'}, {'Answer Code': '2', 'Answer Label': 'The availability of gemcitabine + cisplatin + durvalumab (Imfinzi®) means that I will initiate targeted therapy earlier than I used to'}, {'Answer Code': '3', 'Answer Label': 'The availability of gemcitabine + cisplatin + durvalumab (Imfinzi®) has no impact on when I would initiate targeted therapy'}], 'question_attributes': {'AutoCheckOther': 'true', 'ColumnMask': "GetNum('B1bx1_2') > 0 || GetNum('B1bx2_2') > 0 || GetNum('B1bx3_2') > 0", 'EntityId': '6340'}}

---

Question ID:
C10a

details_normalized:
{'Question ID': 'C10a', 'question_type': 'Single', 'entry_conditions': [], 'conditions': [], 'Question Label': 'C10a - Currently, what is your preferred 2nd line treatment option for relapse/refractory nonresectable/metastatic patients with intrahepatic tumours (iCCA) patients harbouring an IDH1 mutation, regardless of possible access constraints?', 'question_attributes': {'Randomize': 'true', 'PrecodeMask': "isUK()?a('C10a').diff(set('6')):a('C10a')", 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6298'}, 'sub_questions': [{'Variable ID': 'C10a', 'answers': [{'Answer Code': '10', 'Answer Label': 'Ivosidenib (Tibsovo®)'}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '1', 'Answer Label': 'Gemcitabine +/- platinium agent'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda®) or 5-FU monotherapy'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda®) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '98', 'Answer Label': 'Other (please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'C10a_98_other', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
C11a

details_normalized:
{'Question ID': 'C11a', 'question_type': 'Single', 'entry_conditions': [], 'conditions': [], 'Question Label': 'C11a - Currently, what is your preferred 2nd line treatment option for relapse/refractory nonresectable/metastatic patients with intrahepatic tumours (iCCA) patients harbouring an FGFR2 mutation/alteration, regardless of possible access constraints?', 'question_attributes': {'Randomize': 'true', 'PrecodeMask': "MaskC11a() //isBR()?a('C11a').diff(set('8','11')):a('C11a')", 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6296'}, 'sub_questions': [{'Variable ID': 'C11a', 'answers': [{'Answer Code': '8', 'Answer Label': 'Pemigatinib (Pemazyre®) '}, {'Answer Code': '11', 'Answer Label': 'Futibatinib (Lytgobi®) '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '1', 'Answer Label': 'Gemcitabine +/- platinium agent'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda®) or 5-FU monotherapy'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda®) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '98', 'Answer Label': 'Other (please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'C11a_98_other', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
B15

details_normalized:
{'Question ID': 'B15', 'Question Label': 'B15 - Now thinking of all your diagnosed CCA patients, which proportion of them have experienced initial misdiagnosis and/or long diagnostic delay? ', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'B15_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'B15_1 (B15 - Now thinking of all your diagnosed CCA patients, which proportion of them have experienced initial misdiagnosis and/or long diagnostic delay? )'}], 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'InputSuffix': '%', 'EntityId': '6286', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '100', 'Precision': '3'}}

---

Question ID:
hidVersion

details_normalized:
{'Question ID': 'hidVersion', 'Question Label': 'Version - SELECTS BLOCK -- HIDDEN IN LIVE SURVEY', 'question_type': 'Single', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'hidVersion', 'answers': [{'Answer Code': '1', 'Answer Label': 'BLOCK 1'}, {'Answer Code': '2', 'Answer Label': 'BLOCK 2'}, {'Answer Code': '3', 'Answer Label': 'BLOCK 3'}, {'Answer Code': '4', 'Answer Label': 'BLOCK 4'}, {'Answer Code': '5', 'Answer Label': 'BLOCK 5'}, {'Answer Code': '6', 'Answer Label': 'BLOCK 6'}, {'Answer Code': '7', 'Answer Label': 'BLOCK 7'}, {'Answer Code': '8', 'Answer Label': 'BLOCK 8'}, {'Answer Code': '9', 'Answer Label': 'BLOCK 9'}, {'Answer Code': '10', 'Answer Label': 'BLOCK 10'}], 'question_attributes': {'VariableType': 'Hidden', 'AutoCheckOther': 'true', 'NotPerformDataCleaningOnMasking': 'true', 'ExcludeTranslation': 'true', 'EntityId': '6222'}}

---

Question ID:
hidordLoop

details_normalized:
{'Question ID': 'hidordLoop', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Question Label': 'hidordLoop', 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'EntityId': '6223', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual'}, 'sub_questions': [{'Variable ID': 'hidordLoop_1', 'answers': [{'Answer Code': '1', 'Answer Label': 1}]}, {'Variable ID': 'hidordLoop_2', 'answers': [{'Answer Code': '2', 'Answer Label': 2}]}, {'Variable ID': 'hidordLoop_3', 'answers': [{'Answer Code': '3', 'Answer Label': 3}]}, {'Variable ID': 'hidordLoop_4', 'answers': [{'Answer Code': '4', 'Answer Label': 4}]}, {'Variable ID': 'hidordLoop_5', 'answers': [{'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hidordLoop_6', 'answers': [{'Answer Code': '6', 'Answer Label': 6}]}, {'Variable ID': 'hidordLoop_7', 'answers': [{'Answer Code': '7', 'Answer Label': 7}]}, {'Variable ID': 'hidordLoop_8', 'answers': [{'Answer Code': '8', 'Answer Label': 8}]}]}

---

Question ID:
hVersion

details_normalized:
{'Question ID': 'hVersion', 'Question Label': 'Version - SELECTS BLOCK -- HIDDEN IN LIVE SURVEY', 'question_type': 'Single', 'entry_conditions': ['isTest()'], 'conditions': [], 'Variable ID': 'hVersion', 'answers': [{'Answer Code': '1', 'Answer Label': 'BLOCK 1'}, {'Answer Code': '2', 'Answer Label': 'BLOCK 2'}, {'Answer Code': '3', 'Answer Label': 'BLOCK 3'}, {'Answer Code': '4', 'Answer Label': 'BLOCK 4'}, {'Answer Code': '5', 'Answer Label': 'BLOCK 5'}, {'Answer Code': '6', 'Answer Label': 'BLOCK 6'}, {'Answer Code': '7', 'Answer Label': 'BLOCK 7'}, {'Answer Code': '8', 'Answer Label': 'BLOCK 8'}, {'Answer Code': '9', 'Answer Label': 'BLOCK 9'}, {'Answer Code': '10', 'Answer Label': 'BLOCK 10'}], 'question_attributes': {'VariableType': 'Hidden', 'AutoCheckOther': 'true', 'NotPerformDataCleaningOnMasking': 'true', 'ExcludeTranslation': 'true', 'EntityId': '6225'}}

---

Question ID:
hidC1st

details_normalized:
{'Question ID': 'hidC1st', 'question_type': 'Grid', 'entry_conditions': [], 'conditions': [], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Carousel': 'false', 'Dropdown': 'true', 'Disabled': 'true', 'EntityId': '6230'}, 'sub_questions': [{'Variable ID': 'hidC1st_1_1', 'Question Label': '1 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_2_1', 'Question Label': '2 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_3_1', 'Question Label': '3 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_4_1', 'Question Label': '4 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_5_1', 'Question Label': '5 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_1_2', 'Question Label': '1 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_2_2', 'Question Label': '2 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_3_2', 'Question Label': '3 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_4_2', 'Question Label': '4 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_5_2', 'Question Label': '5 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_1_3', 'Question Label': '1 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_2_3', 'Question Label': '2 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_3_3', 'Question Label': '3 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_4_3', 'Question Label': '4 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_5_3', 'Question Label': '5 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_1_4', 'Question Label': '1 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_2_4', 'Question Label': '2 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_3_4', 'Question Label': '3 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_4_4', 'Question Label': '4 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_5_4', 'Question Label': '5 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_1_5', 'Question Label': '1 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_2_5', 'Question Label': '2 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_3_5', 'Question Label': '3 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_4_5', 'Question Label': '4 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'hidC1st_5_5', 'Question Label': '5 (hidC1st - HIDDEN QUESTION ITEMS FROM DESIGN  select { width: 350px; max-width: 350px !important; })', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Long duration of response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Quick time to response', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the trea

---

Question ID:
hBeginTime

details_normalized:
{'Question ID': 'hBeginTime', 'question_type': 'Open', 'entry_conditions': [], 'conditions': [], 'Question Label': 'hBeginTime', 'question_attributes': {'NotRequired': 'true', 'VariableType': 'Hidden', 'FieldWidth': '50', 'Disabled': 'true', 'ExcludeTranslation': 'true', 'Rows': '1', 'EntityId': '6231'}, 'sub_questions': [{'Variable ID': 'hBeginTime_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'hBeginTime_2', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'hBeginTime_3', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'hBeginTime_4', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'hBeginTime_5', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'hBeginTime_6', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'hBeginTime_7', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'hBeginTime_8', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}]}

---

Question ID:
hLeast

details_normalized:
{'Question ID': 'hLeast', 'question_type': 'Single', 'entry_conditions': [], 'conditions': [], 'Question Label': 'hLeast - LEAST Important', 'question_attributes': {'AutoCheckOther': 'true', 'ValidationCode': 'if (f("hMost").toBoolean() && f("hMost").get() == f("hLeast").get())\n    errorMsg(\'D1\'); // Please do not select same Attribute for most and least compelling.\n\nf("D1MostCode")[f("loopDesign")].set(f(\'hidC1st\')[f("hMost")]);\nf("D1LeastCode")[f("loopDesign")].set(f(\'hidC1st\')[f("hLeast")]);', 'EntityId': '6232'}, 'sub_questions': [{'Variable ID': 'hLeast_1', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hLeast_2', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hLeast_3', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hLeast_4', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hLeast_5', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hLeast_6', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hLeast_7', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hLeast_8', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}]}

---

Question ID:
hMost

details_normalized:
{'Question ID': 'hMost', 'question_type': 'Single', 'entry_conditions': [], 'conditions': [], 'Question Label': 'hMost - MOST Important', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6234'}, 'sub_questions': [{'Variable ID': 'hMost_1', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hMost_2', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hMost_3', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hMost_4', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hMost_5', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hMost_6', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hMost_7', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}, {'Variable ID': 'hMost_8', 'answers': [{'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}]}]}

---

Question ID:
hEndTime

details_normalized:
{'Question ID': 'hEndTime', 'question_type': 'Open', 'entry_conditions': [], 'conditions': [], 'Question Label': 'hEndTime', 'question_attributes': {'NotRequired': 'true', 'VariableType': 'Hidden', 'FieldWidth': '50', 'Disabled': 'true', 'ExcludeTranslation': 'true', 'EntityId': '6237'}, 'sub_questions': [{'Variable ID': 'hEndTime_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'hEndTime_2', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'hEndTime_3', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'hEndTime_4', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'hEndTime_5', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'hEndTime_6', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'hEndTime_7', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'hEndTime_8', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}]}

---

Question ID:
hidElapsedTime

details_normalized:
{'Question ID': 'hidElapsedTime', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'Question Label': 'hidElapsedTime', 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6238', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'Precision': '4'}, 'sub_questions': [{'Variable ID': 'hidElapsedTime_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}, {'Variable ID': 'hidElapsedTime_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}, {'Variable ID': 'hidElapsedTime_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}, {'Variable ID': 'hidElapsedTime_1_4', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}, {'Variable ID': 'hidElapsedTime_1_5', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}, {'Variable ID': 'hidElapsedTime_1_6', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}, {'Variable ID': 'hidElapsedTime_1_7', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}, {'Variable ID': 'hidElapsedTime_1_8', 'answers': [{'Answer Code': '1', 'Answer Label': 'hidElapsedTime_1'}]}]}

---

Question ID:
D1MostCode

details_normalized:
{'Question ID': 'D1MostCode', 'question_type': 'Grid', 'entry_conditions': ['isTest()'], 'conditions': [], 'question_attributes': {'NotRequired': 'true', 'VariableType': 'Hidden', 'QuestionLayoutName': 'Grid question', 'Carousel': 'false', 'FieldWidth': '2', 'ExcludeTranslation': 'true', 'EntityId': '6242'}, 'sub_questions': [{'Variable ID': 'D1MostCode_1', 'Question Label': '1 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1MostCode_2', 'Question Label': '2 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1MostCode_3', 'Question Label': '3 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1MostCode_4', 'Question Label': '4 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1MostCode_5', 'Question Label': '5 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1MostCode_6', 'Question Label': '6 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1MostCode_7', 'Question Label': '7 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1MostCode_8', 'Question Label': '8 (D1MostCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}]}

---

Question ID:
D1LeastCode

details_normalized:
{'Question ID': 'D1LeastCode', 'question_type': 'Grid', 'entry_conditions': ['isTest()'], 'conditions': [], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Carousel': 'false', 'FieldWidth': '2', 'ExcludeTranslation': 'true', 'EntityId': '6243'}, 'sub_questions': [{'Variable ID': 'D1LeastCode_1', 'Question Label': '1 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1LeastCode_2', 'Question Label': '2 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1LeastCode_3', 'Question Label': '3 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1LeastCode_4', 'Question Label': '4 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1LeastCode_5', 'Question Label': '5 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1LeastCode_6', 'Question Label': '6 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1LeastCode_7', 'Question Label': '7 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}, {'Variable ID': 'D1LeastCode_8', 'Question Label': '8 (D1LeastCode)', 'answers': [{'Answer Code': '1', 'Answer Label': 'High ORR (overall response rate)'}, {'Answer Code': '2', 'Answer Label': 'Long duration of response'}, {'Answer Code': '3', 'Answer Label': 'High rate of stable disease'}, {'Answer Code': '4', 'Answer Label': 'Quick time to response'}, {'Answer Code': '5', 'Answer Label': 'Ability to administer orally'}, {'Answer Code': '6', 'Answer Label': 'Low rate of grade 3-4 adverse events'}, {'Answer Code': '7', 'Answer Label': 'Patients have good quality of life on the treatment'}, {'Answer Code': '8', 'Answer Label': 'Prolonged overall survival (OS)'}, {'Answer Code': '9', 'Answer Label': 'Prolonged median progression-free survival (PFS)'}, {'Answer Code': '10', 'Answer Label': 'Manageable QTc prolongation'}, {'Answer Code': '11', 'Answer Label': 'Manageable myelosuppression'}, {'Answer Code': '12', 'Answer Label': 'Well-characterized safety profile'}, {'Answer Code': '13', 'Answer Label': 'Easy to prescribe'}]}]}

---

Question ID:
hidPosXMost

details_normalized:
{'Question ID': 'hidPosXMost', 'question_type': 'Multi', 'entry_conditions': ['isTest()'], 'conditions': [], 'Question Label': 'hidPosXMost - Hidden - Count number of times a position is selected for Most column.', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'EntityId': '6244', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual'}, 'sub_questions': [{'Variable ID': 'hidPosXMost_1', 'answers': [{'Answer Code': '1', 'Answer Label': '1 (hidPosXMost - Hidden - Count number of times a position is selected for Most column.)'}]}, {'Variable ID': 'hidPosXMost_2', 'answers': [{'Answer Code': '2', 'Answer Label': '2 (hidPosXMost - Hidden - Count number of times a position is selected for Most column.)'}]}, {'Variable ID': 'hidPosXMost_3', 'answers': [{'Answer Code': '3', 'Answer Label': '3 (hidPosXMost - Hidden - Count number of times a position is selected for Most column.)'}]}, {'Variable ID': 'hidPosXMost_4', 'answers': [{'Answer Code': '4', 'Answer Label': '4 (hidPosXMost - Hidden - Count number of times a position is selected for Most column.)'}]}, {'Variable ID': 'hidPosXMost_5', 'answers': [{'Answer Code': '5', 'Answer Label': '5 (hidPosXMost - Hidden - Count number of times a position is selected for Most column.)'}]}]}

---

Question ID:
hidPosXLeast

details_normalized:
{'Question ID': 'hidPosXLeast', 'question_type': 'Multi', 'entry_conditions': ['isTest()'], 'conditions': [], 'Question Label': 'hidPosXLeast - Hidden - Count number of times a position is selected for Least column.', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'EntityId': '6245', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual'}, 'sub_questions': [{'Variable ID': 'hidPosXLeast_1', 'answers': [{'Answer Code': '1', 'Answer Label': '1 (hidPosXLeast - Hidden - Count number of times a position is selected for Least column.)'}]}, {'Variable ID': 'hidPosXLeast_2', 'answers': [{'Answer Code': '2', 'Answer Label': '2 (hidPosXLeast - Hidden - Count number of times a position is selected for Least column.)'}]}, {'Variable ID': 'hidPosXLeast_3', 'answers': [{'Answer Code': '3', 'Answer Label': '3 (hidPosXLeast - Hidden - Count number of times a position is selected for Least column.)'}]}, {'Variable ID': 'hidPosXLeast_4', 'answers': [{'Answer Code': '4', 'Answer Label': '4 (hidPosXLeast - Hidden - Count number of times a position is selected for Least column.)'}]}, {'Variable ID': 'hidPosXLeast_5', 'answers': [{'Answer Code': '5', 'Answer Label': '5 (hidPosXLeast - Hidden - Count number of times a position is selected for Least column.)'}]}]}

---

Question ID:
D2

details_normalized:
{'Question ID': 'D2', 'question_type': 'Grid', 'entry_conditions': [], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'PrecodeMask': 'MaskD2()', 'AnswerlistOrder': 'Randomize', 'Carousel': 'false', 'EntityId': '6184'}, 'sub_questions': [{'Variable ID': 'D2_1', 'Question Label': "Ivosidenib (Tibsovo®) (D2 - On a scale of 0 to 10 where 0 means 'Extremely unlikely' and 10 means 'Extremely likely', how likely would you be to recommend the following product(s) / regimens for the treatment of eligible 2nd line + nonresectable/metastatic CCA patients to other physicians?   )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Extremely unlikely0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Extremely likely10'}]}, {'Variable ID': 'D2_2', 'Question Label': "Pemigatinib (Pemazyre®) (D2 - On a scale of 0 to 10 where 0 means 'Extremely unlikely' and 10 means 'Extremely likely', how likely would you be to recommend the following product(s) / regimens for the treatment of eligible 2nd line + nonresectable/metastatic CCA patients to other physicians?   )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Extremely unlikely0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Extremely likely10'}]}, {'Variable ID': 'D2_3', 'Question Label': "Futibatnib (Lytgobi®)  (D2 - On a scale of 0 to 10 where 0 means 'Extremely unlikely' and 10 means 'Extremely likely', how likely would you be to recommend the following product(s) / regimens for the treatment of eligible 2nd line + nonresectable/metastatic CCA patients to other physicians?   )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Extremely unlikely0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Extremely likely10'}]}, {'Variable ID': 'D2_4', 'Question Label': "FOLFOX (5-FU, folinic acid, oxaliplatin) (D2 - On a scale of 0 to 10 where 0 means 'Extremely unlikely' and 10 means 'Extremely likely', how likely would you be to recommend the following product(s) / regimens for the treatment of eligible 2nd line + nonresectable/metastatic CCA patients to other physicians?   )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Extremely unlikely0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Extremely likely10'}]}]}

---

Question ID:
HD2

details_normalized:
{'Question ID': 'HD2', 'question_type': 'Grid', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Carousel': 'false', 'Disabled': 'true', 'EntityId': '6213'}, 'sub_questions': [{'Variable ID': 'HD2_1', 'Question Label': 'Ivosidenib (Tibsovo®) (HD2 - Recode NPS score for each treatment)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Promoters'}, {'Answer Code': '2', 'Answer Label': 'Passives'}, {'Answer Code': '3', 'Answer Label': 'Detractors'}]}, {'Variable ID': 'HD2_2', 'Question Label': 'Pemigatinib (Pemazyre®) (HD2 - Recode NPS score for each treatment)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Promoters'}, {'Answer Code': '2', 'Answer Label': 'Passives'}, {'Answer Code': '3', 'Answer Label': 'Detractors'}]}, {'Variable ID': 'HD2_3', 'Question Label': 'Futibatnib (Lytgobi®)  (HD2 - Recode NPS score for each treatment)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Promoters'}, {'Answer Code': '2', 'Answer Label': 'Passives'}, {'Answer Code': '3', 'Answer Label': 'Detractors'}]}, {'Variable ID': 'HD2_4', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (HD2 - Recode NPS score for each treatment)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Promoters'}, {'Answer Code': '2', 'Answer Label': 'Passives'}, {'Answer Code': '3', 'Answer Label': 'Detractors'}]}]}

---

Question ID:
D3

details_normalized:
{'Question ID': 'D3', 'question_type': 'Grid', 'entry_conditions': [], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'PrecodeMask': 'MaskD3()', 'AnswerlistOrder': 'Randomize', 'Carousel': 'false', 'EntityId': '6190'}, 'sub_questions': [{'Variable ID': 'D3_1', 'Question Label': "Ivosidenib (Tibsovo®) (D3 - Using a scale from 0-10 where 0 means 'Completely dissatisfied' and 10 means 'Completely satisfied', please rate your level of satisfaction with the following products for the treatment of eligible 2nd line + nonresectable/metastatic mutated CCA patients )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Completely dissatisfied0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Completely satisfied10'}]}, {'Variable ID': 'D3_2', 'Question Label': "Pemigatinib (Pemazyre®) (D3 - Using a scale from 0-10 where 0 means 'Completely dissatisfied' and 10 means 'Completely satisfied', please rate your level of satisfaction with the following products for the treatment of eligible 2nd line + nonresectable/metastatic mutated CCA patients )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Completely dissatisfied0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Completely satisfied10'}]}, {'Variable ID': 'D3_3', 'Question Label': "Futibatnib (Lytgobi®)  (D3 - Using a scale from 0-10 where 0 means 'Completely dissatisfied' and 10 means 'Completely satisfied', please rate your level of satisfaction with the following products for the treatment of eligible 2nd line + nonresectable/metastatic mutated CCA patients )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Completely dissatisfied0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Completely satisfied10'}]}, {'Variable ID': 'D3_4', 'Question Label': "FOLFOX (5-FU, folinic acid, oxaliplatin) (D3 - Using a scale from 0-10 where 0 means 'Completely dissatisfied' and 10 means 'Completely satisfied', please rate your level of satisfaction with the following products for the treatment of eligible 2nd line + nonresectable/metastatic mutated CCA patients )", 'answers': [{'Answer Code': '0', 'Answer Label': 'Completely dissatisfied0'}, {'Answer Code': '1', 'Answer Label': 1}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 7}, {'Answer Code': '8', 'Answer Label': 8}, {'Answer Code': '9', 'Answer Label': 9}, {'Answer Code': '10', 'Answer Label': 'Completely satisfied10'}]}]}

---

Question ID:
D5

details_normalized:
{'Question ID': 'D5', 'question_type': 'Grid', 'entry_conditions': [], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'PrecodeMask': 'MaskD5()', 'AnswerlistOrder': 'Randomize', 'Carousel': 'false', 'EntityId': '6201'}, 'sub_questions': [{'Variable ID': 'D5_1_1', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High ORR (overall response rate)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_1', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High ORR (overall response rate)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_1', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High ORR (overall response rate)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_1', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High ORR (overall response rate)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_2', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Long duration of response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_2', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Long duration of response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_2', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Long duration of response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_2', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Long duration of response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_4', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High rate of stable disease   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_4', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High rate of stable disease   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_4', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High rate of stable disease   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_4', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  High rate of stable disease   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_5', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Quick time to response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_5', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Quick time to response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_5', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Quick time to response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_5', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Quick time to response   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_6', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Ability to administer orally   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_6', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Ability to administer orally   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_6', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Ability to administer orally   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_6', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Ability to administer orally   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_7', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Low rate of grade 3-4 adverse events   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_7', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Low rate of grade 3-4 adverse events   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_7', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Low rate of grade 3-4 adverse events   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_7', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Low rate of grade 3-4 adverse events   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_8', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Patients have good quality of life on the treatment   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_8', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Patients have good quality of life on the treatment   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_8', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Patients have good quality of life on the treatment   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_8', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Patients have good quality of life on the treatment   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_9', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged overall survival (OS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_9', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged overall survival (OS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_9', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged overall survival (OS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_9', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged overall survival (OS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_10', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged median progression-free survival (PFS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_10', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged median progression-free survival (PFS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_10', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged median progression-free survival (PFS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_10', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Prolonged median progression-free survival (PFS)   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_1_11', 'Question Label': 'Ivosidenib (Tibsovo®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Manageable QTc prolongation   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_2_11', 'Question Label': 'Pemigatinib (Pemazyre®) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Manageable QTc prolongation   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_3_11', 'Question Label': 'Futibatnib (Lytgobi®)  (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Manageable QTc prolongation   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer Code': '2', 'Answer Label': 2}, {'Answer Code': '3', 'Answer Label': 3}, {'Answer Code': '4', 'Answer Label': 4}, {'Answer Code': '5', 'Answer Label': 5}, {'Answer Code': '6', 'Answer Label': 6}, {'Answer Code': '7', 'Answer Label': 'Excellent performance7'}]}, {'Variable ID': 'D5_4_11', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (D5 - How would you rate each of the following regimens’ performance on each attribute for use in eligible 2nd line + nonresectable/metastatic mutated CCA patients, using a 1-7 scale where 1 = poor performance and 7 = excellent performance.  Manageable QTc prolongation   )', 'answers': [{'Answer Code': '99', 'Answer Label': 'Unaware of data for this product', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '1', 'Answer Label': 'Poor performance 1'}, {'Answer 

---

Question ID:
hP0a

details_normalized:
{'Question ID': 'hP0a', 'question_type': 'Multi', 'entry_conditions': ["(/*f('qSurveyType').any('3') && */ Sum(f('HidPRF').values()) > 0)"], 'conditions': [], 'Question Label': 'hP0a - Reminder: number of IDH1m iCCA patients currently under your care', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6103', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '9999', 'Precision': '4'}, 'sub_questions': [{'Variable ID': 'hP0a_1', 'answers': [{'Answer Code': '1', 'Answer Label': '2L (hP0a - Reminder: number of IDH1m iCCA patients currently under your care)'}]}, {'Variable ID': 'hP0a_2', 'answers': [{'Answer Code': '2', 'Answer Label': '3L+ (hP0a - Reminder: number of IDH1m iCCA patients currently under your care)'}]}, {'Variable ID': 'hP0a_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'BSC or not treated (hP0a - Reminder: number of IDH1m iCCA patients currently under your care)'}]}]}

---

Question ID:
P0a

details_normalized:
{'Question ID': 'P0a', 'question_type': 'Multi', 'entry_conditions': ["(/*f('qSurveyType').any('3') && */ Sum(f('HidPRF').values()) > 0)"], 'conditions': [], 'Question Label': 'P0a - Out of those, how many were initiated with a 2L treatment in the past 12 months?', 'question_attributes': {'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6104', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CompareNumQues('P0a','<=','HidPRF','P0a');", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '9999', 'Precision': '4'}, 'sub_questions': [{'Variable ID': 'P0a_1', 'answers': [{'Answer Code': '1', 'Answer Label': '2L (P0a - Out of those, how many were initiated with a 2L treatment in the past 12 months? )'}]}, {'Variable ID': 'P0a_2', 'answers': [{'Answer Code': '2', 'Answer Label': '3L+ (P0a - Out of those, how many were initiated with a 2L treatment in the past 12 months? )'}]}, {'Variable ID': 'P0a_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'BSC or not treated (P0a - Out of those, how many were initiated with a 2L treatment in the past 12 months? )'}]}]}

---

Question ID:
HP0

details_normalized:
{'Question ID': 'HP0', 'Question Label': 'HP0 - Recode for PRF...', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'HP0', 'answers': [{'Answer Code': '1', 'Answer Label': '0 PRF '}, {'Answer Code': '2', 'Answer Label': '1 PRF '}, {'Answer Code': '3', 'Answer Label': '2 PRFs '}, {'Answer Code': '4', 'Answer Label': '3 PRFs '}], 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '6126'}}

---

Question ID:
hPTs

details_normalized:
{'Question ID': 'hPTs', 'Question Label': 'hPTs - TOTAL PRFs', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Variable ID': 'hPTs', 'answers': [{'Answer Code': '1', 'Answer Label': '1 PRF '}, {'Answer Code': '2', 'Answer Label': '2 PRFs '}, {'Answer Code': '3', 'Answer Label': '3 PRFs '}], 'question_attributes': {'VariableType': 'Hidden', 'AutoCheckOther': 'true', 'EntityId': '6347'}}

---

Question ID:
QBeginTimeLoop

details_normalized:
{'Question ID': 'QBeginTimeLoop', 'question_type': 'Open', 'entry_conditions': ['isTest()'], 'conditions': [], 'Question Label': 'QBeginTimeLoop', 'question_attributes': {'NotRequired': 'true', 'VariableType': 'Hidden', 'FieldWidth': '50', 'Disabled': 'true', 'ExcludeTranslation': 'true', 'Rows': '1', 'EntityId': '6084'}, 'sub_questions': [{'Variable ID': 'QBeginTimeLoop_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'QBeginTimeLoop_2', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'QBeginTimeLoop_3', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}]}

---

Question ID:
Loop_ID

details_normalized:
{'Question ID': 'Loop_ID', 'question_type': 'Open', 'entry_conditions': ['isTest()'], 'conditions': [], 'Question Label': 'Loop_ID - Loop ID', 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'FieldWidth': '15', 'Disabled': 'true', 'Rows': '1', 'EntityId': '6085'}, 'sub_questions': [{'Variable ID': 'Loop_ID_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'Loop_ID_2', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'Loop_ID_3', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}]}

---

Question ID:
P1a

details_normalized:
{'Question ID': 'P1a', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P1a - Patients’ current treatment status', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6144'}, 'sub_questions': [{'Variable ID': 'P1a_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Currently treated with anti-tumour treatment in 2L'}, {'Answer Code': '4', 'Answer Label': 'Currently treated with anti-tumour treatment in 3L'}, {'Answer Code': '2', 'Answer Label': 'Currently receiving best supportive care only, with no further anti-tumour treatment'}, {'Answer Code': '3', 'Answer Label': 'Not currently treated / lost sight of patient'}]}, {'Variable ID': 'P1a_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Currently treated with anti-tumour treatment in 2L'}, {'Answer Code': '4', 'Answer Label': 'Currently treated with anti-tumour treatment in 3L'}, {'Answer Code': '2', 'Answer Label': 'Currently receiving best supportive care only, with no further anti-tumour treatment'}, {'Answer Code': '3', 'Answer Label': 'Not currently treated / lost sight of patient'}]}, {'Variable ID': 'P1a_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Currently treated with anti-tumour treatment in 2L'}, {'Answer Code': '4', 'Answer Label': 'Currently treated with anti-tumour treatment in 3L'}, {'Answer Code': '2', 'Answer Label': 'Currently receiving best supportive care only, with no further anti-tumour treatment'}, {'Answer Code': '3', 'Answer Label': 'Not currently treated / lost sight of patient'}]}]}

---

Question ID:
P1a1

details_normalized:
{'Question ID': 'P1a1', 'question_type': 'Single', 'entry_conditions': ["f('P1a').any('2','3')"], 'conditions': [], 'Question Label': 'P1a1 - Patients’ most recent line of anti-tumour drug treatment', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6145'}, 'sub_questions': [{'Variable ID': 'P1a1_1', 'answers': [{'Answer Code': '1', 'Answer Label': '2L'}, {'Answer Code': '2', 'Answer Label': '3L+'}]}, {'Variable ID': 'P1a1_2', 'answers': [{'Answer Code': '1', 'Answer Label': '2L'}, {'Answer Code': '2', 'Answer Label': '3L+'}]}, {'Variable ID': 'P1a1_3', 'answers': [{'Answer Code': '1', 'Answer Label': '2L'}, {'Answer Code': '2', 'Answer Label': '3L+'}]}]}

---

Question ID:
P1b

details_normalized:
{'Question ID': 'P1b', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P1b - Was CCA treatment prescribed as part of an early access programme or clinical trial ?', 'question_attributes': {'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6154'}, 'sub_questions': [{'Variable ID': 'P1b_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Early Access Programme'}, {'Answer Code': '2', 'Answer Label': 'Clinical trial'}, {'Answer Code': '5', 'Answer Label': 'Neither', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}, {'Answer Code': '4', 'Answer Label': 'Other (Please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P1b_4_other_1', 'answers': [{'Answer Code': '4', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P1b_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Early Access Programme'}, {'Answer Code': '2', 'Answer Label': 'Clinical trial'}, {'Answer Code': '5', 'Answer Label': 'Neither', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}, {'Answer Code': '4', 'Answer Label': 'Other (Please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P1b_4_other_2', 'answers': [{'Answer Code': '4', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P1b_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Early Access Programme'}, {'Answer Code': '2', 'Answer Label': 'Clinical trial'}, {'Answer Code': '5', 'Answer Label': 'Neither', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}, {'Answer Code': '4', 'Answer Label': 'Other (Please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P1b_4_other_3', 'answers': [{'Answer Code': '4', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
P1

details_normalized:
{'Question ID': 'P1', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P1 - Patient age', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6164'}, 'sub_questions': [{'Variable ID': 'P1_1', 'answers': [{'Answer Code': '1', 'Answer Label': '18 – 50 years old'}, {'Answer Code': '2', 'Answer Label': '51 - 64 years old '}, {'Answer Code': '3', 'Answer Label': '65 - 74 years old'}, {'Answer Code': '4', 'Answer Label': '75 years old or more '}]}, {'Variable ID': 'P1_2', 'answers': [{'Answer Code': '1', 'Answer Label': '18 – 50 years old'}, {'Answer Code': '2', 'Answer Label': '51 - 64 years old '}, {'Answer Code': '3', 'Answer Label': '65 - 74 years old'}, {'Answer Code': '4', 'Answer Label': '75 years old or more '}]}, {'Variable ID': 'P1_3', 'answers': [{'Answer Code': '1', 'Answer Label': '18 – 50 years old'}, {'Answer Code': '2', 'Answer Label': '51 - 64 years old '}, {'Answer Code': '3', 'Answer Label': '65 - 74 years old'}, {'Answer Code': '4', 'Answer Label': '75 years old or more '}]}]}

---

Question ID:
P2

details_normalized:
{'Question ID': 'P2', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P2 - Patient gender', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6165'}, 'sub_questions': [{'Variable ID': 'P2_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Male'}, {'Answer Code': '2', 'Answer Label': 'Female'}, {'Answer Code': '3', 'Answer Label': 'Non-binary '}, {'Answer Code': '4', 'Answer Label': 'Other / prefer not to say'}]}, {'Variable ID': 'P2_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Male'}, {'Answer Code': '2', 'Answer Label': 'Female'}, {'Answer Code': '3', 'Answer Label': 'Non-binary '}, {'Answer Code': '4', 'Answer Label': 'Other / prefer not to say'}]}, {'Variable ID': 'P2_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Male'}, {'Answer Code': '2', 'Answer Label': 'Female'}, {'Answer Code': '3', 'Answer Label': 'Non-binary '}, {'Answer Code': '4', 'Answer Label': 'Other / prefer not to say'}]}]}

---

Question ID:
P3

details_normalized:
{'Question ID': 'P3', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'AnswerRequiredType': 'Required', 'EntityId': '6166', 'AnswerlistOrder': 'Randomize', 'MultiItemsSelectedMinimum': '1', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();'}, 'sub_questions': [{'Variable ID': 'P3_1_1', 'Question Label': 'Diabetes (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P3_2_1', 'Question Label': 'Obesity (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P3_3_1', 'Question Label': 'Liver disease (hepatitis B, hepatitis C, cirrhosis) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P3_4_1', 'Question Label': 'Primary Sclerosis Cholangitis (PSC) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P3_5_1', 'Question Label': 'Non-Alcoholic fatty acid liver disease (NAFLD) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P3_6_1', 'Question Label': 'Chronic cardiac conditions (hypertension, chronic heart failure). (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P3_7_1', 'Question Label': 'Other abnormalities of the Biliary tract (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P3_8_1', 'Question Label': 'Hepatolithiasis, Cholelithiasis and Choledocholithiasis (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P3_9_1', 'Question Label': 'Inflammatory Bowel Disease (IBD) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P3_98_1', 'Question Label': 'Other (please specify) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_99_1', 'Question Label': 'None of the above (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_98_other_1', 'Question Label': 'P3 - What comorbidities, if any, does this patient have?', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_1_2', 'Question Label': 'Diabetes (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P3_2_2', 'Question Label': 'Obesity (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P3_3_2', 'Question Label': 'Liver disease (hepatitis B, hepatitis C, cirrhosis) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P3_4_2', 'Question Label': 'Primary Sclerosis Cholangitis (PSC) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P3_5_2', 'Question Label': 'Non-Alcoholic fatty acid liver disease (NAFLD) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P3_6_2', 'Question Label': 'Chronic cardiac conditions (hypertension, chronic heart failure). (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P3_7_2', 'Question Label': 'Other abnormalities of the Biliary tract (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P3_8_2', 'Question Label': 'Hepatolithiasis, Cholelithiasis and Choledocholithiasis (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P3_9_2', 'Question Label': 'Inflammatory Bowel Disease (IBD) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P3_98_2', 'Question Label': 'Other (please specify) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_99_2', 'Question Label': 'None of the above (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_98_other_2', 'Question Label': 'P3 - What comorbidities, if any, does this patient have?', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_1_3', 'Question Label': 'Diabetes (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P3_2_3', 'Question Label': 'Obesity (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P3_3_3', 'Question Label': 'Liver disease (hepatitis B, hepatitis C, cirrhosis) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P3_4_3', 'Question Label': 'Primary Sclerosis Cholangitis (PSC) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P3_5_3', 'Question Label': 'Non-Alcoholic fatty acid liver disease (NAFLD) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P3_6_3', 'Question Label': 'Chronic cardiac conditions (hypertension, chronic heart failure). (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P3_7_3', 'Question Label': 'Other abnormalities of the Biliary tract (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P3_8_3', 'Question Label': 'Hepatolithiasis, Cholelithiasis and Choledocholithiasis (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P3_9_3', 'Question Label': 'Inflammatory Bowel Disease (IBD) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P3_98_3', 'Question Label': 'Other (please specify) (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_99_3', 'Question Label': 'None of the above (P3 - What comorbidities, if any, does this patient have?)', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P3_98_other_3', 'Question Label': 'P3 - What comorbidities, if any, does this patient have?', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
P4

details_normalized:
{'Question ID': 'P4', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': "P4 - What was the ECOG performance status of this patient at ^f('P1a1')^ treatment initiation?", 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6167'}, 'sub_questions': [{'Variable ID': 'P4_1', 'answers': [{'Answer Code': '0', 'Answer Label': 'ECOG PS 0'}, {'Answer Code': '1', 'Answer Label': 'ECOG PS 1'}, {'Answer Code': '2', 'Answer Label': 'ECOG PS 2'}, {'Answer Code': '3', 'Answer Label': 'ECOG PS 3'}, {'Answer Code': '4', 'Answer Label': 'ECOG PS 4'}]}, {'Variable ID': 'P4_2', 'answers': [{'Answer Code': '0', 'Answer Label': 'ECOG PS 0'}, {'Answer Code': '1', 'Answer Label': 'ECOG PS 1'}, {'Answer Code': '2', 'Answer Label': 'ECOG PS 2'}, {'Answer Code': '3', 'Answer Label': 'ECOG PS 3'}, {'Answer Code': '4', 'Answer Label': 'ECOG PS 4'}]}, {'Variable ID': 'P4_3', 'answers': [{'Answer Code': '0', 'Answer Label': 'ECOG PS 0'}, {'Answer Code': '1', 'Answer Label': 'ECOG PS 1'}, {'Answer Code': '2', 'Answer Label': 'ECOG PS 2'}, {'Answer Code': '3', 'Answer Label': 'ECOG PS 3'}, {'Answer Code': '4', 'Answer Label': 'ECOG PS 4'}]}]}

---

Question ID:
P5M

details_normalized:
{'Question ID': 'P5M', 'question_type': 'Grid', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P5M_1 (P5M - Select month)', 'question_attributes': {'Carousel': 'false', 'Dropdown': 'true', 'ValidationCode': 'if (!QuestionErrors()) {\n  \n  var xP5 = new Date(f("P5Y")[\'1\'].toNumber(), f("P5M")[\'1\'].toNumber() - 1,1);\n  \n  var today = new Date();\n  \n\tif (xP5.valueOf() > today.valueOf()) {\n    errorMsg("DT1");\n  }\n\n}', 'EntityId': '6169'}, 'sub_questions': [{'Variable ID': 'P5M_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'January'}, {'Answer Code': '2', 'Answer Label': 'February'}, {'Answer Code': '3', 'Answer Label': 'March'}, {'Answer Code': '4', 'Answer Label': 'April'}, {'Answer Code': '5', 'Answer Label': 'May'}, {'Answer Code': '6', 'Answer Label': 'June'}, {'Answer Code': '7', 'Answer Label': 'July'}, {'Answer Code': '8', 'Answer Label': 'August'}, {'Answer Code': '9', 'Answer Label': 'September'}, {'Answer Code': '10', 'Answer Label': 'October'}, {'Answer Code': '11', 'Answer Label': 'November'}, {'Answer Code': '12', 'Answer Label': 'December'}]}, {'Variable ID': 'P5M_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'January'}, {'Answer Code': '2', 'Answer Label': 'February'}, {'Answer Code': '3', 'Answer Label': 'March'}, {'Answer Code': '4', 'Answer Label': 'April'}, {'Answer Code': '5', 'Answer Label': 'May'}, {'Answer Code': '6', 'Answer Label': 'June'}, {'Answer Code': '7', 'Answer Label': 'July'}, {'Answer Code': '8', 'Answer Label': 'August'}, {'Answer Code': '9', 'Answer Label': 'September'}, {'Answer Code': '10', 'Answer Label': 'October'}, {'Answer Code': '11', 'Answer Label': 'November'}, {'Answer Code': '12', 'Answer Label': 'December'}]}, {'Variable ID': 'P5M_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'January'}, {'Answer Code': '2', 'Answer Label': 'February'}, {'Answer Code': '3', 'Answer Label': 'March'}, {'Answer Code': '4', 'Answer Label': 'April'}, {'Answer Code': '5', 'Answer Label': 'May'}, {'Answer Code': '6', 'Answer Label': 'June'}, {'Answer Code': '7', 'Answer Label': 'July'}, {'Answer Code': '8', 'Answer Label': 'August'}, {'Answer Code': '9', 'Answer Label': 'September'}, {'Answer Code': '10', 'Answer Label': 'October'}, {'Answer Code': '11', 'Answer Label': 'November'}, {'Answer Code': '12', 'Answer Label': 'December'}]}]}

---

Question ID:
P5Y

details_normalized:
{'Question ID': 'P5Y', 'question_type': 'Grid', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P5Y_1 (P5Y - Select year)', 'question_attributes': {'Carousel': 'false', 'Dropdown': 'true', 'EntityId': '6170'}, 'sub_questions': [{'Variable ID': 'P5Y_1_1', 'answers': [{'Answer Code': '1990', 'Answer Label': 1990}, {'Answer Code': '1991', 'Answer Label': 1991}, {'Answer Code': '1992', 'Answer Label': 1992}, {'Answer Code': '1993', 'Answer Label': 1993}, {'Answer Code': '1994', 'Answer Label': 1994}, {'Answer Code': '1995', 'Answer Label': 1995}, {'Answer Code': '1996', 'Answer Label': 1996}, {'Answer Code': '1997', 'Answer Label': 1997}, {'Answer Code': '1998', 'Answer Label': 1998}, {'Answer Code': '1999', 'Answer Label': 1999}, {'Answer Code': '2000', 'Answer Label': 2000}, {'Answer Code': '2001', 'Answer Label': 2001}, {'Answer Code': '2002', 'Answer Label': 2002}, {'Answer Code': '2003', 'Answer Label': 2003}, {'Answer Code': '2004', 'Answer Label': 2004}, {'Answer Code': '2005', 'Answer Label': 2005}, {'Answer Code': '2006', 'Answer Label': 2006}, {'Answer Code': '2007', 'Answer Label': 2007}, {'Answer Code': '2008', 'Answer Label': 2008}, {'Answer Code': '2009', 'Answer Label': 2009}, {'Answer Code': '2010', 'Answer Label': 2010}, {'Answer Code': '2011', 'Answer Label': 2011}, {'Answer Code': '2012', 'Answer Label': 2012}, {'Answer Code': '2013', 'Answer Label': 2013}, {'Answer Code': '2014', 'Answer Label': 2014}, {'Answer Code': '2015', 'Answer Label': 2015}, {'Answer Code': '2016', 'Answer Label': 2016}, {'Answer Code': '2017', 'Answer Label': 2017}, {'Answer Code': '2018', 'Answer Label': 2018}, {'Answer Code': '2019', 'Answer Label': 2019}, {'Answer Code': '2020', 'Answer Label': 2020}, {'Answer Code': '2021', 'Answer Label': 2021}, {'Answer Code': '2022', 'Answer Label': 2022}, {'Answer Code': '2023', 'Answer Label': 2023}, {'Answer Code': '2024', 'Answer Label': 2024}, {'Answer Code': '2025', 'Answer Label': 2025}]}, {'Variable ID': 'P5Y_1_2', 'answers': [{'Answer Code': '1990', 'Answer Label': 1990}, {'Answer Code': '1991', 'Answer Label': 1991}, {'Answer Code': '1992', 'Answer Label': 1992}, {'Answer Code': '1993', 'Answer Label': 1993}, {'Answer Code': '1994', 'Answer Label': 1994}, {'Answer Code': '1995', 'Answer Label': 1995}, {'Answer Code': '1996', 'Answer Label': 1996}, {'Answer Code': '1997', 'Answer Label': 1997}, {'Answer Code': '1998', 'Answer Label': 1998}, {'Answer Code': '1999', 'Answer Label': 1999}, {'Answer Code': '2000', 'Answer Label': 2000}, {'Answer Code': '2001', 'Answer Label': 2001}, {'Answer Code': '2002', 'Answer Label': 2002}, {'Answer Code': '2003', 'Answer Label': 2003}, {'Answer Code': '2004', 'Answer Label': 2004}, {'Answer Code': '2005', 'Answer Label': 2005}, {'Answer Code': '2006', 'Answer Label': 2006}, {'Answer Code': '2007', 'Answer Label': 2007}, {'Answer Code': '2008', 'Answer Label': 2008}, {'Answer Code': '2009', 'Answer Label': 2009}, {'Answer Code': '2010', 'Answer Label': 2010}, {'Answer Code': '2011', 'Answer Label': 2011}, {'Answer Code': '2012', 'Answer Label': 2012}, {'Answer Code': '2013', 'Answer Label': 2013}, {'Answer Code': '2014', 'Answer Label': 2014}, {'Answer Code': '2015', 'Answer Label': 2015}, {'Answer Code': '2016', 'Answer Label': 2016}, {'Answer Code': '2017', 'Answer Label': 2017}, {'Answer Code': '2018', 'Answer Label': 2018}, {'Answer Code': '2019', 'Answer Label': 2019}, {'Answer Code': '2020', 'Answer Label': 2020}, {'Answer Code': '2021', 'Answer Label': 2021}, {'Answer Code': '2022', 'Answer Label': 2022}, {'Answer Code': '2023', 'Answer Label': 2023}, {'Answer Code': '2024', 'Answer Label': 2024}, {'Answer Code': '2025', 'Answer Label': 2025}]}, {'Variable ID': 'P5Y_1_3', 'answers': [{'Answer Code': '1990', 'Answer Label': 1990}, {'Answer Code': '1991', 'Answer Label': 1991}, {'Answer Code': '1992', 'Answer Label': 1992}, {'Answer Code': '1993', 'Answer Label': 1993}, {'Answer Code': '1994', 'Answer Label': 1994}, {'Answer Code': '1995', 'Answer Label': 1995}, {'Answer Code': '1996', 'Answer Label': 1996}, {'Answer Code': '1997', 'Answer Label': 1997}, {'Answer Code': '1998', 'Answer Label': 1998}, {'Answer Code': '1999', 'Answer Label': 1999}, {'Answer Code': '2000', 'Answer Label': 2000}, {'Answer Code': '2001', 'Answer Label': 2001}, {'Answer Code': '2002', 'Answer Label': 2002}, {'Answer Code': '2003', 'Answer Label': 2003}, {'Answer Code': '2004', 'Answer Label': 2004}, {'Answer Code': '2005', 'Answer Label': 2005}, {'Answer Code': '2006', 'Answer Label': 2006}, {'Answer Code': '2007', 'Answer Label': 2007}, {'Answer Code': '2008', 'Answer Label': 2008}, {'Answer Code': '2009', 'Answer Label': 2009}, {'Answer Code': '2010', 'Answer Label': 2010}, {'Answer Code': '2011', 'Answer Label': 2011}, {'Answer Code': '2012', 'Answer Label': 2012}, {'Answer Code': '2013', 'Answer Label': 2013}, {'Answer Code': '2014', 'Answer Label': 2014}, {'Answer Code': '2015', 'Answer Label': 2015}, {'Answer Code': '2016', 'Answer Label': 2016}, {'Answer Code': '2017', 'Answer Label': 2017}, {'Answer Code': '2018', 'Answer Label': 2018}, {'Answer Code': '2019', 'Answer Label': 2019}, {'Answer Code': '2020', 'Answer Label': 2020}, {'Answer Code': '2021', 'Answer Label': 2021}, {'Answer Code': '2022', 'Answer Label': 2022}, {'Answer Code': '2023', 'Answer Label': 2023}, {'Answer Code': '2024', 'Answer Label': 2024}, {'Answer Code': '2025', 'Answer Label': 2025}]}]}

---

Question ID:
HP8

details_normalized:
{'Question ID': 'HP8', 'question_type': 'Single', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Question Label': 'HP8 - P5: Recode date of diagnosis...', 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'AutoCheckOther': 'true', 'EntityId': '6176'}, 'sub_questions': [{'Variable ID': 'HP8_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'More than 12 months ago '}, {'Answer Code': '2', 'Answer Label': 'Between 6 and 12 months ago '}, {'Answer Code': '3', 'Answer Label': 'Less than 6 months ago '}]}, {'Variable ID': 'HP8_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'More than 12 months ago '}, {'Answer Code': '2', 'Answer Label': 'Between 6 and 12 months ago '}, {'Answer Code': '3', 'Answer Label': 'Less than 6 months ago '}]}, {'Variable ID': 'HP8_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'More than 12 months ago '}, {'Answer Code': '2', 'Answer Label': 'Between 6 and 12 months ago '}, {'Answer Code': '3', 'Answer Label': 'Less than 6 months ago '}]}]}

---

Question ID:
Ndate

details_normalized:
{'Question ID': 'Ndate', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Question Label': 'Ndate', 'question_attributes': {'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'EntityId': '6465', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'Precision': '6'}, 'sub_questions': [{'Variable ID': 'Ndate_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Ndate_1'}]}, {'Variable ID': 'Ndate_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Ndate_1'}]}, {'Variable ID': 'Ndate_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Ndate_1'}]}]}

---

Question ID:
P7

details_normalized:
{'Question ID': 'P7', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P7 - How frequently do you see this patient?', 'question_attributes': {'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6186'}, 'sub_questions': [{'Variable ID': 'P7_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Every week'}, {'Answer Code': '2', 'Answer Label': 'Every 2 weeks'}, {'Answer Code': '3', 'Answer Label': 'Every 3 weeks'}, {'Answer Code': '4', 'Answer Label': 'Every month'}, {'Answer Code': '5', 'Answer Label': 'Every 2 months'}, {'Answer Code': '6', 'Answer Label': 'Other (please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P7_6_other_1', 'answers': [{'Answer Code': '6', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P7_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Every week'}, {'Answer Code': '2', 'Answer Label': 'Every 2 weeks'}, {'Answer Code': '3', 'Answer Label': 'Every 3 weeks'}, {'Answer Code': '4', 'Answer Label': 'Every month'}, {'Answer Code': '5', 'Answer Label': 'Every 2 months'}, {'Answer Code': '6', 'Answer Label': 'Other (please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P7_6_other_2', 'answers': [{'Answer Code': '6', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P7_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Every week'}, {'Answer Code': '2', 'Answer Label': 'Every 2 weeks'}, {'Answer Code': '3', 'Answer Label': 'Every 3 weeks'}, {'Answer Code': '4', 'Answer Label': 'Every month'}, {'Answer Code': '5', 'Answer Label': 'Every 2 months'}, {'Answer Code': '6', 'Answer Label': 'Other (please specify)', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P7_6_other_3', 'answers': [{'Answer Code': '6', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
P8

details_normalized:
{'Question ID': 'P8', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'question_attributes': {'AnswerRequiredType': 'Required', 'PrecodeMask': "f('P1a1').any('2') ? a('P8'):a('P8').diff(set('5'))", 'MultiItemsSelectedMinimum': '1', 'AutoCheckOther': 'true', 'EntityId': '6189'}, 'sub_questions': [{'Variable ID': 'P8_1_1', 'Question Label': 'At the time of diagnosis / before 1L treatment initiated (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P8_2_1', 'Question Label': 'During 1L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P8_3_1', 'Question Label': 'At progression of 1L treatment/ Before initiation of 2L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P8_4_1', 'Question Label': 'During 2L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P8_5_1', 'Question Label': 'Before 3L treatment (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P8_1_2', 'Question Label': 'At the time of diagnosis / before 1L treatment initiated (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P8_2_2', 'Question Label': 'During 1L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P8_3_2', 'Question Label': 'At progression of 1L treatment/ Before initiation of 2L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P8_4_2', 'Question Label': 'During 2L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P8_5_2', 'Question Label': 'Before 3L treatment (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P8_1_3', 'Question Label': 'At the time of diagnosis / before 1L treatment initiated (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P8_2_3', 'Question Label': 'During 1L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P8_3_3', 'Question Label': 'At progression of 1L treatment/ Before initiation of 2L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P8_4_3', 'Question Label': 'During 2L treatment  (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P8_5_3', 'Question Label': 'Before 3L treatment (P8 - When was the patient tested for IDH1? You may select more than one answer from the list below if patient was tested multiple times. )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}]}

---

Question ID:
P9

details_normalized:
{'Question ID': 'P9', 'question_type': 'Multi', 'entry_conditions': ["f('P8').any('2') && f('P8').size() == 1"], 'conditions': [], 'Question Label': 'P9 - You mentioned that your patient was tested for IDH1 during 1st line, after how many cycles did you conduct testing on this patient', 'question_attributes': {'Numeric': 'true', 'LowerLimit': '1', 'EntityId': '6198', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '15'}, 'sub_questions': [{'Variable ID': 'P9_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'P9_1 (P9 - You mentioned that your patient was tested for IDH1 during 1st line, after how many cycles did you conduct testing on this patient)'}]}, {'Variable ID': 'P9_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'P9_1 (P9 - You mentioned that your patient was tested for IDH1 during 1st line, after how many cycles did you conduct testing on this patient)'}]}, {'Variable ID': 'P9_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'P9_1 (P9 - You mentioned that your patient was tested for IDH1 during 1st line, after how many cycles did you conduct testing on this patient)'}]}]}

---

Question ID:
P10

details_normalized:
{'Question ID': 'P10', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P10 - Which type of molecular test(s) have been performed on this patient for IDH1 mutation?', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6211'}, 'sub_questions': [{'Variable ID': 'P10_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'NGS panel only'}, {'Answer Code': '2', 'Answer Label': 'Single gene PCR only'}, {'Answer Code': '3', 'Answer Label': 'PCR panel only'}, {'Answer Code': '4', 'Answer Label': 'Both NGS panel and PCR (single gene or panel)'}, {'Answer Code': '99', 'Answer Label': 'I don’t know'}]}, {'Variable ID': 'P10_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'NGS panel only'}, {'Answer Code': '2', 'Answer Label': 'Single gene PCR only'}, {'Answer Code': '3', 'Answer Label': 'PCR panel only'}, {'Answer Code': '4', 'Answer Label': 'Both NGS panel and PCR (single gene or panel)'}, {'Answer Code': '99', 'Answer Label': 'I don’t know'}]}, {'Variable ID': 'P10_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'NGS panel only'}, {'Answer Code': '2', 'Answer Label': 'Single gene PCR only'}, {'Answer Code': '3', 'Answer Label': 'PCR panel only'}, {'Answer Code': '4', 'Answer Label': 'Both NGS panel and PCR (single gene or panel)'}, {'Answer Code': '99', 'Answer Label': 'I don’t know'}]}]}

---

Question ID:
P11

details_normalized:
{'Question ID': 'P11', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P11 - How many calendar days did it take to receive the results of IDH1 for this patient?', 'question_attributes': {'Numeric': 'true', 'LowerLimit': '1', 'EntityId': '6214', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': 'if ( !QuestionErrors() )\n{\n\n\tif ( GetNum("P11_1") > 30 && !f(\'hFlag\')[\'P11\'].toBoolean() )\n\t{\n\t\n\t\tf(\'hFlag\')[\'P11\'].set(\'1\');\n\t\terrorMsg(\'P11\');\n\t\n\t}\n\n}', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '365', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'P11_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'P11_1 (P11 - How many calendar days did it take to receive the results of IDH1 for this patient?)'}]}, {'Variable ID': 'P11_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'P11_1 (P11 - How many calendar days did it take to receive the results of IDH1 for this patient?)'}]}, {'Variable ID': 'P11_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'P11_1 (P11 - How many calendar days did it take to receive the results of IDH1 for this patient?)'}]}]}

---

Question ID:
P12

details_normalized:
{'Question ID': 'P12', 'question_type': 'Grid', 'entry_conditions': ['false // added on 05-03-2024'], 'conditions': [], 'question_attributes': {'Carousel': 'false', 'EntityId': '6254'}, 'sub_questions': [{'Variable ID': 'P12_1_1', 'Question Label': 'BRAF (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_2_1', 'Question Label': 'dMMR (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_3_1', 'Question Label': 'FGFR2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_4_1', 'Question Label': 'HER2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_6_1', 'Question Label': 'IDH2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_7_1', 'Question Label': 'MSI (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_8_1', 'Question Label': 'NTRK (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_9_1', 'Question Label': 'PD-L1 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_10_1', 'Question Label': 'TMB (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_1_2', 'Question Label': 'BRAF (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_2_2', 'Question Label': 'dMMR (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_3_2', 'Question Label': 'FGFR2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_4_2', 'Question Label': 'HER2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_6_2', 'Question Label': 'IDH2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_7_2', 'Question Label': 'MSI (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_8_2', 'Question Label': 'NTRK (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_9_2', 'Question Label': 'PD-L1 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_10_2', 'Question Label': 'TMB (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_1_3', 'Question Label': 'BRAF (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_2_3', 'Question Label': 'dMMR (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_3_3', 'Question Label': 'FGFR2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_4_3', 'Question Label': 'HER2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_6_3', 'Question Label': 'IDH2 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_7_3', 'Question Label': 'MSI (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_8_3', 'Question Label': 'NTRK (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_9_3', 'Question Label': 'PD-L1 (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}, {'Variable ID': 'P12_10_3', 'Question Label': 'TMB (P12 - Did this patient test positive to any of the following co-mutations/ alterations/ over expressions?)', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'FieldId': '0'}}]}]}

---

Question ID:
P12A

details_normalized:
{'Question ID': 'P12A', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'question_attributes': {'AnswerRequiredType': 'Required', 'AutoCheckOther': 'true', 'ValidationCode': 'if (!QuestionErrors()) \n{ \nif( f("P12B").toBoolean() && f("P12A").any("11") )\n\t{\n\terrorMsg(\'P12A\')\n\t}\nif( !f("P12B").toBoolean() && f("P12A").none("11") )\n\t{\n\terrorMsg(\'P12B\')\n\t}  \n}', 'EntityId': '6445'}, 'sub_questions': [{'Variable ID': 'P12A_1_1', 'Question Label': 'BRAF (P12A - A Test)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P12A_2_1', 'Question Label': 'dMMR (P12A - A Test)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P12A_3_1', 'Question Label': 'FGFR2 (P12A - A Test)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P12A_4_1', 'Question Label': 'HER2 (P12A - A Test)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P12A_6_1', 'Question Label': 'IDH2 (P12A - A Test)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P12A_7_1', 'Question Label': 'MSI (P12A - A Test)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P12A_8_1', 'Question Label': 'NTRK (P12A - A Test)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P12A_9_1', 'Question Label': 'PD-L1 (P12A - A Test)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P12A_10_1', 'Question Label': 'TMB (P12A - A Test)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P12A_11_1', 'Question Label': 'None (P12A - A Test)', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'P12A_1_2', 'Question Label': 'BRAF (P12A - A Test)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P12A_2_2', 'Question Label': 'dMMR (P12A - A Test)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P12A_3_2', 'Question Label': 'FGFR2 (P12A - A Test)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P12A_4_2', 'Question Label': 'HER2 (P12A - A Test)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P12A_6_2', 'Question Label': 'IDH2 (P12A - A Test)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P12A_7_2', 'Question Label': 'MSI (P12A - A Test)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P12A_8_2', 'Question Label': 'NTRK (P12A - A Test)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P12A_9_2', 'Question Label': 'PD-L1 (P12A - A Test)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P12A_10_2', 'Question Label': 'TMB (P12A - A Test)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P12A_11_2', 'Question Label': 'None (P12A - A Test)', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'P12A_1_3', 'Question Label': 'BRAF (P12A - A Test)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P12A_2_3', 'Question Label': 'dMMR (P12A - A Test)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P12A_3_3', 'Question Label': 'FGFR2 (P12A - A Test)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P12A_4_3', 'Question Label': 'HER2 (P12A - A Test)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P12A_6_3', 'Question Label': 'IDH2 (P12A - A Test)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P12A_7_3', 'Question Label': 'MSI (P12A - A Test)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P12A_8_3', 'Question Label': 'NTRK (P12A - A Test)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P12A_9_3', 'Question Label': 'PD-L1 (P12A - A Test)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P12A_10_3', 'Question Label': 'TMB (P12A - A Test)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P12A_11_3', 'Question Label': 'None (P12A - A Test)', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}]}

---

Question ID:
P12B

details_normalized:
{'Question ID': 'P12B', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'question_attributes': {'AnswerRequiredType': 'NotRequired', 'AutoCheckOther': 'true', 'EntityId': '6446'}, 'sub_questions': [{'Variable ID': 'P12B_1_1', 'Question Label': 'BRAF (P12B - B Tested positive)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P12B_2_1', 'Question Label': 'dMMR (P12B - B Tested positive)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P12B_3_1', 'Question Label': 'FGFR2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P12B_4_1', 'Question Label': 'HER2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P12B_6_1', 'Question Label': 'IDH2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P12B_7_1', 'Question Label': 'MSI (P12B - B Tested positive)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P12B_8_1', 'Question Label': 'NTRK (P12B - B Tested positive)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P12B_9_1', 'Question Label': 'PD-L1 (P12B - B Tested positive)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P12B_10_1', 'Question Label': 'TMB (P12B - B Tested positive)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P12B_11_1', 'Question Label': 'None (P12B - B Tested positive)', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'P12B_1_2', 'Question Label': 'BRAF (P12B - B Tested positive)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P12B_2_2', 'Question Label': 'dMMR (P12B - B Tested positive)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P12B_3_2', 'Question Label': 'FGFR2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P12B_4_2', 'Question Label': 'HER2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P12B_6_2', 'Question Label': 'IDH2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P12B_7_2', 'Question Label': 'MSI (P12B - B Tested positive)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P12B_8_2', 'Question Label': 'NTRK (P12B - B Tested positive)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P12B_9_2', 'Question Label': 'PD-L1 (P12B - B Tested positive)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P12B_10_2', 'Question Label': 'TMB (P12B - B Tested positive)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P12B_11_2', 'Question Label': 'None (P12B - B Tested positive)', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'P12B_1_3', 'Question Label': 'BRAF (P12B - B Tested positive)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P12B_2_3', 'Question Label': 'dMMR (P12B - B Tested positive)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P12B_3_3', 'Question Label': 'FGFR2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P12B_4_3', 'Question Label': 'HER2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P12B_6_3', 'Question Label': 'IDH2 (P12B - B Tested positive)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P12B_7_3', 'Question Label': 'MSI (P12B - B Tested positive)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P12B_8_3', 'Question Label': 'NTRK (P12B - B Tested positive)', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P12B_9_3', 'Question Label': 'PD-L1 (P12B - B Tested positive)', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P12B_10_3', 'Question Label': 'TMB (P12B - B Tested positive)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P12B_11_3', 'Question Label': 'None (P12B - B Tested positive)', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}]}

---

Question ID:
P13

details_normalized:
{'Question ID': 'P13', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P13 - What treatment did the patient receive at initiation of 1st line?', 'question_attributes': {'PrecodeMask': "isBR() ? a('P13').diff(set('3','9')) : isUK() ? a('P13').diff(set('3','6')) : a('P13')", 'Dropdown': 'true', 'AutoCheckOther': 'true', 'EntityId': '6158'}, 'sub_questions': [{'Variable ID': 'P13_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin '}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine  + cisplatin + pembrolizumab (Keytruda&reg;) '}, {'Answer Code': '4', 'Answer Label': 'Another gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono '}, {'Answer Code': '9', 'Answer Label': 'Entrectinib (Rozlytrek&reg;) '}, {'Answer Code': '14', 'Answer Label': 'Larotrectinib (Vitrakvi&reg;) '}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'P13_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin '}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine  + cisplatin + pembrolizumab (Keytruda&reg;) '}, {'Answer Code': '4', 'Answer Label': 'Another gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono '}, {'Answer Code': '9', 'Answer Label': 'Entrectinib (Rozlytrek&reg;) '}, {'Answer Code': '14', 'Answer Label': 'Larotrectinib (Vitrakvi&reg;) '}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'P13_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin '}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine  + cisplatin + pembrolizumab (Keytruda&reg;) '}, {'Answer Code': '4', 'Answer Label': 'Another gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono '}, {'Answer Code': '9', 'Answer Label': 'Entrectinib (Rozlytrek&reg;) '}, {'Answer Code': '14', 'Answer Label': 'Larotrectinib (Vitrakvi&reg;) '}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}]}

---

Question ID:
P13OE

details_normalized:
{'Question ID': 'P13OE', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P13OE - Other approach - Please specify', 'question_attributes': {'OpenText': 'true', 'AutoCheckOther': 'true', 'ValidationCode': 'blankchecklist()', 'EntityId': '6163'}, 'sub_questions': [{'Variable ID': 'P13OE_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'P13OE_1 (P13OE - Other approach - Please specify)'}]}, {'Variable ID': 'P13OE_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'P13OE_1 (P13OE - Other approach - Please specify)'}]}, {'Variable ID': 'P13OE_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'P13OE_1 (P13OE - Other approach - Please specify)'}]}]}

---

Question ID:
P13s

details_normalized:
{'Question ID': 'P13s', 'question_type': 'Multi', 'entry_conditions': ["f('P13').any('1','2','3')"], 'conditions': [], 'question_attributes': {'AnswerRequiredType': 'Required', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6172'}, 'sub_questions': [{'Variable ID': 'P13s_1_1', 'Question Label': 'Gemcitabine + cisplatin + Immunotherapy (^( isUK() || isBR() ) ? "durvalumab" : "pembrolizumab or durvalumab"^)  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P13s_2_1', 'Question Label': 'Immunotherapy maintenance (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P13s_3_1', 'Question Label': 'Gemcitabine + Immunotherapy (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P13s_4_1', 'Question Label': 'Gemcitabine + cisplatin  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P13s_5_1', 'Question Label': 'Gemcitabine monotherapy (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P13s_6_1', 'Question Label': 'Patient was not receiving any 1st line treatment at time of progression (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P13s_98_1', 'Question Label': 'Any other approach (please specify)  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P13s_98_other_1', 'Question Label': 'P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  ', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P13s_1_2', 'Question Label': 'Gemcitabine + cisplatin + Immunotherapy (^( isUK() || isBR() ) ? "durvalumab" : "pembrolizumab or durvalumab"^)  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P13s_2_2', 'Question Label': 'Immunotherapy maintenance (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P13s_3_2', 'Question Label': 'Gemcitabine + Immunotherapy (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P13s_4_2', 'Question Label': 'Gemcitabine + cisplatin  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P13s_5_2', 'Question Label': 'Gemcitabine monotherapy (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P13s_6_2', 'Question Label': 'Patient was not receiving any 1st line treatment at time of progression (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P13s_98_2', 'Question Label': 'Any other approach (please specify)  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P13s_98_other_2', 'Question Label': 'P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  ', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P13s_1_3', 'Question Label': 'Gemcitabine + cisplatin + Immunotherapy (^( isUK() || isBR() ) ? "durvalumab" : "pembrolizumab or durvalumab"^)  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P13s_2_3', 'Question Label': 'Immunotherapy maintenance (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P13s_3_3', 'Question Label': 'Gemcitabine + Immunotherapy (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P13s_4_3', 'Question Label': 'Gemcitabine + cisplatin  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P13s_5_3', 'Question Label': 'Gemcitabine monotherapy (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P13s_6_3', 'Question Label': 'Patient was not receiving any 1st line treatment at time of progression (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P13s_98_3', 'Question Label': 'Any other approach (please specify)  (P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P13s_98_other_3', 'Question Label': 'P13s - When the patient progressed, what first line treatment were they receiving at the time of progression?  ', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
P14

details_normalized:
{'Question ID': 'P14', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P14 - How long did this patient stay on 1st line treatment (including maintenance, if any)?', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6173', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CheckDK('P14','P14DK');\nif(!QuestionErrors() && f('P14DK').size() ==0)\n{\nif(GetNum('P14_1') >= GetNum('Ndate_1'))\n{\n    // errorMsg(f('qErrors')['P14'].label() + GetNum('Ndate_1'))\n  errorMsg('P14')\n}\n}", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '999', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'P14_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Months  (P14 - How long did this patient stay on 1st line treatment (including maintenance, if any)?)'}]}, {'Variable ID': 'P14_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Months  (P14 - How long did this patient stay on 1st line treatment (including maintenance, if any)?)'}]}, {'Variable ID': 'P14_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Months  (P14 - How long did this patient stay on 1st line treatment (including maintenance, if any)?)'}]}]}

---

Question ID:
P14DK

details_normalized:
{'Question ID': 'P14DK', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'Do not have this information  (P14DK)', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6175'}, 'sub_questions': [{'Variable ID': 'P14DK_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P14DK_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P14DK_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}]}

---

Question ID:
P16

details_normalized:
{'Question ID': 'P16', 'question_type': 'Single', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': "P16 - ^f('P1a').any('2','3','4') ? 'Treatment received in 2nd line':'Treatment currently received in 2nd line '^", 'question_attributes': {'PrecodeMask': 'MaskP16()', 'Dropdown': 'true', 'AutoCheckOther': 'true', 'EntityId': '6177'}, 'sub_questions': [{'Variable ID': 'P16_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin'}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine + cisplatin + pembrolizumab (Keytruda&reg;)'}, {'Answer Code': '4', 'Answer Label': 'Any other gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '10', 'Answer Label': 'Ivosidenib (Tibsovo&reg;) '}, {'Answer Code': '12', 'Answer Label': 'Investigational drug (clinical trial) '}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'P16_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin'}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine + cisplatin + pembrolizumab (Keytruda&reg;)'}, {'Answer Code': '4', 'Answer Label': 'Any other gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '10', 'Answer Label': 'Ivosidenib (Tibsovo&reg;) '}, {'Answer Code': '12', 'Answer Label': 'Investigational drug (clinical trial) '}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'P16_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin'}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine + cisplatin + pembrolizumab (Keytruda&reg;)'}, {'Answer Code': '4', 'Answer Label': 'Any other gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '10', 'Answer Label': 'Ivosidenib (Tibsovo&reg;) '}, {'Answer Code': '12', 'Answer Label': 'Investigational drug (clinical trial) '}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}]}

---

Question ID:
P16OE

details_normalized:
{'Question ID': 'P16OE', 'question_type': 'Multi', 'entry_conditions': ["f('loopPTs').toNumber() <= xSet.size() ||  ( f('loopPTs').toNumber() == 2 && f('P21',1).any('1') ) ||  ( f('loopPTs').toNumber() >= 2 && f('P21',1).any('2') )"], 'conditions': [], 'Question Label': 'P16OE - Other approach - Please specify', 'question_attributes': {'OpenText': 'true', 'AutoCheckOther': 'true', 'ValidationCode': 'blankchecklist()', 'EntityId': '6178'}, 'sub_questions': [{'Variable ID': 'P16OE_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'P16OE_1 (P16OE - Other approach - Please specify)'}]}, {'Variable ID': 'P16OE_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'P16OE_1 (P16OE - Other approach - Please specify)'}]}, {'Variable ID': 'P16OE_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'P16OE_1 (P16OE - Other approach - Please specify)'}]}]}

---

Question ID:
P17

details_normalized:
{'Question ID': 'P17', 'question_type': 'Multi', 'entry_conditions': ["true //Removed on 07-03-2025 f('P1a1').any('1')"], 'conditions': [], 'Question Label': "P17 - ^f('P1a').any('1') ? 'How long has this patient been receiving this 2nd line treatment' : 'How long did this patient receive this 2nd line treatment?'^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6203', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CheckDK('P17','P17DK');\nif(!QuestionErrors() && f('P17DK').size() == 0)\n{\n\nif( ( f('P1a').any('1') || f('P1a1').any('1')) && ( Sum(GetNum('P14_1'),GetNum('P17_1')) > GetNum('Ndate_1') ) )\n{\nerrorMsg('P17a')\n}\n \nif( ( f('P1a').any('4') || f('P1a1').any('2')) && ( Sum(GetNum('P14_1'),GetNum('P17_1')) >= GetNum('Ndate_1') ) )\n{\nerrorMsg('P17a')\n}\n  /*\nif( f('P1a').any('2','3') && f('P1a1').any('1') && ( Sum(GetNum('P14_1'),GetNum('P17_1')) != GetNum('Ndate_1') ) )\n{\nerrorMsg('P17b')\n}\nif( f('P1a').any('2','3') && f('P1a1').any('2') && ( Sum(GetNum('P14_1'),GetNum('P17_1')) >= GetNum('Ndate_1') ) )\n{\nerrorMsg('P17c')\n}\nif( f('P1a').any('4') && ( Sum(GetNum('P14_1'),GetNum('P17_1')) >= GetNum('Ndate_1') ) )\n{\nerrorMsg('P17d')\n} */\n}", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '999', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'P17_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': "Months  (P17 - ^f('P1a').any('1') ? 'How long has this patient been receiving this 2nd line treatment' : 'How long did this patient receive this 2nd line treatment?'^)"}]}, {'Variable ID': 'P17_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': "Months  (P17 - ^f('P1a').any('1') ? 'How long has this patient been receiving this 2nd line treatment' : 'How long did this patient receive this 2nd line treatment?'^)"}]}, {'Variable ID': 'P17_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': "Months  (P17 - ^f('P1a').any('1') ? 'How long has this patient been receiving this 2nd line treatment' : 'How long did this patient receive this 2nd line treatment?'^)"}]}]}

---

Question ID:
P17DK

details_normalized:
{'Question ID': 'P17DK', 'question_type': 'Multi', 'entry_conditions': ["true //Removed on 07-03-2025 f('P1a1').any('1')"], 'conditions': [], 'Question Label': 'Do not have this information  (P17DK)', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6343'}, 'sub_questions': [{'Variable ID': 'P17DK_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P17DK_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P17DK_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}]}

---

Question ID:
P18

details_normalized:
{'Question ID': 'P18', 'question_type': 'Multi', 'entry_conditions': ["f('P1a').any('1') //Added on 07-03-2025"], 'conditions': [], 'question_attributes': {'AnswerRequiredType': 'Required', 'PrecodeMask': "MaskP18() //isUK() ? a('P18').diff(set('3')) : a('P18')", 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6256'}, 'sub_questions': [{'Variable ID': 'P18_1_1', 'Question Label': 'Gemcitabine + cisplatin alone (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P18_2_1', 'Question Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P18_3_1', 'Question Label': 'Gemcitabine  + cisplatin + pembrolizumab (Keytruda&reg;) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P18_4_1', 'Question Label': 'Any other gemcitabine-based regimen  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P18_5_1', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P18_6_1', 'Question Label': 'FOLFIRI (5-FU, folinic acid, irinotecan) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P18_7_1', 'Question Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P18_15_1', 'Question Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^ (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '15', 'Answer Label': ''}]}, {'Variable ID': 'P18_10_1', 'Question Label': 'Ivosidenib (Tibsovo&reg;)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P18_12_1', 'Question Label': 'Investigational drug (clinical trial)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'P18_98_1', 'Question Label': 'Any other approach (please specify)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_99_1', 'Question Label': 'None, patient is not expected to receive a 3L treatment/ patient is expected to receive best supportive care (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_98_other_1', 'Question Label': 'P18 - What would be your next preferred treatment option for this patient in 3rd Line?', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_1_2', 'Question Label': 'Gemcitabine + cisplatin alone (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P18_2_2', 'Question Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P18_3_2', 'Question Label': 'Gemcitabine  + cisplatin + pembrolizumab (Keytruda&reg;) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P18_4_2', 'Question Label': 'Any other gemcitabine-based regimen  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P18_5_2', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P18_6_2', 'Question Label': 'FOLFIRI (5-FU, folinic acid, irinotecan) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P18_7_2', 'Question Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P18_15_2', 'Question Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^ (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '15', 'Answer Label': ''}]}, {'Variable ID': 'P18_10_2', 'Question Label': 'Ivosidenib (Tibsovo&reg;)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P18_12_2', 'Question Label': 'Investigational drug (clinical trial)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'P18_98_2', 'Question Label': 'Any other approach (please specify)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_99_2', 'Question Label': 'None, patient is not expected to receive a 3L treatment/ patient is expected to receive best supportive care (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_98_other_2', 'Question Label': 'P18 - What would be your next preferred treatment option for this patient in 3rd Line?', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_1_3', 'Question Label': 'Gemcitabine + cisplatin alone (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P18_2_3', 'Question Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P18_3_3', 'Question Label': 'Gemcitabine  + cisplatin + pembrolizumab (Keytruda&reg;) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P18_4_3', 'Question Label': 'Any other gemcitabine-based regimen  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P18_5_3', 'Question Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P18_6_3', 'Question Label': 'FOLFIRI (5-FU, folinic acid, irinotecan) (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P18_7_3', 'Question Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P18_15_3', 'Question Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^ (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '15', 'Answer Label': ''}]}, {'Variable ID': 'P18_10_3', 'Question Label': 'Ivosidenib (Tibsovo&reg;)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P18_12_3', 'Question Label': 'Investigational drug (clinical trial)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'P18_98_3', 'Question Label': 'Any other approach (please specify)  (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_99_3', 'Question Label': 'None, patient is not expected to receive a 3L treatment/ patient is expected to receive best supportive care (P18 - What would be your next preferred treatment option for this patient in 3rd Line?)', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P18_98_other_3', 'Question Label': 'P18 - What would be your next preferred treatment option for this patient in 3rd Line?', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
P19

details_normalized:
{'Question ID': 'P19', 'question_type': 'Single', 'entry_conditions': ["f('P1a').any('2','3','4') //Removed on 07-03-2025 f('P1a1').any('2')"], 'conditions': [], 'Question Label': 'P19 - Treatment received in 3rd line', 'question_attributes': {'PrecodeMask': 'MaskP19()', 'Dropdown': 'true', 'AutoCheckOther': 'true', 'EntityId': '6260'}, 'sub_questions': [{'Variable ID': 'P19_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin '}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine + cisplatin + pembrolizumab (Keytruda&reg;)'}, {'Answer Code': '4', 'Answer Label': 'Any other gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '10', 'Answer Label': 'Ivosidenib (Tibsovo&reg;) '}, {'Answer Code': '12', 'Answer Label': 'Investigational drug (clinical trial) ', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'P19_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin '}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine + cisplatin + pembrolizumab (Keytruda&reg;)'}, {'Answer Code': '4', 'Answer Label': 'Any other gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '10', 'Answer Label': 'Ivosidenib (Tibsovo&reg;) '}, {'Answer Code': '12', 'Answer Label': 'Investigational drug (clinical trial) ', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'P19_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Gemcitabine + cisplatin '}, {'Answer Code': '2', 'Answer Label': 'Gemcitabine  + cisplatin + durvalumab (Imfinzi&reg;) '}, {'Answer Code': '3', 'Answer Label': 'Gemcitabine + cisplatin + pembrolizumab (Keytruda&reg;)'}, {'Answer Code': '4', 'Answer Label': 'Any other gemcitabine-based regimen '}, {'Answer Code': '5', 'Answer Label': 'FOLFOX (5-FU, folinic acid, oxaliplatin)'}, {'Answer Code': '6', 'Answer Label': 'FOLFIRI (5-FU, folinic acid, irinotecan)'}, {'Answer Code': '7', 'Answer Label': 'Capecitabine (Xeloda&reg;) / 5-FU mono'}, {'Answer Code': '15', 'Answer Label': 'Pembrolizumab (Keytruda&reg;) monotherapy ^isUK()?"(MSI-H patients)":""^'}, {'Answer Code': '10', 'Answer Label': 'Ivosidenib (Tibsovo&reg;) '}, {'Answer Code': '12', 'Answer Label': 'Investigational drug (clinical trial) ', 'answer_attributes': {'KeepPosition': 'true'}}, {'Answer Code': '98', 'Answer Label': 'Any other approach', 'answer_attributes': {'KeepPosition': 'true'}}]}]}

---

Question ID:
P19OE

details_normalized:
{'Question ID': 'P19OE', 'question_type': 'Multi', 'entry_conditions': ["f('P1a').any('2','3','4') //Removed on 07-03-2025 f('P1a1').any('2')"], 'conditions': [], 'Question Label': 'P19OE - Other approach - Please specify', 'question_attributes': {'OpenText': 'true', 'AutoCheckOther': 'true', 'ValidationCode': 'blankchecklist()', 'EntityId': '6261'}, 'sub_questions': [{'Variable ID': 'P19OE_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'P19OE_1 (P19OE - Other approach - Please specify)'}]}, {'Variable ID': 'P19OE_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'P19OE_1 (P19OE - Other approach - Please specify)'}]}, {'Variable ID': 'P19OE_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'P19OE_1 (P19OE - Other approach - Please specify)'}]}]}

---

Question ID:
P20

details_normalized:
{'Question ID': 'P20', 'question_type': 'Multi', 'entry_conditions': ["( f('P1a').any('2','3') && f('P1a1').any('2')) || f('P1a').any('4') //Removed on 07-03-2025 f('P1a').any('1','2') && f('P1a1').any('2')"], 'conditions': [], 'Question Label': "P20 - ^f('P1a').any('2','3') ? 'How long has this patient received this 3rd line treatment?':'How long has this patient been receiving this 3rd line treatment?'^", 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6264', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CheckDK('P20','P20DK');\nif(!QuestionErrors() && f('P20DK').size() == 0)\n{\n  \n  if(  Sum(GetNum('P14_1'),GetNum('P17_1'),GetNum('P20_1')) > GetNum('Ndate_1')  )\n      {\n      errorMsg('P20a')\n      }\n  /*\n\n if( f('P1a').any('2','3') && f('P1a1').any('1') && ( Sum(GetNum('P14_1'),GetNum('P17_1'),GetNum('P20_1')) != GetNum('Ndate_1') ) )\n{\nerrorMsg('P20a')\n}\nif( f('P1a').any('2','3') && f('P1a1').any('2') && ( Sum(GetNum('P14_1'),GetNum('P17_1'),GetNum('P20_1')) != GetNum('Ndate_1') ) )\n{\nerrorMsg('P20b')\n}\nif( f('P1a').any('4') && ( Sum(GetNum('P14_1'),GetNum('P17_1'),GetNum('P20_1')) != GetNum('Ndate_1') ) )\n{\nerrorMsg('P20c')\n} */\n}", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '999', 'Precision': '3'}, 'sub_questions': [{'Variable ID': 'P20_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': "Months  (P20 - ^f('P1a').any('2','3') ? 'How long has this patient received this 3rd line treatment?':'How long has this patient been receiving this 3rd line treatment?'^)"}]}, {'Variable ID': 'P20_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': "Months  (P20 - ^f('P1a').any('2','3') ? 'How long has this patient received this 3rd line treatment?':'How long has this patient been receiving this 3rd line treatment?'^)"}]}, {'Variable ID': 'P20_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': "Months  (P20 - ^f('P1a').any('2','3') ? 'How long has this patient received this 3rd line treatment?':'How long has this patient been receiving this 3rd line treatment?'^)"}]}]}

---

Question ID:
P20DK

details_normalized:
{'Question ID': 'P20DK', 'question_type': 'Multi', 'entry_conditions': ["( f('P1a').any('2','3') && f('P1a1').any('2')) || f('P1a').any('4') //Removed on 07-03-2025 f('P1a').any('1','2') && f('P1a1').any('2')"], 'conditions': [], 'Question Label': 'Do not have this information  (P20DK)', 'question_attributes': {'AutoCheckOther': 'true', 'EntityId': '6346'}, 'sub_questions': [{'Variable ID': 'P20DK_1_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P20DK_1_2', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P20DK_1_3', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}]}

---

Question ID:
P20a

details_normalized:
{'Question ID': 'P20a', 'question_type': 'Multi', 'entry_conditions': ["f('P16').none('10')"], 'conditions': [], 'question_attributes': {'AnswerRequiredType': 'Required', 'PrecodeMask': 'maskP20a()', 'AutoCheckOther': 'true', 'ValidationCode': 'checkOS();', 'EntityId': '6268'}, 'sub_questions': [{'Variable ID': 'P20a_1_1', 'Question Label': 'Poor general condition (e.g., low ECOG status, advanced age) (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P20a_2_1', 'Question Label': 'Comorbidities (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P20a_3_1', 'Question Label': 'Co-mutations/ alterations/ over expressions present  (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P20a_4_1', 'Question Label': 'Patient preferred another treatment option (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P20a_5_1', 'Question Label': 'Patient refused therapy, did not want to receive another systemic therapy (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P20a_6_1', 'Question Label': 'Hospital/MDT protocol suggests a different approach (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P20a_7_1', 'Question Label': 'National guidelines recommend an alternative treatment (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P20a_8_1', 'Question Label': 'Peers/KOL suggest a different approach (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P20a_9_1', 'Question Label': 'Lack of access or supply issues with targeted therapy (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P20a_10_1', 'Question Label': 'Cost and reimbursement issues (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P20a_11_1', 'Question Label': 'Reservations about the efficacy of targeted therapies (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'P20a_12_1', 'Question Label': 'Concerns regarding the safety of targeted therapies (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'P20a_13_1', 'Question Label': 'Targeted therapies used in later lines or for relapse/refractory patients (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '13', 'Answer Label': ''}]}, {'Variable ID': 'P20a_14_1', 'Question Label': 'Unable to wait for IDH1 mutation test results to start treatment (please specify why) (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_98_1', 'Question Label': 'Other, please specify  (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_14_other_1', 'Question Label': 'P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? ', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_98_other_1', 'Question Label': 'P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? ', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_1_2', 'Question Label': 'Poor general condition (e.g., low ECOG status, advanced age) (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P20a_2_2', 'Question Label': 'Comorbidities (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P20a_3_2', 'Question Label': 'Co-mutations/ alterations/ over expressions present  (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P20a_4_2', 'Question Label': 'Patient preferred another treatment option (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P20a_5_2', 'Question Label': 'Patient refused therapy, did not want to receive another systemic therapy (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P20a_6_2', 'Question Label': 'Hospital/MDT protocol suggests a different approach (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P20a_7_2', 'Question Label': 'National guidelines recommend an alternative treatment (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P20a_8_2', 'Question Label': 'Peers/KOL suggest a different approach (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P20a_9_2', 'Question Label': 'Lack of access or supply issues with targeted therapy (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P20a_10_2', 'Question Label': 'Cost and reimbursement issues (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P20a_11_2', 'Question Label': 'Reservations about the efficacy of targeted therapies (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'P20a_12_2', 'Question Label': 'Concerns regarding the safety of targeted therapies (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'P20a_13_2', 'Question Label': 'Targeted therapies used in later lines or for relapse/refractory patients (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '13', 'Answer Label': ''}]}, {'Variable ID': 'P20a_14_2', 'Question Label': 'Unable to wait for IDH1 mutation test results to start treatment (please specify why) (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_98_2', 'Question Label': 'Other, please specify  (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_14_other_2', 'Question Label': 'P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? ', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_98_other_2', 'Question Label': 'P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? ', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_1_3', 'Question Label': 'Poor general condition (e.g., low ECOG status, advanced age) (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'P20a_2_3', 'Question Label': 'Comorbidities (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'P20a_3_3', 'Question Label': 'Co-mutations/ alterations/ over expressions present  (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'P20a_4_3', 'Question Label': 'Patient preferred another treatment option (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'P20a_5_3', 'Question Label': 'Patient refused therapy, did not want to receive another systemic therapy (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'P20a_6_3', 'Question Label': 'Hospital/MDT protocol suggests a different approach (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'P20a_7_3', 'Question Label': 'National guidelines recommend an alternative treatment (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '7', 'Answer Label': ''}]}, {'Variable ID': 'P20a_8_3', 'Question Label': 'Peers/KOL suggest a different approach (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'P20a_9_3', 'Question Label': 'Lack of access or supply issues with targeted therapy (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '9', 'Answer Label': ''}]}, {'Variable ID': 'P20a_10_3', 'Question Label': 'Cost and reimbursement issues (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'P20a_11_3', 'Question Label': 'Reservations about the efficacy of targeted therapies (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'P20a_12_3', 'Question Label': 'Concerns regarding the safety of targeted therapies (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'P20a_13_3', 'Question Label': 'Targeted therapies used in later lines or for relapse/refractory patients (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '13', 'Answer Label': ''}]}, {'Variable ID': 'P20a_14_3', 'Question Label': 'Unable to wait for IDH1 mutation test results to start treatment (please specify why) (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_98_3', 'Question Label': 'Other, please specify  (P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_14_other_3', 'Question Label': 'P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? ', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}, {'Variable ID': 'P20a_98_other_3', 'Question Label': 'P20a - Why did you not consider a targeted therapy for IDH1 mutation as a 2nd line for this patient? ', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'Other': 'true', 'KeepPosition': 'true'}}]}]}

---

Question ID:
P21

details_normalized:
{'Question ID': 'P21', 'question_type': 'Single', 'entry_conditions': ['f(\'loopPTs\').any(\'1\') && f(\'HP0\').any(\'3\',\'4\')\n\n//(GetNum("P0a_1") > 1 || GetNum("P0a_2") > 1 || GetNum("P0a_3") > 1) && f(\'loopPTs\').any(\'1\')\n\n//f(\'qSurveyType\').any(\'3\') && GetNum("HidPRF_1") >= 3 && f(\'HP0\').any(\'2\') && f(\'loopPTs\').any(\'1\')'], 'conditions': [], 'Question Label': "P21 - Would you like to complete another patient record form? Based on your previous responses, you have the option to fill ^Sum(GetNum('P0a_1'),GetNum('P0a_2'),GetNum('P0a_3')) == 2 ? 'one additional form':'two additional forms'^  For each completed form, you would receive an additional incentive", 'question_attributes': {'PrecodeMask': 'Sum(GetNum("P0a_1"),GetNum("P0a_2"),GetNum("P0a_3")) > 2 ? a(\'P21\'):a(\'P21\').diff(set(\'2\'))', 'AutoCheckOther': 'true', 'EntityId': '6265'}, 'sub_questions': [{'Variable ID': 'P21_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes, I want to fill one additional patient record form'}, {'Answer Code': '2', 'Answer Label': 'Yes, I want to fill two additional patient record forms'}, {'Answer Code': '3', 'Answer Label': 'No, I don’t want to fill additional patient record forms'}]}, {'Variable ID': 'P21_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes, I want to fill one additional patient record form'}, {'Answer Code': '2', 'Answer Label': 'Yes, I want to fill two additional patient record forms'}, {'Answer Code': '3', 'Answer Label': 'No, I don’t want to fill additional patient record forms'}]}, {'Variable ID': 'P21_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes, I want to fill one additional patient record form'}, {'Answer Code': '2', 'Answer Label': 'Yes, I want to fill two additional patient record forms'}, {'Answer Code': '3', 'Answer Label': 'No, I don’t want to fill additional patient record forms'}]}]}

---

Question ID:
countChart

details_normalized:
{'Question ID': 'countChart', 'question_type': 'Single', 'entry_conditions': ['isTest()'], 'conditions': [], 'Question Label': 'countChart - complete flag for chart', 'question_attributes': {'NotRequired': 'true', 'AutoCheckOther': 'true', 'Disabled': 'true', 'EntityId': '6092'}, 'sub_questions': [{'Variable ID': 'countChart_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}]}, {'Variable ID': 'countChart_2', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}]}, {'Variable ID': 'countChart_3', 'answers': [{'Answer Code': '1', 'Answer Label': 'Yes', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}, {'Answer Code': '2', 'Answer Label': 'No', 'answer_attributes': {'ListSource': 'list_yesno', 'ColumnWidth': '100'}}]}]}

---

Question ID:
QEndTimeLoop

details_normalized:
{'Question ID': 'QEndTimeLoop', 'question_type': 'Open', 'entry_conditions': ['isTest()'], 'conditions': [], 'Question Label': 'QEndTimeLoop', 'question_attributes': {'NotRequired': 'true', 'FieldWidth': '50', 'Disabled': 'true', 'ExcludeTranslation': 'true', 'Rows': '1', 'EntityId': '6093'}, 'sub_questions': [{'Variable ID': 'QEndTimeLoop_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'QEndTimeLoop_2', 'answers': [{'Answer Code': '2', 'Answer Label': ''}]}, {'Variable ID': 'QEndTimeLoop_3', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}]}

---

Question ID:
hidF1Order

details_normalized:
{'Question ID': 'hidF1Order', 'question_type': 'Multi', 'entry_conditions': ['isTest() //Show only in test mode'], 'conditions': [], 'Question Label': 'hidF1Order - //Hidden question to store randomization order', 'question_attributes': {'Randomize': 'true', 'VariableType': 'Hidden', 'NotRequired': 'true', 'Numeric': 'true', 'EntityId': '6141', 'UpperLimitType': 'SmallerOrEqual', 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'Disabled': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'PrecodeMask': 'MaskF1()'}, 'sub_questions': [{'Variable ID': 'hidF1Order_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Ivosidenib (Tibsovo&reg;)  (hidF1Order - //Hidden question to store randomization order)'}]}, {'Variable ID': 'hidF1Order_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Pemigatinib (Pemazyre&reg;) (hidF1Order - //Hidden question to store randomization order)'}]}, {'Variable ID': 'hidF1Order_3', 'answers': [{'Answer Code': '3', 'Answer Label': 'Futibatinib (Lytgobi&reg;)  (hidF1Order - //Hidden question to store randomization order)'}]}]}

---

Question ID:
F1

details_normalized:
{'Question ID': 'F1', 'question_type': 'Multi', 'entry_conditions': [], 'conditions': [], 'question_attributes': {'Randomize': 'true', 'AnswerRequiredType': 'Required', 'EntityId': '6134', 'AnswerlistOrder': 'Randomize', 'AutoCheckOther': 'true', 'SubHeaderOrder': 'Randomize'}, 'sub_questions': [{'Variable ID': 'F1_1_1', 'Question Label': 'In-person or virtual discussion with pharmaceutical company representatives (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'F1_3_1', 'Question Label': 'Journal publication (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'F1_4_1', 'Question Label': 'Poster/presentation at a conference, CME, or symposium (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'F1_5_1', 'Question Label': 'Colleague in my practice / area (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'F1_6_1', 'Question Label': 'Manufacturer’s website (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'F1_7_1', 'Question Label': 'Website other than the manufacturer (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '7', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_8_1', 'Question Label': 'Email from manufacturers / manufacturer representatives (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'F1_9_1', 'Question Label': 'Social media (Twitter, LinkedIn, Facebook) (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '9', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_10_1', 'Question Label': 'Journal advertisement (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'F1_11_1', 'Question Label': 'National expert / thought leader (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'F1_12_1', 'Question Label': 'Guidelines recommendations (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'F1_13_1', 'Question Label': 'Recommendations from other foundations or societies (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '13', 'Answer Label': ''}]}, {'Variable ID': 'F1_14_1', 'Question Label': 'Professional medical: apps/tools (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_15_1', 'Question Label': 'In-person or virtual discussion with pharmaceutical company MSL (Medical science liaison) professional (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '15', 'Answer Label': ''}]}, {'Variable ID': 'F1_98_1', 'Question Label': 'Any other source  (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_99_1', 'Question Label': 'I have not seen any information about this treatment  (F1 - In the past 12 months, where have you seen information about Ivosidenib (Tibsovo&reg;)  for CCA? )', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_1_2', 'Question Label': 'In-person or virtual discussion with pharmaceutical company representatives (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'F1_3_2', 'Question Label': 'Journal publication (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'F1_4_2', 'Question Label': 'Poster/presentation at a conference, CME, or symposium (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'F1_5_2', 'Question Label': 'Colleague in my practice / area (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'F1_6_2', 'Question Label': 'Manufacturer’s website (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'F1_7_2', 'Question Label': 'Website other than the manufacturer (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '7', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_8_2', 'Question Label': 'Email from manufacturers / manufacturer representatives (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'F1_9_2', 'Question Label': 'Social media (Twitter, LinkedIn, Facebook) (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '9', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_10_2', 'Question Label': 'Journal advertisement (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'F1_11_2', 'Question Label': 'National expert / thought leader (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'F1_12_2', 'Question Label': 'Guidelines recommendations (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'F1_13_2', 'Question Label': 'Recommendations from other foundations or societies (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '13', 'Answer Label': ''}]}, {'Variable ID': 'F1_14_2', 'Question Label': 'Professional medical: apps/tools (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_15_2', 'Question Label': 'In-person or virtual discussion with pharmaceutical company MSL (Medical science liaison) professional (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '15', 'Answer Label': ''}]}, {'Variable ID': 'F1_98_2', 'Question Label': 'Any other source  (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_99_2', 'Question Label': 'I have not seen any information about this treatment  (F1 - In the past 12 months, where have you seen information about Pemigatinib (Pemazyre&reg;) for CCA? )', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_1_3', 'Question Label': 'In-person or virtual discussion with pharmaceutical company representatives (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '1', 'Answer Label': ''}]}, {'Variable ID': 'F1_3_3', 'Question Label': 'Journal publication (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '3', 'Answer Label': ''}]}, {'Variable ID': 'F1_4_3', 'Question Label': 'Poster/presentation at a conference, CME, or symposium (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '4', 'Answer Label': ''}]}, {'Variable ID': 'F1_5_3', 'Question Label': 'Colleague in my practice / area (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '5', 'Answer Label': ''}]}, {'Variable ID': 'F1_6_3', 'Question Label': 'Manufacturer’s website (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '6', 'Answer Label': ''}]}, {'Variable ID': 'F1_7_3', 'Question Label': 'Website other than the manufacturer (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '7', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_8_3', 'Question Label': 'Email from manufacturers / manufacturer representatives (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '8', 'Answer Label': ''}]}, {'Variable ID': 'F1_9_3', 'Question Label': 'Social media (Twitter, LinkedIn, Facebook) (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '9', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_10_3', 'Question Label': 'Journal advertisement (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '10', 'Answer Label': ''}]}, {'Variable ID': 'F1_11_3', 'Question Label': 'National expert / thought leader (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '11', 'Answer Label': ''}]}, {'Variable ID': 'F1_12_3', 'Question Label': 'Guidelines recommendations (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '12', 'Answer Label': ''}]}, {'Variable ID': 'F1_13_3', 'Question Label': 'Recommendations from other foundations or societies (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '13', 'Answer Label': ''}]}, {'Variable ID': 'F1_14_3', 'Question Label': 'Professional medical: apps/tools (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '14', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_15_3', 'Question Label': 'In-person or virtual discussion with pharmaceutical company MSL (Medical science liaison) professional (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '15', 'Answer Label': ''}]}, {'Variable ID': 'F1_98_3', 'Question Label': 'Any other source  (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '98', 'Answer Label': '', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F1_99_3', 'Question Label': 'I have not seen any information about this treatment  (F1 - In the past 12 months, where have you seen information about Futibatinib (Lytgobi&reg;)  for CCA? )', 'answers': [{'Answer Code': '99', 'Answer Label': '', 'answer_attributes': {'Punch': 'Single', 'KeepPosition': 'true'}}]}]}

---

Question ID:
F3ax1

details_normalized:
{'Question ID': 'F3ax1', 'question_type': 'Multi', 'entry_conditions': ['true //Removed on 14-03-2025 maskF3a().size() > 0'], 'conditions': [], 'Question Label': 'F3ax1 - ASales Representatives', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6290', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CheckDK3D('F3ax1', 'F3aDKx1');\n\nif(isUK())\n{\nif( !f('F3aDKx1').toBoolean() && f('F3ax1').size() !=3)\n  {errorMsg('F3aerr1')}\n}\nif(!(isUK() ))\n{\nif( !f('F3aDKx1').toBoolean() && f('F3ax1').size() !=2)\n  {errorMsg('F3aerr1')}\n}", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '99', 'ColumnMask': "true //maskF3a().isect(set('1')).size()>0"}, 'sub_questions': [{'Variable ID': 'F3ax1_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)  (F3ax1 - ASales Representatives)'}]}, {'Variable ID': 'F3ax1_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)  (F3ax1 - ASales Representatives)'}]}, {'Variable ID': 'F3ax1_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) (F3ax1 - ASales Representatives)'}]}]}

---

Question ID:
F3ax2

details_normalized:
{'Question ID': 'F3ax2', 'question_type': 'Multi', 'entry_conditions': ['true //Removed on 14-03-2025 maskF3a().size() > 0'], 'conditions': [], 'Question Label': 'F3ax2 - BMSLs', 'question_attributes': {'NotRequired': 'true', 'Numeric': 'true', 'LowerLimit': '0', 'EntityId': '6291', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'ValidationCode': "CheckDK3D('F3ax2', 'F3aDKx2');\n\nif(isUK())\n{\nif( !f('F3aDKx2').toBoolean() && f('F3ax2').size() !=3)\n  {errorMsg('F3aerr2')}\n}\nif(!(isUK() ))\n{\nif( !f('F3aDKx2').toBoolean() && f('F3ax2').size() !=2)\n  {errorMsg('F3aerr2')}\n}", 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '99', 'ColumnMask': "true //maskF3a().isect(set('2')).size()>0"}, 'sub_questions': [{'Variable ID': 'F3ax2_1', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)  (F3ax2 - BMSLs)'}]}, {'Variable ID': 'F3ax2_2', 'answers': [{'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)  (F3ax2 - BMSLs)'}]}, {'Variable ID': 'F3ax2_4', 'answers': [{'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) (F3ax2 - BMSLs)'}]}]}

---

Question ID:
F3aDKx1

details_normalized:
{'Question ID': 'F3aDKx1', 'Question Label': 'No visits from sales representatives/MSL from the above companies  (F3aDKx1)', 'question_type': 'Multi', 'entry_conditions': ['true //Removed on 14-03-2025 maskF3a().size() > 0'], 'conditions': [], 'Variable ID': 'F3aDKx1_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}], 'question_attributes': {'AutoCheckOther': 'true', 'ColumnMask': "true //maskF3a().isect(set('1')).size()>0", 'EntityId': '6294'}}

---

Question ID:
F3aDKx2

details_normalized:
{'Question ID': 'F3aDKx2', 'Question Label': 'No visits from sales representatives/MSL from the above companies  (F3aDKx2)', 'question_type': 'Multi', 'entry_conditions': ['true //Removed on 14-03-2025 maskF3a().size() > 0'], 'conditions': [], 'Variable ID': 'F3aDKx2_1', 'answers': [{'Answer Code': '1', 'Answer Label': ''}], 'question_attributes': {'AutoCheckOther': 'true', 'ColumnMask': "true //maskF3a().isect(set('2')).size()>0", 'EntityId': '6295'}}

---

Question ID:
F4b

details_normalized:
{'Question ID': 'F4b', 'question_type': 'Grid', 'entry_conditions': ['maskF4bN().size()>0'], 'conditions': [], 'question_attributes': {'Carousel': 'true', 'EntityId': '6148'}, 'sub_questions': [{'Variable ID': 'F4b_1', 'Question Label': 'The company offers high quality educational meetings/events in CCA (F4b - Please indicate which of the following pharmaceutical companies you associate with each of these attributes, based on their activities in CCA. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': '^f("DumF4b").size() ==2?"Both":""^^f("DumF4b").size() ==3?"ALL":""^ companies', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '99', 'Answer Label': 'None / no opinion', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F4b_2', 'Question Label': 'The company’s sales representatives always follow-up on my questions/requests in a timely manner (F4b - Please indicate which of the following pharmaceutical companies you associate with each of these attributes, based on their activities in CCA. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': '^f("DumF4b").size() ==2?"Both":""^^f("DumF4b").size() ==3?"ALL":""^ companies', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '99', 'Answer Label': 'None / no opinion', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F4b_3', 'Question Label': 'The company’s sales representative provides appropriate, relevant for my practice and up-to-date CCA and product-related information (F4b - Please indicate which of the following pharmaceutical companies you associate with each of these attributes, based on their activities in CCA. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': '^f("DumF4b").size() ==2?"Both":""^^f("DumF4b").size() ==3?"ALL":""^ companies', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '99', 'Answer Label': 'None / no opinion', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F4b_4', 'Question Label': 'The frequency of the company’s sales representative visits is appropriate (F4b - Please indicate which of the following pharmaceutical companies you associate with each of these attributes, based on their activities in CCA. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': '^f("DumF4b").size() ==2?"Both":""^^f("DumF4b").size() ==3?"ALL":""^ companies', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '99', 'Answer Label': 'None / no opinion', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F4b_5', 'Question Label': 'The company is patient centric, e.g., provides tools, support, materials & services for me and my CCA patients/caregivers (F4b - Please indicate which of the following pharmaceutical companies you associate with each of these attributes, based on their activities in CCA. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': '^f("DumF4b").size() ==2?"Both":""^^f("DumF4b").size() ==3?"ALL":""^ companies', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '99', 'Answer Label': 'None / no opinion', 'answer_attributes': {'KeepPosition': 'true'}}]}, {'Variable ID': 'F4b_6', 'Question Label': 'The company interacts with me in a personalized way taking my personal preferences into account (channels used, content provided, timing of interactions, etc)  (F4b - Please indicate which of the following pharmaceutical companies you associate with each of these attributes, based on their activities in CCA. )', 'answers': [{'Answer Code': '1', 'Answer Label': 'Servier / Tibsovo&reg; (ivosidenib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '2', 'Answer Label': 'Incyte Corporation / Pemazyre&reg; (pemigatinib)', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '4', 'Answer Label': 'Taiho /Lytgobi&reg; (futibatinib) ', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '3', 'Answer Label': '^f("DumF4b").size() ==2?"Both":""^^f("DumF4b").size() ==3?"ALL":""^ companies', 'answer_attributes': {'FieldId': '0'}}, {'Answer Code': '99', 'Answer Label': 'None / no opinion', 'answer_attributes': {'KeepPosition': 'true'}}]}]}

---

Question ID:
hidOEBatch

details_normalized:
{'Question ID': 'hidOEBatch', 'Question Label': 'hidOEBatch', 'question_type': 'Open', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'hidOEBatch', 'answers': [{'Answer Code': '0', 'Answer Label': ''}], 'question_attributes': {'ExcludeFromReporting': 'true', 'VariableType': 'Hidden', 'UpperLimitType': 'SmallerOrEqual', 'LowerLimitType': 'GreaterOrEqual', 'Numeric': 'true', 'Rows': '1', 'ExcludeTranslation': 'true', 'EntityId': '3254'}}

---

Question ID:
hidDVBatch

details_normalized:
{'Question ID': 'hidDVBatch', 'Question Label': 'hidDVBatch', 'question_type': 'Open', 'entry_conditions': [], 'conditions': [], 'Variable ID': 'hidDVBatch', 'answers': [{'Answer Code': '0', 'Answer Label': ''}], 'question_attributes': {'ExcludeFromReporting': 'true', 'VariableType': 'Hidden', 'UpperLimitType': 'SmallerOrEqual', 'LowerLimitType': 'GreaterOrEqual', 'Numeric': 'true', 'Rows': '1', 'ExcludeTranslation': 'true', 'EntityId': '3255'}}

---

Question ID:
surveyLOI

details_normalized:
{'Question ID': 'surveyLOI', 'Question Label': "surveyLOI - This question holds the LOI in minutes, for each respondent.  THE VARIABLE TYPE FOR THIS QUESTION MUST BE SET TO 'HIDDEN'.", 'question_type': 'Open', 'entry_conditions': ['false //LOI vars ans scripts'], 'conditions': [], 'Variable ID': 'surveyLOI', 'answers': [{'Answer Code': '0', 'Answer Label': ''}], 'question_attributes': {'Scale': '2', 'VariableType': 'Hidden', 'UpperLimitType': 'SmallerOrEqual', 'LowerLimitType': 'GreaterOrEqual', 'Numeric': 'true', 'Precision': '20', 'LowerLimit': '0', 'Rows': '1', 'ExcludeTranslation': 'true', 'EntityId': '2753912551', 'Columns': '20'}}

---

Question ID:
qOverlap

details_normalized:
{'Question ID': 'qOverlap', 'Question Label': 'qOverlap', 'question_type': 'Single', 'entry_conditions': ['IsInProductionMode()'], 'conditions': [], 'Variable ID': 'qOverlap', 'answers': [{'Answer Code': '1', 'Answer Label': 'OverLap'}, {'Answer Code': '2', 'Answer Label': 'Fresh'}], 'question_attributes': {'VariableType': 'Hidden', 'AutoCheckOther': 'true', 'ExcludeTranslation': 'true', 'EntityId': '6468'}}

---

Question ID:
totCharts

details_normalized:
{'Question ID': 'totCharts', 'Question Label': 'totCharts', 'question_type': 'Multi', 'entry_conditions': ['false'], 'conditions': [], 'Variable ID': 'totCharts_0', 'answers': [{'Answer Code': '0', 'Answer Label': 0}], 'question_attributes': {'VariableType': 'Hidden', 'Numeric': 'true', 'LowerLimit': '-200', 'NotPerformDataCleaningOnMasking': 'true', 'EntityId': '6079', 'UpperLimitType': 'SmallerOrEqual', 'AutoCheckOther': 'true', 'OpenText': 'true', 'LowerLimitType': 'GreaterOrEqual', 'UpperLimit': '9999', 'Precision': '4'}}

---

## function_def
Function Name:
ShowLogo

Function Definition:
function ShowLogo() {<br>  var logo = ''<br>  // add language codes that should not see M3 Logo in first IF condition. Hide for M360<br>  if(f('l').any('XX') || f('hSLFlags').any('l')) {<br>    logo = ''  //No logo displayed<br>  }

---

Function Name:
CheckOpenLengthMultiOE

Function Definition:
function CheckOpenLengthMultiOE(qid,min,max,type) {<br>var regex = /\r\n/g;<br>var precodes = f(qid).categories();<br>for (var i=0;i<precodes.length;++i)<br>{<br>var code = precodes[i];<br><br>var txt : String = f(qid)[code].get().replace(regex,' ');<br><br>f('qErrNum')[1].set(min);<br>f('qErrNum')[2].set(max);<br><br>  <br>if (type == 'chars')<br>{<br>  var lngstr;<br>  var count=0;<br>  <br>  lngstr = txt.length;<br>  <br>  for (var j=0;j<lngstr;j++) <br>   if (txt.charCodeAt(j)!=32) <br>    count = count + 1;<br><br>if(count < min && min != '0')<br> errorMsg('13')<br><br>if(count > max && max != '0')<br> errorMsg('14')<br>}

---

Function Name:
errorMsg

Function Definition:
function errorMsg(errCode) {<br>    if(a("qErrors").isect(set(errCode)).size() > 0)<br>    {<br>         RaiseError();<br>         SetQuestionErrorMessage(CurrentLang(), f('qErrors')[errCode].label());<br>     }

---

Function Name:
hideTitle

Function Definition:
function hideTitle() {<br> if ( !((f("qHidMode").get()=='1' || isTest()) && f('hSLFlags').none('t')) ) {<br>    return "<style>.cf-question__title { display: none; }

---

Function Name:
showHideTitleSt

Function Definition:
function showHideTitleSt() {<br>if((f("qHidMode").get()=='1' || isTest()) && f('hSLFlags').none('t'))<br>{<br>return ""<br>}

---

Function Name:
showHideTitleEnd

Function Definition:
function showHideTitleEnd() {<br>if((f("qHidMode").get()=='1' || isTest())  && f('hSLFlags').none('t'))<br>{<br>return ""<br>}

---

Function Name:
sethRawLink

Function Definition:
function sethRawLink() {<br>         // extract current URL components<br>  var hostname = Request.ServerVariables("SERVER_NAME");<br>  var script   = Request.ServerVariables("SCRIPT_NAME");<br>  var qs       = "?"+Request.ServerVariables("QUERY_STRING");<br>  <br>  var rawLink = "https://"+hostname+script+qs;<br>  //var ulink = "https://"+hostname+script+"?r="+CurrentID()+"&s="+CurrentSID();<br>  var ulink = GetRespondentUrl();<br><br>  if(!f("hRawLink").toBoolean()) f("hRawLink").set(rawLink);<br>  if(!f("hULink").toBoolean()) f("hULink").set(ulink);<br>}

---

Function Name:
setLiveQids

Function Definition:
function setLiveQids() {<br>  if(f("hCurrQid").toBoolean() && (f("hCurrQid").get() != CurrentForm()) && CurrentForm()!=undefined)<br>  {<br>    f("hPrevQid").set(f("hCurrQid").get());<br>    if(f("hAllQids").get().indexOf(CurrentForm()+"#") == -1)<br>     {<br>       var prevQids = f("hAllQids").get();<br>       f("hAllQids").set(prevQids+"#"+CurrentForm()+"#");<br>     }

---

Function Name:
genLink

Function Definition:
function genLink() {<br>  if ( !isDynTerm() ) {<br>    // construct new query string components<br>     var lqs = "&l=" + CurrentLang();<br>     var qid = CurrentForm();<br>     var finalLink;<br>     var sURL : String = GetRespondentUrl();<br>     <br>     if(sURL.indexOf("extwix") == -1) <br>       finalLink = sURL+lqs+"&testing=1&__goto=";  //To Construct Normal Production Link<br>     else<br>       finalLink = sURL+"&testing=1&__goto=";     //To Construct External Quick Test Link<br>  <br>     //Preparing Dropdown list with Jump Links built above.<br>     var shtml="<script>"+<br>       "function jumpLink(objCombo)"+<br>       "{"+<br>       "if(objCombo.value!=''){window.location.assign(objCombo.value);}

---

Function Name:
BackButton

Function Definition:
function BackButton() {<br>if ((f('qTesting').get() == '1' || f('qSurveyType').any('2') || !IsInProductionMode()) && f('hSLFlags').none('b'))<br> var txt = "";<br>else<br> txt = "<style>.cf-navigation-back {display:none;}

---

Function Name:
RequireCheck

Function Definition:
function RequireCheck(qid) {<br>  if ( !QuestionErrors() ) {<br>  if(!f(qid).toBoolean()) {<br>    RaiseError();<br>    SetQuestionErrorMessage(CurrentLang(), f('qErrors')['1'].label());<br>    }

---

Function Name:
RequireCheck3D

Function Definition:
function RequireCheck3D(qid) {<br>  if ( !QuestionErrors() ) {<br>  if(!f(qid).toBoolean()) {<br>    f('qErrNum')['3'].set(f(qid).text())<br>    errorMsg(f('qErrors')['35'].label()+ f('qErrors')['1'].label());<br>    f('qErrNum')['3'].set(null)<br>    }

---

Function Name:
findTheme

Function Definition:
function findTheme() {<br>  if (f('l').get()=='2057') return "No logo no support email";<br>  else return "Main theme";<br>  }

---

Function Name:
Setzero

Function Definition:
function Setzero(qid) { <br>  if (f(qid).size() > 0) {<br>    var x=f(qid).domainValues()<br>    for(var i=0;i<x.length;i++) {<br>      if (!f(qid)[x[i]].toBoolean()) { f(qid)[x[i]].set(0)}

---

Function Name:
Setzero2

Function Definition:
function Setzero2(qid) { <br><br>    var x=f(qid).domainValues()<br>    for(var i=0;i<x.length;i++) {<br>      if (!f(qid)[x[i]].toBoolean()) { f(qid)[x[i]].set(0)}

---

Function Name:
Setzero3

Function Definition:
function Setzero3(qid) { <br><br>    var x=a(qid).members()<br>    for(var i=0;i<x.length;i++) {<br>      if (!f(qid)[x[i]].toBoolean()) { f(qid)[x[i]].set(0)}

---

Function Name:
CopyForm

Function Definition:
function CopyForm(from,to) {<br>   var fromType = from.getType();<br>   var toType = to.getType();<br><br>   if(fromType != toType)<br>     return false;<br><br>   else {<br>     if(fromType != "COMPOUND")<br>         to.set(from.get());<br><br>     else if(fromType == "COMPOUND") {<br>        var fcodes = from.domainValues();<br>        var tcodes = to.domainValues();<br><br>        if(fcodes.length == tcodes.length) {<br>           for(var i = 0; i < fcodes.length; i++) {<br>              if(fcodes[i].toString()==tcodes[i].toString())<br>                 to[fcodes[i]].set(from[fcodes[i]].get());<br>              else<br>                 return false;<br>           }

---

Function Name:
zipcodeValidation

Function Definition:
function zipcodeValidation(qid,pre) {<br>  <br>var pcode = f(qid)[pre].get();<br>  if(f('qCountry').get()=='2057')<br>  {<br>   var re = /^(?:(?:[a-z]{1,2}

---

Function Name:
GreaterThan

Function Definition:
function GreaterThan(qid, num) {<br>  var s = new Set();<br>  var dom = f(qid).domainValues();<br>  for (var i=0; i<dom.length; ++i)<br>    if (f(qid)[dom[i]].toNumber() > num)<br>      s.add(dom[i]);<br>  return s;<br>  <br>}

---

Function Name:
LessThan

Function Definition:
function LessThan(qid, num) {<br>  var s = new Set();<br>  var dom = f(qid).domainValues();<br>  for (var i=0; i<dom.length; ++i)<br>    if (f(qid)[dom[i]].toNumber() < num)<br>      s.add(dom[i]);<br>  return s;<br>  <br>}

---

Function Name:
EqualTo

Function Definition:
function EqualTo(qid, num) {<br>  var s = new Set();<br>  var dom = f(qid).domainValues();<br>  for (var i=0; i<dom.length; ++i)<br>    if (f(qid)[dom[i]].toNumber() == num)<br>      s.add(dom[i]);<br>  return s;<br>}

---

Function Name:
InBetween

Function Definition:
function InBetween(qid, lownum, highnum) {<br>return GreaterThan(qid, lownum).isect(LessThan(qid, highnum));<br>  <br>}

---

Function Name:
mincheckopen

Function Definition:
function mincheckopen(countstr) {<br>  var regex = /\r\n/g;<br>  var val = countstr.replace(regex,' ');<br>  var charcnt:int=0;<br>  for( var j=0;j<val.length;j++ )<br>  {<br>    if(val.charCodeAt(j)!=32)<br>    {<br>      charcnt=charcnt+1;<br>    }

---

Function Name:
blankcheckopen

Function Definition:
function blankcheckopen() {<br>  <br>  if ( f(CurrentForm()).toBoolean() ) {<br>  var regex = /\r\n/g;<br>  var val,lngstr;<br>  var flag; <br>  val = f(CurrentForm()).get().replace(regex,' ');<br>  lngstr = val.length;<br>    	mincheckopen(val);<br>  for (var j=0;j<lngstr;j++) {<br>    if (val.charCodeAt(j)==32) {<br>      flag=0;  <br>      }

---

Function Name:
blankchecklist

Function Definition:
function blankchecklist() {<br><br> if ( f(CurrentForm()).toBoolean() ) {<br>  var regex = /\r\n/g;<br>  var precodes = f(CurrentForm()).domainValues(); <br>  var val,lngstr;<br>  var flag; <br>  for (var i=0;i<precodes.length;i++) {<br>    val = "";<br>    if (f(CurrentForm())[precodes[i]].toBoolean()) { val = f(CurrentForm())[precodes[i]].get().replace(regex,' '); }

---

Function Name:
OtherSpecify

Function Definition:
function OtherSpecify(qid,code) {<br>  blankcheckotherNew(qid,code);<br>  var sErrorMsg : String<br>  var formType = f(qid).getType();<br>  if (formType == "COMPOUND") {<br>    if (f(qid)[code].get()=='1' && !f(qid+'_'+code+'_other').toBoolean()) {<br>      sErrorMsg = f('qErrors')[2].label()+f(qid)[code].label()+f('qErrors')[3].label();<br>      RaiseError();<br>      SetQuestionErrorMessage(CurrentLang(),sErrorMsg);<br>      }

---

Function Name:
NumericWithOE

Function Definition:
function NumericWithOE(qid,code) {<br>  RequireCheck(qid)<br>  if ( f(qid+'_'+code+'_other').toBoolean() )<br>  {<br>      	 mincheckopen(f(qid+'_'+code+'_other').get());<br>         blankcheckotherNew(qid,code);<br>  }

---

Function Name:
RankingWithOE

Function Definition:
function RankingWithOE(qid,code) {<br>  RequireCheck(qid)<br>  if ( f(qid+'_'+code+'_other').toBoolean() )<br>  {<br>       	 mincheckopen(f(qid+'_'+code+'_other').get());<br>         blankcheckotherNew(qid,code);<br>  }

---

Function Name:
OtherSpecifyGrid

Function Definition:
function OtherSpecifyGrid(qid,code) {<br>  if ( f(qid)[code].toBoolean() && f(qid+'_'+code+'_other').toBoolean()) <br>    {<br>      mincheckopen(f(qid+'_'+code+'_other').get());<br>    }

---

Function Name:
OtherSpecify3D

Function Definition:
function OtherSpecify3D(gID, qID, qType, code) {<br>  var bAnswered: Boolean<br>  var bOther: Boolean<br>  var bGoodOther: Boolean<br>  bAnswered = false;<br>  bOther = false;<br>  bGoodOther = false;<br>  <br>  //check if Other was selected in any of the columns, for Numeric should be >0<br>  for (var i=0; i<qID.length; i++) <br>  {<br>   if(qType[i]=="S" && f(qID[i]).any(code)) bAnswered = true;<br>   if(qType[i]=="M" && f(qID[i]).any(code)) bAnswered = true;<br>   if(qType[i]=="N" && f(qID[i])[code].toNumber()>0) bAnswered = true;<br>   if(qType[i]=="G" && f(qID[i])[code].toBoolean()) bAnswered = true;<br>  }

---

Function Name:
MultiGridOther

Function Definition:
function MultiGridOther(qid,code) {<br>  blankcheckotherNew(qid,code);<br>  var sErrorMsg : String<br>  var precodes = Get3DGridQuestionIds(qid).toString();<br>  var regex = /\r\n/g;<br>  precodes = precodes.split(",")<br>  <br>  for (var i=1;i<precodes.length;++i)<br>  {<br>  var ques = precodes[i];  <br>      if (f(ques).any(code) && !f(qid+'_'+code+'_other').toBoolean() ) {<br>      sErrorMsg = f('qErrors')[2].label()+ f(ques+"_"+code).label() +f('qErrors')[3].label();<br>      errorMsg(sErrorMsg);<br>   }

---

Function Name:
trim

Function Definition:
function trim(strText) { <br>// this will get rid of leading spaces <br>while (strText.substr(0,1) == ' ') <br>strText = strText.substr(1, strText.length);<br> <br>// this will get rid of trailing spaces <br>while (strText.substr(strText.length-1,strText.length) == ' ')<br>strText = strText.substr(0, strText.length-1);<br>return strText;<br>}

---

Function Name:
blankcheckotherNew

Function Definition:
function blankcheckotherNew(qid,code) {<br>  var val,lngstr;<br>  var flag; <br>  val = f(qid+'_'+code+'_other').get();<br>  lngstr = val.length;<br>  for (var j=0;j<lngstr;j++) {<br>    if (val.charCodeAt(j)==32) flag=0;  <br>    else {   <br>      flag=1; <br>      break;<br>      }

---

Function Name:
blankcheckotherNew2

Function Definition:
function blankcheckotherNew2(qid,code) {<br>  var val,lngstr;<br>  var flag : int =0; <br>  val = f(qid+'_'+code+'_other').get();<br>  lngstr = val.length;<br>  for (var j=0;j<lngstr;j++) <br>  {<br>    if (val.charCodeAt(j)!=32) <br>   {   <br>    flag=1; <br>    break;<br>   }

---

Function Name:
CheckOpenLength

Function Definition:
function CheckOpenLength(qid,min,max,type) {<br>var regex = /\r\n/g;<br>var txt : String = f(qid).get().replace(regex,' ');<br><br>f('qErrNum')[1].set(min);<br>f('qErrNum')[2].set(max);<br><br>  <br>if (type == 'chars')<br>{<br>  var lngstr;<br>  var count=0;<br>  <br>  lngstr = txt.length;<br>  <br>  for (var j=0;j<lngstr;j++) <br>   if (txt.charCodeAt(j)!=32) <br>    count = count + 1;<br><br>if(count < min && min != '0')<br> errorMsg('13')<br><br>if(count > max && max != '0')<br> errorMsg('14')<br><br>}

---

Function Name:
CheckOpenLengthMulti

Function Definition:
function CheckOpenLengthMulti(qid,min,max,type) {<br>var regex = /\r\n/g;<br>var precodes = f(qid).domainValues();<br>for (var i=0;i<precodes.length;++i)<br>{<br>var code = precodes[i];<br><br>var txt : String = f(qid)[code].get().replace(regex,' ');<br><br>f('qErrNum')[1].set(min);<br>f('qErrNum')[2].set(max);<br><br>  <br>if (type == 'chars')<br>{<br>  var lngstr;<br>  var count=0;<br>  <br>  lngstr = txt.length;<br>  <br>  for (var j=0;j<lngstr;j++) <br>   if (txt.charCodeAt(j)!=32) <br>    count = count + 1;<br><br>if(count < min && min != '0')<br> errorMsg(f(qid)[code].label() + ": " + f('qErrors')[13].label())<br><br>if(count > max && max != '0')<br> errorMsg(f(qid)[code].label() + ": " + f('qErrors')[14].label())<br>}

---

Function Name:
mincheckopenMD

Function Definition:
function mincheckopenMD(countstr) {<br>  var regex = /\r\n/g;<br>  var val = countstr.replace(regex,' ');<br>  var charcnt:int=0;<br>  for( var j=0;j<val.length;j++ )<br>  {<br>    if(val.charCodeAt(j)!=32)<br>    {<br>      charcnt=charcnt+1;<br>    }

---

Function Name:
ClearForm

Function Definition:
function ClearForm(frmName) {<br>if (typeof(frmName) == "undefined")<br>{<br> frmName=CurrentForm();<br>}

---

Function Name:
CheckDK

Function Definition:
function CheckDK(qid,qiddk) {<br><br>if (!QuestionErrors()) {<br>  if (!f(qid).toBoolean() && !f(qiddk).toBoolean()) {<br>    RaiseError();<br>    SetQuestionErrorMessage(CurrentLang(),f('qErrors')['1'].label());<br>    }

---

Function Name:
CheckDK3D

Function Definition:
function CheckDK3D(qid,qiddk) {<br>{<br>ClearForm('qErrNum');<br>f('qErrNum')[3].set(f(CurrentForm()).text());<br>CheckDK(qid,qiddk)<br>f('qErrNum')[3].set(null);<br>}

---

Function Name:
CheckDKRows

Function Definition:
function CheckDKRows(qid,qiddk) {<br>if (!QuestionErrors()) {<br>var codes = f(qid).domainValues()<br>for (var i = 0; i<codes.length;i++)<br>{<br>  var code = codes[i]<br>  if (!f(qid)[code].toBoolean() && !f(qiddk)[code].toBoolean()) {<br>    errorMsg(f(qid)[code].label()+": "+f('qErrors')['1'].label())<br>    break;<br>    }

---

Function Name:
GetNum

Function Definition:
function GetNum(QID) {<br>if (f(QID).toBoolean())<br>  return f(QID).toNumber()<br>else<br>  return 0;<br>}

---

Function Name:
GetNumLoop

Function Definition:
function GetNumLoop(QID,loop) {<br>if (f(QID,loop).toBoolean())<br>  return f(QID,loop).toNumber()<br>else<br>  return 0;<br>}

---

Function Name:
CheckMultiOpen

Function Definition:
function CheckMultiOpen() {<br>  var precodes = f(CurrentForm()).domainValues();<br>  <br>  if ( f(CurrentForm()).toBoolean() ) {<br>  blankchecklist();<br>  }

---

Function Name:
CheckSequence

Function Definition:
function CheckSequence(precodesIn) {<br>  var valid = true;<br>  <br>  for ( var i = 0; i < precodesIn.length - 1; i++ )<br>  {<br>    if ( !f(CurrentForm())[precodesIn[i]].toBoolean() && f(CurrentForm())[precodesIn[i+1]].toBoolean() )<br>      {<br>         valid = false;<br>      }

---

Function Name:
CheckUnique

Function Definition:
function CheckUnique(precodesIn) {<br>  var valid = true;<br><br>  for ( var i = 0; i < precodesIn.length; i++ )<br>  {<br>    for ( var j = i + 1; j < precodesIn.length; j++ )<br>    {<br>      if ( f(CurrentForm())[precodesIn[i]].toBoolean() && f(CurrentForm())[precodesIn[j]].toBoolean() )<br>      {<br>        if ( trim(f(CurrentForm())[precodesIn[i]].get().toUpperCase()) == trim(f(CurrentForm())[precodesIn[j]].get().toUpperCase()) )<br>        {<br>          valid = false;<br>        }

---

Function Name:
CheckMultiOpen3D

Function Definition:
function CheckMultiOpen3D() {<br>ClearForm('qErrNum');<br>f('qErrNum')[3].set(f(CurrentForm()).text());<br>CheckMultiOpen(); <br>f('qErrNum')[3].set(null);<br>}

---

Function Name:
PopulateFrom

Function Definition:
function PopulateFrom(qid,qid2) {<br>var allq2=f(qid).domainValues()<br>for(var i=0;i<allq2.length;i++)<br>{<br>  if(a(qid2).inc(allq2[i]) && f(qid2)[allq2[i]].toBoolean())<br>    f(qid)[allq2[i]].set(f(qid2)[allq2[i]].get())<br>else<br>  f(qid)[allq2[i]].set(0)<br>}

---

Function Name:
PopulateFromLoop

Function Definition:
function PopulateFromLoop(qid,qid2,iNum) {<br>var allq2=f(qid).domainValues()<br>for(var i=0;i<allq2.length;i++)<br>{<br>  if(a(qid2,iNum).inc(allq2[i]) && f(qid2,iNum)[allq2[i]].toBoolean())<br>    f(qid)[allq2[i]].set(f(qid2,iNum)[allq2[i]].get())<br>else<br>  f(qid)[allq2[i]].set(0)<br>}

---

Function Name:
storeRandOrder

Function Definition:
function storeRandOrder(qid) {<br>	var hqid = f(qid);<br>	var codes = hqid.domainValues();<br>	for(var i=0;i<codes.length;i++)<br>	hqid[codes[i]].set(i+1);<br>}

---

Function Name:
FindMinMax

Function Definition:
function FindMinMax(qid,find,numItems) {<br><br>  var precodes = f(qid).domainValues();<br><br><br>  // Build an array of code/value pairs<br>  var a = [];<br>  <br>  for (var i=0; i<precodes.length; ++i)<br>    a[i] = {code: precodes[i], val : f(qid)[precodes[i]].toNumber()}

---

Function Name:
SortVals

Function Definition:
function SortVals(a, b) {<br>	var x = parseFloat(a.val);<br>	var y = parseFloat(b.val);<br><br>	if (x>y) <br> 	 return -1;<br>	else if (x<y)<br> 	 return 1;<br>	else<br> 	 return 0;<br><br>//Used by FindMinMax function<br>}

---

Function Name:
CompareNum

Function Definition:
function CompareNum(qid,check,num,type) {<br><br>if ( !QuestionErrors() )  {<br><br>var sum = Sum(f(qid).values());<br>var bflag = false<br>var errtxt = "";<br><br>f('qErrNum')[1].set(num);<br>f('qErrNum')[2].set(sum);<br><br>if (type == 'rows')<br>{<br>var codes = f(qid).domainValues();<br><br><br>for (var i=0;i<codes.length;++i)<br> {<br> errtxt = "";<br> if ( f('qErrNum')[3].toBoolean() ) { errtxt =  errtxt + f('qErrors')[36].label(); }

---

Function Name:
CompareNum3D

Function Definition:
function CompareNum3D(qid,check,num,type) {<br>ClearForm('qErrNum');<br>f('qErrNum')[3].set(f(CurrentForm()).text());<br>CompareNum(qid,check,num,type) <br>f('qErrNum')[3].set(null);<br>}

---

Function Name:
CompareNumAnsw

Function Definition:
function CompareNumAnsw(qid,check,num) {<br>var bflag = false<br><br>if ( !QuestionErrors() )  {<br> <br> var sum = GetNum(qid)<br> var errtxt = "";<br><br> f('qErrNum')[1].set(num);<br> f('qErrNum')[2].set(sum);<br> <br> if ( f('qErrNum')[3].toBoolean() ) { errtxt =  errtxt + f('qErrors')[36].label(); }

---

Function Name:
CompareNumQues

Function Definition:
function CompareNumQues(qid1,check,qid2,qidcodes) {<br>if ( !QuestionErrors() )  {<br><br>var bflag = false;<br>var errtxt = "";<br>var codes = f(qidcodes).domainValues();<br><br><br>for (var i=0;i<codes.length;++i)<br>{<br> f('qErrNum')[1].set(GetNum(qid2+'_'+codes[i]));<br> <br> errtxt = "";<br> if ( f('qErrNum')[3].toBoolean() ) { errtxt =  errtxt + f('qErrors')[36].label(); }

---

Function Name:
CompareNumQues3D

Function Definition:
function CompareNumQues3D(qid1,check,qid2,qidcodes) {<br>ClearForm('qErrNum');<br>f('qErrNum')[3].set(f(CurrentForm()).text());<br>CompareNumQues(qid1,check,qid2,qidcodes) <br>f('qErrNum')[3].set(null)<br>}

---

Function Name:
CheckUniqueNum

Function Definition:
function CheckUniqueNum() {<br> <br>  var precodes = f(CurrentForm()).domainValues();<br>  var valid = true;<br> <br>  for ( var i = 0; i < precodes.length; i++ )<br>  {<br>    for ( var j = i + 1; j < precodes.length; j++ )<br>    {<br>      if ( f(CurrentForm())[precodes[i]].toBoolean() && f(CurrentForm())[precodes[j]].toBoolean() )<br>      {<br>        if ( f(CurrentForm())[precodes[i]].toNumber() == f(CurrentForm())[precodes[j]].toNumber() )<br>        {<br>          errorMsg('12')<br>        }

---

Function Name:
SumRows

Function Definition:
function SumRows(qid,columns,total,qid2) {<br>var val = 0;<br>var precodes = f(qid+'1').domainValues();<br>var flag = false;<br><br>for(var i=0;i<precodes.length;++i)<br>{<br>var code = precodes[i];<br>var sum = 0;<br>for (var j=1; j <= columns; j++)<br>{<br>var a : int = f(qid+j)[code].toBoolean() ? f(qid+j)[code].toNumber() : 0;<br>sum = sum +a;<br>}

---

Function Name:
SumRowsDK

Function Definition:
function SumRowsDK(qid,columns,total,qid2,qiddk) {<br>var val = 0;<br>var precodes = f(qid+'1').domainValues();<br>var flag = false;<br><br>	for(var i=0;i<precodes.length;++i)<br>	{<br>		if(!f(qiddk)[precodes[i]].toBoolean())<br>		{<br>			var code = precodes[i];<br>			var sum = 0;<br>			for (var j=1; j <= columns; j++)<br>			{<br>			var a : int = f(qid+j)[code].toBoolean() ? f(qid+j)[code].toNumber() : 0;<br>			sum = sum +a;<br>			}

---

Function Name:
CatchError

Function Definition:
function CatchError() {<br>   if( QuestionErrors()) <br>{RaiseError();<br>SetQuestionErrorMessage(CurrentLang(),'QuestionErrors');<br>}

---

Function Name:
TermSetup

Function Definition:
function TermSetup(code,ir) {<br>  f('screenStatusAll')['SCREENER_QUIT'].set(null)<br>  f('screenStatusAll')['SURVEY_QUIT'].set(null)<br>  f('screenStatus').set(code);<br>  if(f('qTesting')!='1' || (isTest() && ir==0)) {<br>    f('screenStatusAll')[code].set('1');<br>  }

---

Function Name:
ClearSoftScreenID

Function Definition:
function ClearSoftScreenID(code) {<br>  f('screenStatusAll_'+code).set(0);<br>}

---

Function Name:
ColumnForm

Function Definition:
function ColumnForm(gridName, iNum, qName, color, width, type) {<br> var s = "";<br> var sColName = '"#desktop_'+qName+"_text"<br> var codes = f(qName).domainValues()<br> for (var i = 0;i<codes.length;i++)<br> {<br>   s = s + '$("#desktop_'+qName+'_'+codes[i]+'").parent().parent().css("background","'+ color +'");';<br>   s = s + '$( "td" ).has( "#desktop_'+qName+'_'+codes[i]+'").css("background","'+ color +'");';<br>   if (type=='hide')   <br>   {<br>    s = s + '$("#desktop_'+qName+'_'+codes[i]+'").parent().parent().parent().css("border","0");';<br>    s = s + '$("#desktop_'+qName+'_'+codes[i]+'").parent().parent().parent().html("");';<br>   }

---

Function Name:
ColMaskShowDum

Function Definition:
function ColMaskShowDum(s, iNum) {<br> var iNum2 :int = (iNum+1)*1<br> return (s.inc(iNum) && s.isect(nnset(iNum2,99)).size()>0)<br>}

---

Function Name:
ColMaskHideDum

Function Definition:
function ColMaskHideDum(s,gid,qid,iNum) {<br> var ss = ""<br> for (var i=1;i<=iNum;i++)<br> {<br>  var iNum1 = (i+1)*1<br>  if (s.inc(i) && s.isect(nnset(iNum1,10+iNum)).size()>0)<br>   ss = ss + ColumnForm(gid, 2*(s.isect(nset(i)).size()) , qid+i, '#A6A6A8', 20, 'hide')<br> }

---

Function Name:
MultiQuotaCheck

Function Definition:
function MultiQuotaCheck(qid,quota) {<br> var c = f(qid).categories();<br> ClearForm(qid)<br> <br>  var bflag = true;<br><br> for (var i=0; i<c.length; ++i)<br> {<br>  f(qid)[c[i]].set(1);<br>  if (!qf(quota)) bflag=false;<br>  <br>  f(qid)[c[i]].set(0);<br>}

---

Function Name:
PriorityCompare

Function Definition:
function PriorityCompare(a, b) {<br> return b.priority-a.priority;<br>}

---

Function Name:
SetNegScale

Function Definition:
function SetNegScale(qid,sub) {<br>ClearForm(qid);<br>  <br>var codes = f('h'+qid).domainValues();<br><br>for (var i=0;i<codes.length;++i)<br> if (f('h'+qid)[codes[i]].toBoolean())   <br>  f(qid)[codes[i]].set(f('h'+qid)[codes[i]].toNumber() - sub);<br><br>}

---

Function Name:
MultiGridTXT

Function Definition:
function MultiGridTXT(qidG, qid, s, txt) {<br> var sTXT = new String();<br> var codes = f(qid).categories()<br> for (var i=0;i<codes.length;i++)<br> {<br>  var code = codes[i]<br>  if (s.inc(code))<br>   sTXT = sTXT +f(qidG+"_"+code+"_Other").get() + txt<br>  else<br>   sTXT = sTXT + f(qid)[code].label() + txt<br>  }

---

Function Name:
HideFWDButton

Function Definition:
function HideFWDButton(iSec) {<br>var txt = ""<br>var iDelay = iSec*1000<br>if (!IsInProductionMode())<br>  iDelay = 3000<br>txt = txt+'$("button.cf-navigation__button.cf-navigation-next").hide(); $(".cf-navigation").css("display","block");'<br>txt = txt+'setTimeout(function(){'<br>txt = txt+'$("button.cf-navigation__button.cf-navigation-next").show(); $(".cf-navigation").css("display","flex");'<br>txt = txt+'}

---

Function Name:
DisplayPrevious

Function Definition:
function DisplayPrevious(currqid,prevqid,nvar,ltxt,rtxt,bgcolor,qtype,mobileRendering) {<br>var precodes = f(currqid).domainValues();<br>var s : String ='';<br>  <br>if( !mobileRendering ){<br>  var style="var style=$('<style>.cf-question__content--mobile{display: none !important}

---

Function Name:
CheckBlankRespones

Function Definition:
function CheckBlankRespones(qid,precodes,col) {<br>var codes = precodes.members();<br><br>for (var i=0;i<codes.length;++i)<br>{<br> var code = codes[i];<br><br> if (GetNum(qid+'_'+code) >= 0)<br> {<br>  if (col == 'col') {<br>   f('qErrNum')[3].set(f(qid).text())<br>   errorMsg( f(qid)[code].label() + f('qErrors')['38'].label() );<br>  }

---

Function Name:
SetResponsesNull

Function Definition:
function SetResponsesNull(qid,precodes) {<br>var codes = precodes.members();<br><br>for (var i=0;i<codes.length;++i)<br> f(qid)[codes[i]].set(null);<br><br>}

---

Function Name:
ValidateDisabledCells

Function Definition:
function ValidateDisabledCells(currqid,prevqid,col) {<br>var precodes = f(prevqid).domainValues();<br><br>for (var i=0; i<precodes.length; ++i)<br>{<br>var code = precodes[i];<br><br>if (GetNum(prevqid+'_'+code) == 0 && f(currqid)[code].toBoolean())<br>{<br> if (col == 'col') {<br>	f('qErrNum')[3].set(f(currqid).text())<br>   errorMsg(f(currqid)[code].label() + f('qErrors')['38'].label());<br>   }

---

Function Name:
setIntLength

Function Definition:
function setIntLength(code) {<br> if (IsInProductionMode()) {<br><br> f('qTimeStamp')[code].set( new Date())<br> <br><br><br> if ( !f('qTimeStamp')['screener'].toBoolean() ) <br>  f('qTimeStamp')['screener'].set( f('qTimeStamp')[code].get() )<br> <br> var prevSec = f('qTimeStamp').categories();   <br> var x = prevSec.length-2<br> var prevCode = prevSec[x];<br> var date1 = new Date(f('qTimeStamp')[code].get()); <br> var date2 = new Date(f('qTimeStamp')[prevCode].get());<br> var timeDiff=Math.ceil((Math.ceil(date1.getTime()-date2.getTime())/600)/100);<br> <br> f('qIntLen')[code].set(timeDiff) <br><br> //Response.Write("prevSec="+prevSec);<br> //Response.Write("<br>prevSec.length="+prevSec.length);<br> //Response.Write("<br>x="+x);<br> <br> if (code == 'surveyLOI') {<br><br>  f('qTimeStamp')['main'].set( new Date() )<br>  <br>  //Main survey LOI<br>  var date3 = new Date(f('qTimeStamp')['screener'].get()); <br>  var mainLOI = Math.ceil(((Math.ceil(date1.getTime()-date3.getTime())/600)/100));<br>  f('qIntLen')['main'].set(mainLOI) <br> <br>  //Full survey LOI <br>  var date4 = new Date(f('qTimeStamp')['start'].get()); <br>  var fullLOI = Math.ceil(((Math.ceil(date1.getTime()-date4.getTime())/600)/100));<br><br>   f('qIntLen')[code].set(fullLOI) <br>   <br>   if ( !f('qIntLen')['screener'].toBoolean() )<br>	f('qIntLen')['screener'].set(f('qIntLen')['surveyLOI'].get())<br> }

---

Function Name:
setElapseTime

Function Definition:
function setElapseTime(qid) {<br>// if (IsInProductionMode()) {<br><br> f('hElapse')[2].set( new Date())<br><br> var date1 = new Date( f('hElapse')[1].get()); <br> var date2 = new Date( f('hElapse')[2].get());<br><br> var timeDiff=Math.ceil((Math.ceil(date2.getTime()-date1.getTime())/1000));<br> <br> f(qid)[1].set(timeDiff) <br>// }

---

Function Name:
CheckUsername

Function Definition:
function CheckUsername(qIDs,limit) {<br>var flag = true;<br><br>for (var i=1;i<=limit;++i) {<br><br>var username = "";	<br>	<br>	for (var x=0;x<qIDs.length;++x) {<br>     username = username + "y" + f(qIDs[x]).get();<br>	}

---

Function Name:
CheckIPlist

Function Definition:
function CheckIPlist() {<br>var precodes = f('qIPs').domainValues();<br>var flag = false;<br><br>for (var i=1;i<=precodes;++i) {<br>if (f('IPaddress').get() == f('qIPs')[precodes[i]].label()) {<br> flag = true;<br> break;<br> }

---

Function Name:
CheckUniqueIP

Function Definition:
function CheckUniqueIP() {<br>var flag = true;<br><br>var username = f('IPaddress').get();	<br>	<br>f('username').set(username)<br>	<br>if (!isUsernameTaken(f('username'))) {<br> flag = false;<br> }

---

Function Name:
CheckTestID

Function Definition:
function CheckTestID() {<br>var flag = false;<br><br>var precodes = [2,268245,268246,357462,268248,268250,268252,434264,434265,434266,434267,434268,434269,434270,434271,434272,434273,5778968,5778967,5778966,5778965,5778964,5778963,5778962,5778961,5778960,5778959,5778958,5778957,5778956,5778955,5778954,5778953,5778952,5778951,5778950,5778949,5778947,5778940]; //f('QTestIDs').domainValues();<br><br>for (var i=0;i<precodes.length;++i)<br>{<br>var code = precodes[i];<br><br>if (f('user_id').get() == code)<br> flag = true;<br>}

---

Function Name:
GetMinimum

Function Definition:
function GetMinimum(fset, fquota, fselection) {<br> var jset = new Set();<br> jset = jset.union(fset);<br> var num : int = jset.size();<br> var aMin = 9999;<br> var codeMin;<br> for(var i=0;i<num;++i)<br> {<br>  var precodes = jset.members();<br>  var RandCode = Math.floor(Math.random()*precodes.length)<br>  var code = precodes[RandCode];   <br>  f (fselection)[code].set(1)<br>  var a = (qc(fquota)+2)/(qt(fquota)+2);<br>  if (a < aMin) <br>  {<br>   aMin = a;<br>   codeMin = code<br>  }

---

Function Name:
GetMinimumMulti

Function Definition:
function GetMinimumMulti(fset,n,fquota,fselection) {<br>	var s1 = fset;<br>	var s2 = new Set();<br>				<br>	for(var i : int =0; i<n;++i)	{<br>		var code = GetMinimum(s1, fquota, fselection)<br>		s1.remove(code)<br>		s2.add(code)<br>	}

---

Function Name:
GetMinimumS

Function Definition:
function GetMinimumS(fset, fquota, fselection) {<br> var jset = new Set();<br> jset = jset.union(fset);<br> var num : int = jset.size();<br> var aMin = 9999;<br> var codeMin;<br> for(var i=0;i<num;++i)<br> {<br>  var precodes = jset.members();<br>  var RandCode = Math.floor(Math.random()*precodes.length)<br>  var code = precodes[RandCode];   <br>  f(fselection).set(code)<br>  var a = (qc(fquota)+2)/(qt(fquota)+2);<br>  if (a < aMin) <br>  {<br>   aMin = a;<br>   codeMin = code<br>  }

---

Function Name:
GetOpenVersion

Function Definition:
function GetOpenVersion(qidVersion,quotaName) {<br>var v = f(qidVersion);<br>var available = nset(v.domainValues().length); //set of available codes from version question<br><br>while(available.size()>0)<br> {<br>  var precodes = available.members();<br>  var code = precodes[Math.floor(Math.random()*precodes.length)]; //randomly pick one of the codes<br>  v.set(code); //set that code in "version" question<br><br>  if(!qf(quotaName))  //if quota is not full, end with this code in "version"<br>  {<br>  break;<br>  }

---

Function Name:
pickLRCell

Function Definition:
function pickLRCell(qid, quotaid,num,maskQID) {<br><br>	var i,quota_count,j,temp,len,quota_target, pct_short;<br>	<br>	var DEBUG = f('qTesting').toNumber() == 1;<br><br>	var arrCodes = new Array();<br>	var arrCounts = new Array();<br>	var arrPrecodes = f(qid).domainValues();<br>//Response.Write("arrPrecodes: "+arrPrecodes)<br><br>var currentIndex = arrPrecodes.length;<br>var temporaryValue;<br>var randomIndex;<br><br>  // While there remain elements to shuffle...<br>  while (0 !== currentIndex) {<br><br>    // Pick a remaining element...<br>    randomIndex = Math.floor(Math.random() * currentIndex);<br>    currentIndex -= 1;<br><br>    // And swap it with the current element.<br>    temporaryValue = arrPrecodes [currentIndex];<br>    arrPrecodes [currentIndex] = arrPrecodes [randomIndex];<br>    arrPrecodes [randomIndex] = temporaryValue;<br>  }

---

Function Name:
setDKNumeric

Function Definition:
function setDKNumeric(QID) {<br><br>var s=''<br>var precodes = f(QID).domainValues()<br>var code=0;<br>s=s +'setInterval(function(){'<br><br>for(var i=0; i<precodes.length; i++)<br>{<br>   code=precodes[i]<br><br>	s=s + 'if ($("div#desktop_'+QID+'DK_1").hasClass("cf-checkbox-answer--selected")){$("input#desktop_'+QID+'_'+ code+'").attr("disabled", true);$("input#desktop_'+QID+'_'+ code+'").css("pointer-events", "none");$("input#desktop_'+QID+'_'+ code+'").val("");$("input#desktop_'+QID+'_'+ code+'").css("background-color", "#e8e8e8"); }

---

Function Name:
setDKNumeric_OLD

Function Definition:
function setDKNumeric_OLD(QID) {<br><br>var s=''<br>var precodes = f(QID).domainValues()<br>var code=0;<br>s=s +'setInterval(function(){'<br><br>for(var i=0; i<precodes.length; i++)<br>{<br>   code=precodes[i]<br><br>	s=s + 'if ($("div#desktop_'+QID+'DK_'+ code+'").hasClass("cf-checkbox-answer--selected")){$("input#desktop_'+QID+'_'+ code+'").attr("disabled", true);$("input#desktop_'+QID+'_'+ code+'").css("pointer-events", "none");$("input#desktop_'+QID+'_'+ code+'").val("");$("input#desktop_'+QID+'_'+ code+'").css("background-color", "#e8e8e8"); }

---

Function Name:
setDKDropdown

Function Definition:
function setDKDropdown(QID) {<br>var s=''<br><br>s='setInterval(function(){if ($("div#'+QID+'DK_1").hasClass("cf-checkbox-answer--selected")){$("select#'+QID+'_input").attr("disabled", true); $("select#'+QID+'_input").val("");}

---

Function Name:
setDKRows3D

Function Definition:
function setDKRows3D(QID) {<br><br>var s=''<br>var precodes = f(QID).domainValues()<br>var code=0;<br>s=s +'setInterval(function(){'<br><br>for(var i=0; i<precodes.length; i++)<br>{<br>   code=precodes[i]<br><br><br><br>   s=s + 'if ($("div#desktop_'+QID+'DK_'+ code+'").hasClass("cf-checkbox-answer--selected")){$("input#desktop_'+QID+'_'+ code+'").attr("disabled", true);$("input#desktop_'+QID+'_'+ code+'").css("pointer-events", "none");$("input#desktop_'+QID+'_'+ code+'").val("");$("input#desktop_'+QID+'_'+ code+'").css("background-color", "#e8e8e8"); }

---

Function Name:
isTest

Function Definition:
function isTest() {<br>var iTest = false;<br><br>if ((f('qTesting').toNumber() == 1) || (!IsInProductionMode()) || (Request.QueryString("__inmemorytest") == 1)) { <br>  iTest=true; <br>  if (!f('qTesting').toBoolean()) { f('qTesting').set(1); }

---

Function Name:
echo

Function Definition:
function echo(text) {<br>   if (isTest()) {<br>      return Response.Write("<li>"+text);<br>   }

---

Function Name:
isTestId

Function Definition:
function isTestId() {<br>  return f('qTesting') == 1 && f("hULink").toBoolean() && (f('showJumpLinks').toNumber()==1 || f('showJumpLinks').toNumber()==2);<br>}

---

Function Name:
getUniqueLink

Function Definition:
function getUniqueLink() {<br><br>var iULString = "";<br><br>if (isTestId() && f('hSLFlags').none('j')) {<br>  iULString+= '<DIV id=footerInfo3 class=footer><CENTER><B>Unique Link'+ tooltip("","Copy and save this link if you want to resume your session later.", "showIcon: true") +'</B> ('+f("SurveyID")+ ', r=' +CurrentID()+ '): <SPAN style="COLOR: blue">'+f("hULink").get() + '&l=' + CurrentLang() +'</SPAN><span id="btn_surveylink" onclick="copyUniqueLink()">Copy to Clipboard</span></CENTER></DIV></CENTER></DIV>';<br>  iULString+= '<script>\n ';<br>  iULString+= 'function copyUniqueLink() {\n ';<br>  iULString+= '  var copyText = "' + f("hULink").get() + "&l=" + CurrentLang() + '" \n ';<br>  iULString+= '  navigator.clipboard.writeText(copyText);\n ';<br>  iULString+= '  alert("Link Copied! \\n\\n"+copyText);\n ';<br>  iULString+= '}

---

Function Name:
callBlind

Function Definition:
function callBlind() {<br>var hflags = Request.QueryString("blind").toLocaleString();<br><br>if (hflags != 0 && hflags != "" && hflags != undefined) {<br>  ClearForm('hSLFlags');<br>  if (hflags.indexOf('l') != -1) { f('hSLFlags_l').set(1) }

---

Function Name:
OEMinChars

Function Definition:
function OEMinChars() {<br>  var noofchar = 2; //default<br>  var lang = CurrentLang();<br>  <br>  //Chinese languages<br>  if (lang==4 || lang==3076 || lang==5124 || lang==43012 || lang==34820 || lang==44036 || lang==2052 || lang==32772 || lang==4100 || lang==1028 || lang==31748 )<br>    noofchar = 1; <br>  <br>  return noofchar;<br>}

---

Function Name:
validateOEs

Function Definition:
function validateOEs() {<br>var vArr = [];<br>var minChar = OEMinChars();<br><br><br>//vArr.push("<SCRIPT>");<br>vArr.push("if (window.addEventListener) {");<br>vArr.push("    document.getElementById('forwardbutton').addEventListener('click', function(event) {");<br>vArr.push("        if (validateOEs()) {");<br>vArr.push("          $('#oealert').show();");<br>vArr.push("          $('.errorquestion').hide();");<br>vArr.push("          $('.questionarea').css('margin-top','0px');");<br>vArr.push("          $(window).scrollTop(0);");<br>vArr.push("          event = $.event.fix(event);");<br>vArr.push("          event.preventDefault();");<br>vArr.push("        }

---

Function Name:
getOEMsg

Function Definition:
function getOEMsg() {<br>var minChar = OEMinChars();<br><br>var iMsg = f('qErrors_OEAlert').label();<br>var reg = new RegExp('\\[\\[\\]\\]', 'g');<br>iMsg = iMsg.replace(reg, minChar);<br><br><br>return iMsg;<br>}

---

Function Name:
isQuotaFull

Function Definition:
function isQuotaFull() {<br>  ClearForm('qHardQuota')<br>  var form  = f('qHardQuota'),<br>      dv = form.domainValues(),<br>      strarry;<br>  <br>  var re = /OVERQUOTA_/;<br>  <br>  for ( var q=0; q<dv.length; q++)<br>  if( re.test(dv[q]) )	{<br>  	strarry = dv[q].split("_");<br>    //Response.Write("strarryQID:"+strarry[1]+"<br>");<br>  	if ( qf(strarry[1]) ) {<br>      form['OVERQUOTA_'+strarry[1]].set(1);<br>      return true;<br>  }

---

Function Name:
getEndRedirects

Function Definition:
function getEndRedirects(sample, status) {<br>var retURL = "";<br><br>var hashTest="";<br> <br>var QualityScore=""<br>if( !isTest() && enableIQS()  ){<br>    QualityScore="&ssi="+CurrentPID()+"&qscore=1";<br>}

---

Function Name:
checkOtherSpecify

Function Definition:
function checkOtherSpecify(aQIDs, aCodes, QID3d) {<br>  //Run for all other specify codes<br>  for (var i=0;i<aCodes.length;i++) {<br>    //All questions except 3D Grids<br>    if ((QID3d == '' || QID3d==undefined) && aQIDs.length==1) {<br>      var iQIDs = aQIDs[0].split(":");<br>      var qid = iQIDs[0];<br>      var qType = iQIDs[1].toUpperCase();<br>      var code = aCodes[i];<br>      var sErrorMsg;<br>      var errorFlag = false;<br>      var iLabelOther = "";<br>               <br>      switch (qType) {<br>          //Single, Multi, Open and Grid<br>          case "S" : case "M" : case "O" : case "G" :<br>            if (f(qid).any(code) && !f(qid+'_'+code+'_other').toBoolean()) {<br>              if (f(qid).getType()=="COMPOUND")<br>                sErrorMsg = f('qErrors_2').label()+f(qid+"_"+code).label()+f('qErrors_3').label();<br>               else <br>                sErrorMsg = f('qErrors_2').label()+f(qid).valueLabel()+f('qErrors_3').label();<br>              if (qType=="G") { f(qid)[code].set(null); }

---

Function Name:
checkMinCharsOEs

Function Definition:
function checkMinCharsOEs(input, labeloe) {<br>var str = trim(input);<br>var noofchar = OEMinChars();<br>var lang=CurrentLang();<br><br>if ((lang==4 || lang==3076 || lang==5124 || lang==43012 || lang==34820 || lang==44036 || lang==2052 || lang==32772 || lang==4100 || lang==1028 || lang==31748) && noofchar ==2 ) { noofchar = 1; }

---

Function Name:
checkOS

Function Definition:
function checkOS(exc) {<br><br>	if (!QuestionErrors())<br>	{<br>		var ids=[];<br>		var gridname="";<br>		var qNamesInGrid=Get3DGridQuestionIds(CurrentForm());<br>		if( is3D() ){  //it means 3Dgrid<br>		    gridname=getGridName();<br>			ids=Get3DGridQuestionIds(gridname).slice(1)<br>		}

---

Function Name:
isRanking

Function Definition:
function isRanking(id) {<br>		var rankQ=false<br>		try{<br>			First(id)<br>			rankQ=true;			<br>		}

---

Function Name:
is3D

Function Definition:
function is3D(id) {<br>		var is3Dgrid=true;<br>		var allQs=getAllQs()<br>		for( var i=0; i<allQs.length; i++ ){<br>			<br>			if( allQs[i]==CurrentForm() ){<br>				is3Dgrid=false;<br>				break;<br>			}

---

Function Name:
getGridName

Function Definition:
function getGridName() {<br>		var gridN=""<br>		var allQs=getAllQs()<br>		for( var i=0; i<allQs.length; i++ ){<br>			var gridIDs=Get3DGridQuestionIds(allQs[i]);<br>			for( var n=0; n<gridIDs.length; n++ ){<br>				if( gridIDs[n]==CurrentForm() ){<br>					gridN=allQs[i];<br>					break;<br>				}

---

Function Name:
getAllQs

Function Definition:
function getAllQs() {<br>		if( Request.Form("__loopProgress")==undefined ){  //question is not in the loop<br>			return GetQuestionIds(true, false);<br>		}

---

Function Name:
timeOutMsg

Function Definition:
function timeOutMsg() {<br>var txt = "";<br>if( isTest() || f('qSurveyType').any('2','4') || f('hSType').any('2') || !IsInProductionMode() )<br>    txt+="";<br>else{<br>txt +="<script type=\"text/javascript\">\n";<br>txt +="var idleTime = 0;\n";<br>txt +="$(document).ready(function () {\n";<br>txt +="//Increment the idle time counter every minute.\n";<br>txt +="var idleInterval = setInterval(timerIncrement, 60000); // 1 minute\n";<br><br>txt +="//Zero the idle timer on mouse click.\n";<br>txt +="$(this).click(function (e) {\n";<br>txt +="idleTime = 0;\n";<br>txt +="document.getElementById(\"TimeoutMessage\").style.display=\"none\";\n";<br>txt +="}

---

Function Name:
timerIncrement

Function Definition:
function timerIncrement() {\n";<br>txt +="idleTime = idleTime + 1;\n";<br>txt +="if (idleTime >= "+GetNum('hidTimeOutMin_1')+") { // 5 minutes\n";<br>txt +="document.getElementById(\"TimeoutMessage\").style.display=\"block\";\n";<br>txt +="}

---

Function Name:
SHA256

Function Definition:
function SHA256(s) {<br> var chrsz = 8;<br> var hexcase = 0;<br><br> function safe_add (x, y) {<br> var lsw = (x & 0xFFFF) + (y & 0xFFFF);<br> var msw = (x >> 16) + (y >> 16) + (lsw >> 16);<br> return (msw << 16) | (lsw & 0xFFFF);<br> }

---

Function Name:
S

Function Definition:
function S(X, n) { return ( X >>> n ) | (X << (32 - n)); }

---

Function Name:
R

Function Definition:
function R(X, n) { return ( X >>> n ); }

---

Function Name:
Ch

Function Definition:
function Ch(x, y, z) { return ((x & y) ^ ((~x) & z)); }

---

Function Name:
Maj

Function Definition:
function Maj(x, y, z) { return ((x & y) ^ (x & z) ^ (y & z)); }

---

Function Name:
Sigma0256

Function Definition:
function Sigma0256(x) { return (S(x, 2) ^ S(x, 13) ^ S(x, 22)); }

---

Function Name:
Sigma1256

Function Definition:
function Sigma1256(x) { return (S(x, 6) ^ S(x, 11) ^ S(x, 25)); }

---

Function Name:
Gamma0256

Function Definition:
function Gamma0256(x) { return (S(x, 7) ^ S(x, 18) ^ R(x, 3)); }

---

Function Name:
Gamma1256

Function Definition:
function Gamma1256(x) { return (S(x, 17) ^ S(x, 19) ^ R(x, 10)); }

---

Function Name:
core_sha256

Function Definition:
function core_sha256(m, l) {<br> var K = new Array(0x428A2F98, 0x71374491, 0xB5C0FBCF, 0xE9B5DBA5, 0x3956C25B, 0x59F111F1, 0x923F82A4, 0xAB1C5ED5, 0xD807AA98, 0x12835B01, 0x243185BE, 0x550C7DC3, 0x72BE5D74, 0x80DEB1FE, 0x9BDC06A7, 0xC19BF174, 0xE49B69C1, 0xEFBE4786, 0xFC19DC6, 0x240CA1CC, 0x2DE92C6F, 0x4A7484AA, 0x5CB0A9DC, 0x76F988DA, 0x983E5152, 0xA831C66D, 0xB00327C8, 0xBF597FC7, 0xC6E00BF3, 0xD5A79147, 0x6CA6351, 0x14292967, 0x27B70A85, 0x2E1B2138, 0x4D2C6DFC, 0x53380D13, 0x650A7354, 0x766A0ABB, 0x81C2C92E, 0x92722C85, 0xA2BFE8A1, 0xA81A664B, 0xC24B8B70, 0xC76C51A3, 0xD192E819, 0xD6990624, 0xF40E3585, 0x106AA070, 0x19A4C116, 0x1E376C08, 0x2748774C, 0x34B0BCB5, 0x391C0CB3, 0x4ED8AA4A, 0x5B9CCA4F, 0x682E6FF3, 0x748F82EE, 0x78A5636F, 0x84C87814, 0x8CC70208, 0x90BEFFFA, 0xA4506CEB, 0xBEF9A3F7, 0xC67178F2);<br> var HASH = new Array(0x6A09E667, 0xBB67AE85, 0x3C6EF372, 0xA54FF53A, 0x510E527F, 0x9B05688C, 0x1F83D9AB, 0x5BE0CD19);<br> var W = new Array(64);<br> var a, b, c, d, e, f, g, h, i, j;<br> var T1, T2;<br><br> m[l >> 5] |= 0x80 << (24 - l % 32);<br> m[((l + 64 >> 9) << 4) + 15] = l;<br><br> for ( var i = 0; i<m.length; i+=16 ) {<br> a = HASH[0];<br> b = HASH[1];<br> c = HASH[2];<br> d = HASH[3];<br> e = HASH[4];<br> f = HASH[5];<br> g = HASH[6];<br> h = HASH[7];<br><br> for ( var j = 0; j<64; j++) {<br> if (j < 16) W[j] = m[j + i];<br> else W[j] = safe_add(safe_add(safe_add(Gamma1256(W[j - 2]), W[j - 7]), Gamma0256(W[j - 15])), W[j - 16]);<br><br> T1 = safe_add(safe_add(safe_add(safe_add(h, Sigma1256(e)), Ch(e, f, g)), K[j]), W[j]);<br> T2 = safe_add(Sigma0256(a), Maj(a, b, c));<br><br> h = g;<br> g = f;<br> f = e;<br> e = safe_add(d, T1);<br> d = c;<br> c = b;<br> b = a;<br> a = safe_add(T1, T2);<br> }

---

Function Name:
str2binb

Function Definition:
function str2binb(str) {<br> var bin = Array();<br> var mask = (1 << chrsz) - 1;<br> for(var i = 0; i < str.length * chrsz; i += chrsz) {<br> bin[i>>5] |= (str.charCodeAt(i / chrsz) & mask) << (24 - i % 32);<br> }

---

Function Name:
Utf8Encode

Function Definition:
function Utf8Encode(string) {<br> string = string.replace(/\r\n/g,'\n');<br> var utftext = '';<br><br> for (var n = 0; n < string.length; n++) {<br><br> var c = string.charCodeAt(n);<br><br> if (c < 128) {<br> utftext += String.fromCharCode(c);<br> }

---

Function Name:
binb2hex

Function Definition:
function binb2hex(binarray) {<br> var hex_tab = hexcase ? '0123456789ABCDEF' : '0123456789abcdef';<br> var str = '';<br> for(var i = 0; i < binarray.length * 4; i++) {<br> str += hex_tab.charAt((binarray[i>>2] >> ((3 - i % 4)*8+4)) & 0xF) +<br> hex_tab.charAt((binarray[i>>2] >> ((3 - i % 4)*8 )) & 0xF);<br> }

---

Function Name:
getHash

Function Definition:
function getHash() {<br>	var s = '';<br>	var encode =  f('user_id').get() + f('survey_key').get() +'qCK8wZmdXEPkdrZREg4I';<br>  	s = SHA256(encode);<br>    return s;<br>}

---

Function Name:
popup

Function Definition:
function popup(code, params) {<br><br>  var options=""<br>  if( params!=undefined && params.split(':').length>1)  options=", "+params;<br>  var linkCode=code.split(",").length>1 ? code.split(",")[0].replace(/ /gi, "") : code<br>  var contentCode=code.split(",").length>1 ? code.split(",")[1].replace(/ /gi, "") : code.slice(0,-4)<br>  var JS=""<br>  JS+="<span id="+linkCode+">"+f('ProductProfile')[linkCode].label()+"</span>"<br>  JS+="<span style='display: none' id="+contentCode+"container>"+f('ProductProfile')[contentCode].label()+"</span>"<br>  JS+="<script id=M3popupScript>\n"<br>  JS+="$(window).ready(function(){\n";<br>  JS+="var selfScriptTag=$('script[id=M3popupScript]').not('[used=true]').eq(0).attr('used','true')\n";<br>  JS+="if( selfScriptTag.length>0 ){\n";<br>  JS+="var profileEl = selfScriptTag.prev()\n"<br>  JS+="var linkEl= selfScriptTag.prev().prev().find('.proflink').length>0 ? selfScriptTag.prev().prev().find('.proflink') : selfScriptTag.prev().prev();\n"<br>  JS+="m3.popup({profile : profileEl, link: linkEl"+options+"}

---

Function Name:
tooltip

Function Definition:
function tooltip(linkwording, content, params) {<br>  var options="";<br>  var finalContent="";<br>  try{<br>    finalContent=f('ProductProfile')[content].label()  <br>  }

---

Function Name:
getInstLabel

Function Definition:
function getInstLabel(code) {<br>  return replaceQuotes(f('hInstrText_'+code).label());<br>}

---

Function Name:
getErrorLabel

Function Definition:
function getErrorLabel(code) {<br>  return replaceQuotes(f('qErrors_'+code).label());<br>}

---

Function Name:
getTitleLabel

Function Definition:
function getTitleLabel(code) {<br>  return replaceQuotes(f('qTitle_'+code).label());<br>}

---

Function Name:
replaceQuotes

Function Definition:
function replaceQuotes(txt) {<br>txt = txt.replace(/\'/g, "&#39;");<br>txt = txt.replace(/\"/g, "&#34;");<br>txt = txt.replace(/\’/g, "&#146;");<br>txt = txt.replace(/\“/g, "&#147;");<br>txt = txt.replace(/\”/g, "&#148;");<br><br>return txt;<br>}

---

Function Name:
buildTestScreen

Function Definition:
function buildTestScreen(qids) {<br>/***<br>Usage: Creates a html table to display results from questions for testing purposes.  Utilize for Singe, Multi, Number, Open questions, etc. that are not in 3D grids.<br> <br>Add to info node: ^buildTestScreen(new Array("Q101","Q102","Q103"))^<br>                          <br>***/<br>var str = "";<br>if (isTest()){<br>		<br>	str +='*** Shown only for testing purposes ***';<br>	str +='<br /><br />\n';<br>	str +='<table id="myTestTable">\n';<br>	str +='<tr><th>QID</th><th>Code(s) selected</th><th>Label(s) selected</th></tr>\n';<br><br><br><br>	for(var i : int = 0;i<qids.length;i++)<br>	{<br>		var form = qids[i];<br><br>		if(f(form).CODED)<br>		{<br>			str +='<tr><th>'+form+'</th><th>'+f(form).get()+'</th><th>'+f(form).valueLabel()+'</th></tr>\n';<br>		}

---

Function Name:
showTerm

Function Definition:
function showTerm() {<br>  return true;<br>}

---

Function Name:
dynTermScript

Function Definition:
function dynTermScript() {<br>  if( showTerm()  && isTest() && !isDynTerm())  return termJS();<br>}

---

Function Name:
isDynTerm

Function Definition:
function isDynTerm() {<br>  return Request.Form("bgterm")==1;<br>  //return Request.QueryString("bgterm")==1;<br>}

---

Function Name:
termJS

Function Definition:
function termJS() {<br><br>var JS="\n";<br>JS+="      <script>      \n";<br>JS+="      $(window).load(function(){      \n";<br>JS+="        var currentRequest= null     \n";<br>JS+="        $('.cf-question').eq('0').prepend($('<div id=terminfo></div>'))      \n";<br>JS+="        $('#terminfo').css({position: 'relative', height: '0px', overflow: 'visible', top: '-20px', color: 'red', 'font-size':'14px'}

---

Function Name:
checkWix

Function Definition:
function checkWix() {      \n";<br>JS+="          if (typeof wix != 'undefined') {       \n";<br>JS+="              wix.onCallbackComplete.subscribe(function() {      \n";<br>JS+="              userEvents();      \n";<br>JS+="          }

---

Function Name:
userEvents

Function Definition:
function userEvents() {      \n";<br>JS+="          $('.cf-page__question-list').find('[role=radio], [role=checkbox], .cf-radio-answer__content').on('click',checkTerm);      \n";<br>JS+="          $('input, select, textarea').on('click keyup change', checkTerm);      \n";<br>JS+="          $('.cf-page__question-list').find('select').on('change',checkTerm);      \n";<br>JS+="        }

---

Function Name:
checkTerm

Function Definition:
function checkTerm() {      \n";<br>JS+="          clearTimeout(delaySubmit);      \n";<br>JS+="          delaySubmit=setTimeout(function(){      \n";<br>JS+="       $('.DynTermStuff').html('');     \n";<br>JS+="      var Qs=window.Confirmit.page.formValues;      \n";<br>JS+="      for( var i=0; i<Qs.length; i++ ){      \n";<br>JS+="        var qName=Qs[i].name;      \n";<br>JS+="        var qValue=Qs[i].value;      \n";<br>JS+="        var hidInput=$(\"<input type=hidden name='\"+qName+\"' value='\"+qValue+\"'>\");      \n";<br>JS+="         DynTermStuff.append(hidInput);      \n";<br>JS+="      }

---

Function Name:
ctlsubmit

Function Definition:
function ctlsubmit() {      \n";<br>JS+="      	    $('.dynTermWait').show()      \n";<br>JS+="      	     var form=$('#page_form');      \n";<br>JS+="              var post_url = form.attr('action')/*+'&bgterm=1'*/;       \n";<br>//JS+="              var post_url = form.attr('action');       \n";<br>JS+="              var request_method = form.attr('method');      \n";<br>JS+="              var form_data = form.serialize();       \n";<br>JS+="             currentRequest= $.ajax({      \n";<br>JS+="                beforeSend: function(){if( currentRequest!=null ) currentRequest.abort(); }

---

Function Name:
isUS

Function Definition:
function isUS() { return f('qCountry').any('1033'); }

---

Function Name:
isES

Function Definition:
function isES() { return f('qCountry').any('10'); }

---

Function Name:
isCA

Function Definition:
function isCA() { return f('qCountry').any('4105','3084'); }

---

Function Name:
isCH

Function Definition:
function isCH() { return f('qCountry').any('4108','2055','2064'); }

---

Function Name:
isCN

Function Definition:
function isCN() { return f('qCountry').any('4'); }

---

Function Name:
isJP

Function Definition:
function isJP() { return f('qCountry').any('17'); }

---

Function Name:
isKR

Function Definition:
function isKR() { return f('qCountry').any('18'); }

---

Function Name:
isRU

Function Definition:
function isRU() { return f('qCountry').any('25'); }

---

Function Name:
isFR

Function Definition:
function isFR() { return f('qCountry').any('12'); }

---

Function Name:
isDE

Function Definition:
function isDE() { return f('qCountry').any('7'); }

---

Function Name:
isUK

Function Definition:
function isUK() { return f('qCountry').any('2057'); }

---

Function Name:
isIT

Function Definition:
function isIT() { return f('qCountry').any('16'); }

---

Function Name:
isBR

Function Definition:
function isBR() { return f('qCountry').any('1046'); }

---

Function Name:
captureScrQIDs

Function Definition:
function captureScrQIDs() {<br>  var JS="";<br>  var scrQID = "hScrAnswered";  //Stores all answered QIDs from screener<br>  var curQID = Request("vqid"); //Capture QID(s) on previous page<br>  var sExclQIDs = ['qCountry','SPECIALTY']; //add IDs to be excluded here as an array e.g. ['qCountry','SPECIALTY','AE1','s4','s2g'];<br><br>  //save collected qids in a Confirmit variable<br>  if (typeof(curQID) != "undefined" && curQID != "") {<br>    if (!f(scrQID).toBoolean()) {<br>      var acurQID = curQID.split(",");<br>      for (var i=0;i<acurQID.length;i++) {<br>        var qflag = 0;<br>        //Check if QID is in exclusion list <br>        for (var k=0;k<sExclQIDs.length;k++) {<br>          if ( sExclQIDs[k].toUpperCase()==acurQID[i].toUpperCase() ) {<br>            qflag++;<br>          }

---

Function Name:
getPixelContent

Function Definition:
function getPixelContent() {<br>var vArr = [];<br>var status = "";<br><br>if ( f('screenStatus').any('SCREENER_QUIT') ) { status = "S"; }

---

Function Name:
RoundANumber

Function Definition:
function RoundANumber(number, noofdecimalplaces) {<br>var seedno : int = 1;<br>for (var i=1;i<=noofdecimalplaces;i++) seedno = seedno*10;<br><br>return Math.round(number*seedno)/seedno;<br>}

---

Function Name:
checkQtaMilestonesForDVAlert

Function Definition:
function checkQtaMilestonesForDVAlert() {<br>var body = "";<br>var subject = "";<br>var toEmail = "";<br>var fromEmail = "NoReply@m3global.com";<br>var ccEmail = "";<br>var bccEmail = "";<br>var qtaTarget = 0;<br>var qtaCount = 0;<br>var qtaPercent = 0;<br>var totQuotaTarget = 0;<br>var totQuotaCount = 0;<br>var totQuotaPercent = 0;<br>var fQtaCount = 0;<br>var fTotalQtaCount = 0;<br><br>body += "<style>th {background:#002F66;color:#ffffff;font-size:16px;}

---

Function Name:
generatePretestPassword

Function Definition:
function generatePretestPassword() {<br>  var strPassword = "ABCDEFGHIJKLMNOPQRSTUVWXYZ123456789";<br>  var strRandomPwd = "";<br>  <br>  while (strRandomPwd.length<5) {<br>    var randomNumber : float = Math.random()*strPassword.length;<br>    var randomIndex : int = Math.floor(randomNumber);<br>    var char = strPassword.substr(randomIndex ,1);<br>    strRandomPwd += char<br>  }

---

Function Name:
blockResponsiveRenderingOnWholeSurvey

Function Definition:
function blockResponsiveRenderingOnWholeSurvey() {<br>  var flag = false; //default: false - change to true if no responsive rendering is needed<br><br>  var JS = "";<br><br>  JS += "//Block responsive rendering\n"<br>  JS += "setInterval(function () {\n";<br>  JS += "  $('.cf-question__content--mobile').css('display','none');\n";<br>  JS += "  $('.cf-question__content--desktop').css('display','block');\n";<br>  JS += "  if (screen.width<500) {\n";<br>  JS += "    $('meta[name=viewport]').prop('content', 'width=device-width, initial-scale=.55');\n";<br>  JS += "  }

---

Function Name:
runJSCheckOnEachPage

Function Definition:
function runJSCheckOnEachPage() {<br>  var flag = true; //Default setting<br><br>  return flag;<br>}

---

Function Name:
blockOnMobileDevices

Function Definition:
function blockOnMobileDevices() {<br>  return false; //default setting - change to 'true' if you want to block the survey on mobile devices<br>}

---

Function Name:
checkBrowserCompatibility

Function Definition:
function checkBrowserCompatibility() {<br>  if ((!IsInProductionMode()) || (Request.QueryString("__inmemorytest") == 1)) { return "" }

---

Function Name:
getLinkHowToEnableJS

Function Definition:
function getLinkHowToEnableJS() {<br>var sLink = "https:"+"//www.enable-javascript.com/";<br>//Another online site example: https:"+"//javascripton.com/enable-javascript-apple-safari/<br><br>var lang = CurrentLang();<br><br>switch (parseInt(lang)) {<br>  case 5	: sLink = sLink + 'cz/'; break;  //Czech<br>  case 19	: sLink = sLink + 'nl/'; break;  //Dutch<br>  case 12	: sLink = sLink + 'fr/'; break;  //French<br>  case 3084	: sLink = sLink + 'fr/'; break;  //French (Canada)<br>  case 7	: sLink = sLink + 'de/'; break;  //German<br>  case 14	: sLink = sLink + 'hu/'; break;  //Hungarian<br>  case 33	: sLink = sLink + 'id/'; break;  //Indonesian<br>  case 16	: sLink = sLink + 'it/'; break;  //Italian<br>  case 17	: sLink = sLink + 'ja/'; break;  //Japanese<br>  case 18	: sLink = sLink + 'ko/'; break;  //Korean<br>  case 20	: sLink = sLink + 'no/'; break;  //Norwegian<br>  case 21	: sLink = sLink + 'pl/'; break;  //Polish<br>  case 22	: sLink = sLink + 'pt/'; break;  //Portuguese<br>  case 1046	: sLink = sLink + 'pt/'; break;  //Portuguese (Brazil)<br>  case 25	: sLink = sLink + 'ru/'; break;  //Russian<br>  case 10	: sLink = sLink + 'es/'; break;  //Spanish<br>  case 2058	: sLink = sLink + 'es/'; break;  //Spanish (Mexican)<br>  case 30	: sLink = sLink + 'th/'; break;  //Thai<br>  case 31	: sLink = sLink + 'tr/'; break;  //Turkish<br>  //default	: "";<br>}

---

Function Name:
setWebpageRestrictions

Function Definition:
function setWebpageRestrictions() {<br>  var setRestrictions = true; //change to false to remove all restrictions, otherwise amend individual flags based on need<br><br>  var flags = [];<br>  var noCopyPaste = true; //disable copy paste to avoid data being copied over from other AI sources .e.g. ChatGPT<br>  var noPrint = true;  //page print<br>  var noRightClick = true; //right click<br>  var noScreenshot = true; //screenshots<br>  var noImgDrag = true; //image dragging on the page<br>  <br>  //remove restrictions in test mode<br>  if ( isTest() ) { noRightClick = false; }

---

Function Name:
getPageSecurityScripts

Function Definition:
function getPageSecurityScripts() {<br>  var sArr = [];<br>  var flags = setWebpageRestrictions(); //get flags<br>  var noCopyPaste = flags[0];<br>  var noPrint = flags[1];<br>  var noRightClick = flags[2];<br>  var noScreenshot = flags[3];<br>  var noImgDrag = flags[4];<br>   <br>  sArr.push("function callPageSecurityScripts() {");<br>  <br>  //do not allow copy text<br>  if (noCopyPaste) {<br>    sArr.push("  //do not allow copy text");<br>    sArr.push("  if ($('.allowCopyPaste').length==0) {");<br>    sArr.push("    var exclEleArr = ['listCompare','compareText','convertText'];");<br>    sArr.push("    document.body.oncopy = function(){return false}

---

Function Name:
disableBack

Function Definition:
function disableBack() {window.history.forward()}

---

Function Name:
getLanguages

Function Definition:
function getLanguages() {<br>var sLang = new Set();<br><br>//Example for CAN<br>//if (f('hCountry').get()=='4105') { sLang = sLang.union(set(2057,12)) }

---

Function Name:
getOS

Function Definition:
function getOS() {<br>   var a = Request.ServerVariables("HTTP_USER_AGENT");<br> <br>   if (a.indexOf("Android") != -1)<br>      return "Android";<br>   else if (a.indexOf("iPhone") != -1)<br>      return "iPhone";<br>   else if (a.indexOf("iPad") != -1)<br>      return "iPad";<br>   else if (a.indexOf("iPod") != -1)<br>      return "iPod";<br>   else if (a.indexOf("BlackBerry") != -1)<br>      return "BlackBerry";<br>   else if (a.indexOf("Windows Phone") != -1)<br>      return "Windows Phone"; <br>   else if (a.indexOf("Windows") != -1)<br>      return "Windows"; <br>   else if (a.indexOf("Mac") != -1)<br>      return "MacOS";<br>   else if (a.indexOf("Linux") != -1)<br>      return "Linux";<br>   else<br>      return "Unknown OS";<br>}

---

Function Name:
enableIQS

Function Definition:
function enableIQS() {<br>  var flag = true; //set to false if Quality Score not needed.<br><br>  //now removed IQS switch from MR, setting IQSenable=1 for all<br>  if ( !isTest() ) f("IQSenable").set("1") <br><br>  if ( !IsInProductionMode() || f("IQSenable").none("1") ) flag = false; //disable in test mode   or  no trigger to enable  from MR<br><br>  return flag;  <br>}

---

Function Name:
enableIQSRAflags

Function Definition:
function enableIQSRAflags() {<br>  var flag = true; //set to false if RAResult flags not needed.<br><br>  if ( !enableIQS() ) flag =false<br>  return flag;  <br>}

---

Function Name:
iqsExcludeOEs

Function Definition:
function iqsExcludeOEs() {<br>  //specify OE IDs that should be exluded from quality check, eg: return ["Q15","D20"]<br>  //we should exlude OEs for zip codes, autofilled OEs, OEs used for numeric answers, etc.<br><br>   return []<br>}

---

Function Name:
iqsIsBrandQuestion

Function Definition:
function iqsIsBrandQuestion() {<br>  //specify OE IDs which are asked for brand names, eg: return  ["Q15","D20"]<br><br>   return [] <br>}

---

Function Name:
IQSlayout

Function Definition:
function IQSlayout() {<br>  if( enableIQS() ){<br>    var sc="";<br>    sc+="<input id=ClientID alt='' size=20 type=hidden value="+f('IQSvars')['client_id'].get()+" name=ClientID>\n";<br>    sc+="<input id=SurveyID alt='' size=20 type=hidden value="+f('IQSvars')['survey_id'].get()+" name=SurveyID>\n";<br>    sc+="<input id=PanelistID alt='' size=20 type=hidden value="+f('IQSvars')['response_id'].get()+" name=PanelistID>\n";<br>    sc+="<input id=LangCode alt='' size=20 type=hidden value="+f('IQSvars')['langcode'].get()+" name=LangCode>\n";<br>    sc+="<style>label[for*=ra__], input[id*=ra__]{ position: absolute}

---

Function Name:
RVID_ResponseTXT

Function Definition:
function RVID_ResponseTXT() {<br>  var txt="";<br>  txt+="<style>.cf-question__content, .footcontainer, #page_form{ display:none !important }

---

Function Name:
CallQSService

Function Definition:
function CallQSService(e) { try{ imperium_qualityscore.CollectData('first_survey_page_1', '', () => {}

---

Function Name:
RVIDResponseComplete

Function Definition:
function RVIDResponseComplete() {\n";<br>  txt+="  var currentQuestion = Confirmit.page.getQuestion('RVID_Response');\n";<br>  txt+="  currentQuestion.setValue('1', document.getElementById('Score').value);\n";<br>  txt+="  currentQuestion.setValue('2', document.getElementById('isNew').value);\n";<br>  txt+="  currentQuestion.setValue('3', document.getElementById('RVid').value);\n";<br>  txt+="  setTimeout(function(){ Confirmit.page.next() }

---

Function Name:
hQualityScoreAnalyzeTXT

Function Definition:
function hQualityScoreAnalyzeTXT() {<br>  var txt="";<br>  txt+="<input type='hidden' id='qualityscore_collect_disabled'>\n";<br>  txt+="<style>.cf-question__content, .footcontainer{ display:none !important }

---

Function Name:
submitForm

Function Definition:
function submitForm() {\n";<br>  txt+="    if(!submitted){\n";<br>  txt+="      submitted = 1;\n";<br>  txt+="      document.querySelector('.cf-navigation-next').click();\n";<br>  txt+="    }

---

Function Name:
AnalyzeDataReponse

Function Definition:
function AnalyzeDataReponse(jsonData) {\n";<br>  txt+="    try {	\n";<br>  txt+="      if (jsonData.StatusCode == 200) {\n";<br>  txt+="         var currentQuestion = Confirmit.page.getQuestion('hQualityScoreAnalyze');\n";<br>  txt+="         currentQuestion.setValue('1', jsonData.Score)\n";<br>  txt+="         currentQuestion.setValue('2', jsonData.StraightlineRanking)\n";<br>  txt+="         currentQuestion.setValue('3', jsonData.SpeedingRanking)\n";<br>  txt+="         currentQuestion.setValue('4', jsonData.RASRanking)\n";<br>  txt+="         currentQuestion.setValue('5', jsonData.RedoRanking)\n";<br>  txt+="         currentQuestion.setValue('6', jsonData.AccelerationRanking)\n";<br>  txt+="         currentQuestion.setValue('7', jsonData.VelocityRanking)\n";<br>  txt+="         currentQuestion.setValue('8', jsonData.InactivityRanking)\n";<br>  txt+="         currentQuestion.setValue('9', jsonData.StraightlineCount)\n";<br>  txt+="         currentQuestion.setValue('10', jsonData.MatrixQuestionCount)\n";<br>  txt+="         currentQuestion.setValue('11', JSON.stringify(jsonData.MatrixStraightlineStatuses))\n";<br>  txt+="         currentQuestion.setValue('12', jsonData.RASAverage)\n";<br>  txt+="         currentQuestion.setValue('13', jsonData.OpenEndsAnswered)\n";<br>  txt+="         currentQuestion.setValue('14', JSON.stringify(jsonData.OpenEndScores))\n";<br>  txt+="         currentQuestion.setValue('15', jsonData.RVid)\n";<br>  txt+="         currentQuestion.setValue('16', jsonData.Pages)\n";<br>  txt+="         currentQuestion.setValue('17', jsonData.DistinctPages)\n";<br>  txt+="         currentQuestion.setValue('18', jsonData.TransactionGuid)\n";<br>  txt+="         currentQuestion.setValue('19', JSON.stringify(jsonData.OutlierGroups))\n";<br>  txt+="         currentQuestion.setValue('20', jsonData.Mode)\n";<br>  txt+="         currentQuestion.setValue('21', JSON.stringify(jsonData.OpenEndFlags))\n";<br>  txt+="      }

---

Function Name:
getLangCode

Function Definition:
function getLangCode() {<br> var l=f("l").get();<br> if(l=="") l="blank"<br> var lcode={<br>/*Afrikaans*/ "l_54"  :  "N/A",<br>/*Albanian*/ "l_28"  :  "N/A",<br>/*Amharic*/ "l_528"  :  "N/A",<br>/*Arabic*/ "l_1"  :  "AR",<br>/*Arabic (Algeria)*/ "l_5121"  :  "AR",<br>/*Arabic (Bahrain)*/ "l_15361"  :  "AR",<br>/*Arabic (Egypt)*/ "l_3073"  :  "AR",<br>/*Arabic (Iraq)*/ "l_2049"  :  "AR",<br>/*Arabic (Jordan)*/ "l_11265"  :  "AR",<br>/*Arabic (Kuwait)*/ "l_13313"  :  "AR",<br>/*Arabic (Lebanon)*/ "l_12289"  :  "AR",<br>/*Arabic (Libya)*/ "l_4097"  :  "AR",<br>/*Arabic (Morocco)*/ "l_6145"  :  "AR",<br>/*Arabic (Oman)*/ "l_8193"  :  "AR",<br>/*Arabic (Qatar)*/ "l_16385"  :  "AR",<br>/*Arabic (Saudi Arabia)*/ "l_1025"  :  "AR",<br>/*Arabic (Syria)*/ "l_10241"  :  "AR",<br>/*Arabic (Tunisia)*/ "l_7169"  :  "AR",<br>/*Arabic (U.A.E.)*/ "l_14337"  :  "AR",<br>/*Arabic (Yemen)*/ "l_9217"  :  "AR",<br>/*Armenian*/ "l_43"  :  "N/A",<br>/*Assamese*/ "l_77"  :  "N/A",<br>/*Azeri*/ "l_44"  :  "N/A",<br>/*Azeri (Cyrillic)*/ "l_2092"  :  "N/A",<br>/*Azeri (Latin)*/ "l_1068"  :  "N/A",<br>/*Basque*/ "l_45"  :  "N/A",<br>/*Belarusian*/ "l_35"  :  "N/A",<br>/*Bengali*/ "l_69"  :  "N/A",<br>/*Bosnian*/ "l_513"  :  "N/A",<br>/*Bulgarian*/ "l_2"  :  "BG",<br>/*Burmese*/ "l_531"  :  "N/A",<br>/*Catalan*/ "l_3"  :  "N/A",<br>/*Chinese*/ "l_4"  :  "ZH-CHT",<br>/*Chinese (Hong Kong SAR, PRC)*/ "l_3076"  :  "ZH-CHT",<br>/*Chinese (Macau SAR)*/ "l_5124"  :  "ZH-CHT",<br>/*Chinese (Malaysia)*/ "l_43012"  :  "ZH-CHT",<br>/*Chinese (Mandarin)*/ "l_34820"  :  "ZH-CHT",<br>/*Chinese (Mongolian)*/ "l_44036"  :  "ZH-CHT",<br>/*Chinese (PRC)*/ "l_2052"  :  "ZH-CHT",<br>/*Chinese (Simplified)*/ "l_32772"  :  "ZH-CHS",<br>/*Chinese (Singapore)*/ "l_4100"  :  "ZH-CHT",<br>/*Chinese (Taiwan)*/ "l_1028"  :  "ZH-CHT",<br>/*Chinese (Traditional)*/ "l_31748"  :  "ZH-CHT",<br>/*Czech*/ "l_5"  :  "CS",<br>/*Danish*/ "l_6"  :  "DA",<br>/*Dari*/ "l_517"  :  "N/A",<br>/*Dutch*/ "l_19"  :  "NL",<br>/*Dutch (Belgium)*/ "l_2067"  :  "NL",<br>/*Dutch (Netherlands)*/ "l_1043"  :  "NL",<br>/*English*/ "l_9"  :  "EN",<br>/*English (Australia)*/ "l_3081"  :  "EN",<br>/*English (Belize)*/ "l_10249"  :  "EN",<br>/*English (Canada)*/ "l_4105"  :  "EN",<br>/*English (Caribbean)*/ "l_9225"  :  "EN",<br>/*English (Garo)*/ "l_36873"  :  "EN",<br>/*English (Ireland)*/ "l_6153"  :  "EN",<br>/*English (Jamaica)*/ "l_8201"  :  "EN",<br>/*English (Malaysia)*/ "l_41993"  :  "EN",<br>/*English (New Zealand)*/ "l_5129"  :  "EN",<br>/*English (Philippines)*/ "l_13321"  :  "EN",<br>/*English (Somali)*/ "l_33801"  :  "EN",<br>/*English (South Africa)*/ "l_7177"  :  "EN",<br>/*English (Tagalog)*/ "l_32777"  :  "EN",<br>/*English (Trinidad)*/ "l_11273"  :  "EN",<br>/*English*/ "l_2057"  :  "EN",<br>/*English*/ "l_1033"  :  "EN",<br>/*English (Zimbabwe)*/ "l_12297"  :  "EN",<br>/*Estonian*/ "l_37"  :  "N/A",<br>/*Faeroese*/ "l_56"  :  "N/A",<br>/*Farsi*/ "l_41"  :  "N/A",<br>/*Filipino*/ "l_532"  :  "N/A",<br>/*Finnish*/ "l_11"  :  "FI",<br>/*French*/ "l_12"  :  "FR",<br>/*French (Belgium)*/ "l_2060"  :  "FR",<br>/*French (Canada)*/ "l_3084"  :  "FR",<br>/*French (Luxembourg)*/ "l_5132"  :  "FR",<br>/*French (Monaco)*/ "l_6156"  :  "FR",<br>/*French (Standard)*/ "l_1036"  :  "FR",<br>/*French (Switzerland)*/ "l_4108"  :  "FR",<br>/*Gaelic*/ "l_515"  :  "N/A",<br>/*Georgian*/ "l_55"  :  "N/A",<br>/*German*/ "l_7"  :  "DE",<br>/*German (Austria)*/ "l_3079"  :  "DE",<br>/*German (Liechtenstein)*/ "l_5127"  :  "DE",<br>/*German (Luxembourg)*/ "l_4103"  :  "DE",<br>/*German (Standard)*/ "l_1031"  :  "DE",<br>/*German (Switzerland)*/ "l_2055"  :  "DE",<br>/*Greek*/ "l_8"  :  "N/A",<br>/*Greenlandic*/ "l_514"  :  "N/A",<br>/*Gujarati*/ "l_71"  :  "N/A",<br>/*Haitian / Creole*/ "l_520"  :  "N/A",<br>/*Hebrew*/ "l_13"  :  "N/A",<br>/*Hindi*/ "l_57"  :  "N/A",<br>/*Hungarian*/ "l_14"  :  "HU",<br>/*Icelandic*/ "l_15"  :  "N/A",<br>/*Indonesian*/ "l_33"  :  "ID",<br>/*Indonesian (Bahasa)*/ "l_32801"  :  "ID",<br>/*Indonesian (Indonesia)*/ "l_1057"  :  "ID",<br>/*Italian*/ "l_16"  :  "IT",<br>/*Italian (Standard)*/ "l_1040"  :  "IT",<br>/*Italian (Switzerland)*/ "l_2064"  :  "IT",<br>/*Japanese*/ "l_17"  :  "JA",<br>/*Japanese (Japan)*/ "l_1041"  :  "JA",<br>/*Japanese (Japanese)*/ "l_37905"  :  "JA",<br>/*Kannada*/ "l_75"  :  "N/A",<br>/*Karen*/ "l_530"  :  "N/A",<br>/*Karen (Pa'O)*/ "l_40466"  :  "N/A",<br>/*Kashmiri*/ "l_96"  :  "N/A",<br>/*Kashmiri (India)*/ "l_2144"  :  "N/A",<br>/*Kazak*/ "l_63"  :  "N/A",<br>/*Khasi*/ "l_525"  :  "N/A",<br>/*Khmer*/ "l_519"  :  "N/A",<br>/*Khmer (Cambodian)*/ "l_33287"  :  "N/A",<br>/*Kirundi*/ "l_529"  :  "N/A",<br>/*Konkani*/ "l_87"  :  "N/A",<br>/*Korean*/ "l_18"  :  "KO",<br>/*Korean (Johab)*/ "l_2066"  :  "KO",<br>/*Korean (Korea)*/ "l_1042"  :  "KO",<br>/*Latvian*/ "l_38"  :  "N/A",<br>/*Lithuanian*/ "l_39"  :  "N/A",<br>/*Lithuanian (Classic)*/ "l_2087"  :  "N/A",<br>/*Lithuanian (Lithuania)*/ "l_1063"  :  "N/A",<br>/*Macedonian*/ "l_47"  :  "N/A",<br>/*Malay*/ "l_62"  :  "MS",<br>/*Malay (Brunei Darussalam)*/ "l_2110"  :  "MS",<br>/*Malay (Malaysian)*/ "l_1086"  :  "MS",<br>/*Malayalam*/ "l_76"  :  "N/A",<br>/*Manipuri*/ "l_88"  :  "N/A",<br>/*Marathi*/ "l_78"  :  "N/A",<br>/*Mizo*/ "l_526"  :  "N/A",<br>/*Nagamese*/ "l_527"  :  "N/A",<br>/*Nepali*/ "l_97"  :  "N/A",<br>/*Nepali (India)*/ "l_2145"  :  "N/A",<br>/*Norwegian*/ "l_20"  :  "NN",<br>/*Norwegian (Bokmål)*/ "l_1044"  :  "NN",<br>/*Norwegian (Nynorsk)*/ "l_2068"  :  "NN",<br>/*Oriya*/ "l_72"  :  "N/A",<br>/*Pashto*/ "l_516"  :  "N/A",<br>/*Pashto (Afgan)*/ "l_33284"  :  "N/A",<br>/*Pashto (Deewa)*/ "l_34308"  :  "N/A",<br>/*Polish*/ "l_21"  :  "PL",<br>/*Portuguese*/ "l_22"  :  "PT",<br>/*Portuguese (Brazil)*/ "l_1046"  :  "PT",<br>/*Portuguese (Standard)*/ "l_2070"  :  "PT",<br>/*Punjabi*/ "l_70"  :  "N/A",<br>/*Romanian*/ "l_24"  :  "RO",<br>/*Russian*/ "l_25"  :  "RU",<br>/*Sanskrit*/ "l_79"  :  "N/A",<br>/*Serbian / Croatian*/ "l_26"  :  "N/A",<br>/*Serbian / Croatian (Croatian)*/ "l_1050"  :  "N/A",<br>/*Serbian / Croatian (Cyrillic)*/ "l_3098"  :  "N/A",<br>/*Serbian / Croatian (Latin)*/ "l_2074"  :  "N/A",<br>/*Sindhi*/ "l_89"  :  "N/A",<br>/*Sinhalese*/ "l_518"  :  "N/A",<br>/*Slovak*/ "l_27"  :  "SK",<br>/*Slovenian*/ "l_36"  :  "N/A",<br>/*Sotho*/ "l_521"  :  "N/A",<br>/*Spanish*/ "l_10"  :  "ES",<br>/*Spanish (Argentina)*/ "l_11274"  :  "ES",<br>/*Spanish (Bolivia)*/ "l_16394"  :  "ES",<br>/*Spanish (Chile)*/ "l_13322"  :  "ES",<br>/*Spanish (Colombia)*/ "l_9226"  :  "ES",<br>/*Spanish (Costa Rica)*/ "l_5130"  :  "ES",<br>/*Spanish (Dominican Republic)*/ "l_7178"  :  "ES",<br>/*Spanish (Ecuador)*/ "l_12298"  :  "ES",<br>/*Spanish (El Salvador)*/ "l_17418"  :  "ES",<br>/*Spanish (Guatemala)*/ "l_4106"  :  "ES",<br>/*Spanish (Honduras)*/ "l_18442"  :  "ES",<br>/*Spanish (Mexican)*/ "l_2058"  :  "ES",<br>/*Spanish (Modern Sort)*/ "l_3082"  :  "ES",<br>/*Spanish (Nicaragua)*/ "l_19466"  :  "ES",<br>/*Spanish (Panama)*/ "l_6154"  :  "ES",<br>/*Spanish (Paraguay)*/ "l_15370"  :  "ES",<br>/*Spanish (Peru)*/ "l_10250"  :  "N/A",<br>/*Spanish (Puerto Rico)*/ "l_20490"  :  "N/A",<br>/*Spanish (Spain)*/ "l_40970"  :  "ES",<br>/*Spanish (Traditional Sort)*/ "l_1034"  :  "ES",<br>/*Spanish (Uruguay)*/ "l_14346"  :  "ES",<br>/*Spanish (Venezuela)*/ "l_8202"  :  "ES",<br>/*Swahili*/ "l_65"  :  "N/A",<br>/*Swedish*/ "l_29"  :  "SV",<br>/*Swedish (Finland)*/ "l_2077"  :  "SV",<br>/*Swedish (Sweden)*/ "l_1053"  :  "SV",<br>/*Tamil*/ "l_73"  :  "N/A",<br>/*Tatar*/ "l_68"  :  "N/A",<br>/*Telugu*/ "l_74"  :  "N/A",<br>/*Thai*/ "l_30"  :  "TH",<br>/*Thai (Lao)*/ "l_38942"  :  "TH",<br>/*Thai (Thai)*/ "l_1054"  :  "TH",<br>/*Tswana*/ "l_522"  :  "N/A",<br>/*Turkish*/ "l_31"  :  "TR",<br>/*Ukrainian*/ "l_34"  :  "N/A",<br>/*Urdu*/ "l_32"  :  "N/A",<br>/*Urdu (India)*/ "l_2080"  :  "N/A",<br>/*Urdu (Pakistan)*/ "l_1056"  :  "N/A",<br>/*Uzbek*/ "l_67"  :  "N/A",<br>/*Uzbek (Cyrillic)*/ "l_2115"  :  "N/A",<br>/*Uzbek (Latin)*/ "l_1091"  :  "N/A",<br>/*Vietnamese*/ "l_42"  :  "VI",<br>/*Welsh*/ "l_512"  :  "N/A",<br>/*Xhosa*/ "l_523"  :  "N/A",<br>/*Zulu*/ "l_524"  :  "N/A",<br>/*blank*/ "l_blank" :"N/A"<br>}

---

Function Name:
getCountryCode

Function Definition:
function getCountryCode(fromtest) {<br> var ccode=fromtest!=undefined ? fromtest  :  f("hCountry").get();<br> var cntry={<br><br>/*Argentina*/ "c_11274"  :  "AR",<br>/*Armenia*/ "c_43"  :  "AM",<br>/*Australia*/ "c_3081"  :  "AU",<br>/*Austria*/ "c_3079"  :  "AT",<br>/*Albania*/ "c_28"  :  "AL",<br>/*Algeria*/ "c_5121"  :  "DZ",<br>/*Bahrain*/ "c_15361"  :  "BH",<br>/*Belarus*/ "c_35"  :  "BY",<br>/*Belgium*/ "c_2067"  :  "BE",<br>/*Belgium*/ "c_2060"  :  "BE",<br>/*Brazil*/ "c_1046"  :  "BR",<br>/*Bulgaria*/ "c_2"  :  "BG",<br>/*Canada*/ "c_3084"  :  "CA",<br>/*Canada*/ "c_4105"  :  "CA",<br>/*Chile*/ "c_13322"  :  "CL",<br>/*China*/ "c_4"  :  "CN",<br>/*China*/ "c_31748"  :  "CN",<br>/*Colombia*/ "c_9226"  :  "CO",<br>/*Croatia*/ "c_1050"  :  "HR",<br>/*Cyprus*/ "c_XXX"  :  "CY",<br>/*Czech Republic*/ "c_5"  :  "CZ",<br>/*Denmark*/ "c_6"  :  "DK",<br>/*Egypt*/ "c_3073"  :  "EG",<br>/*Estonia*/ "c_37"  :  "EE",<br>/*Finland*/ "c_11"  :  "FI",<br>/*France*/ "c_12"  :  "FR",<br>/*Georgia*/ "c_55"  :  "GE",<br>/*Germany*/ "c_7"  :  "DE",<br>/*Greece*/ "c_8"  :  "GR",<br>/*Hong Kong*/ "c_3076"  :  "HK",<br>/*Hungary*/ "c_14"  :  "HU",<br>/*Iceland*/ "c_15"  :  "IS",<br>/*India*/ "c_57"  :  "IN",<br>/*India*/ "c_2144"  :  "IN",<br>/*India*/ "c_2145"  :  "IN",<br>/*India*/ "c_2080"  :  "IN",<br>/*Indonesia*/ "c_33"  :  "ID",<br>/*Indonesia*/ "c_32801"  :  "ID",<br>/*Indonesia*/ "c_1057"  :  "ID",<br>/*Iraq*/ "c_2049"  :  "IQ",<br>/*Ireland*/ "c_6153"  :  "IE",<br>/*Israel*/ "c_13"  :  "IL",<br>/*Italy*/ "c_16"  :  "IT",<br>/*Italy*/ "c_1040"  :  "IT",<br>/*Italy*/ "c_2064"  :  "IT",<br>/*Japan*/ "c_17"  :  "JP",<br>/*Japan*/ "c_1041"  :  "JP",<br>/*Japan*/ "c_37905"  :  "JP",<br>/*Jordan*/ "c_11265"  :  "JO",<br>/*Kazakhstan*/ "c_63"  :  "KZ",<br>/*Kenya*/ "c_65"  :  "KE",<br>/*Korea*/ "c_18"  :  "KR",<br>/*Korea*/ "c_1042"  :  "KR",<br>/*Kuwait*/ "c_13313"  :  "KW",<br>/*Latvia*/ "c_38"  :  "LV",<br>/*Lebanon*/ "c_12289"  :  "LB",<br>/*Libya*/ "c_4097"  :  "LY",<br>/*Lithuania*/ "c_39"  :  "LT",<br>/*Lithuania*/ "c_2087"  :  "LT",<br>/*Lithuania*/ "c_1063"  :  "LT",<br>/*Luxembourg*/ "c_5132"  :  "LU",<br>/*Luxembourg*/ "c_4103"  :  "LU",<br>/*Macau SAR*/ "c_5124"  :  "MO",<br>/*Malaysia*/ "c_41993"  :  "MY",<br>/*Malaysia*/ "c_43012"  :  "MY",<br>/*Malaysia*/ "c_1086"  :  "MY",<br>/*Malta*/ "c_XXX"  :  "MT",<br>/*Mexico*/ "c_2058"  :  "MX",<br>/*Moldova*/ "c_XXX"  :  "MD",<br>/*Morocco*/ "c_6145"  :  "MA",<br>/*Netherlands*/ "c_19"  :  "NL",<br>/*Netherlands*/ "c_1043"  :  "NL",<br>/*New Zealand*/ "c_5129"  :  "NZ",<br>/*Norway*/ "c_20"  :  "NO",<br>/*Norway*/ "c_1044"  :  "NO",<br>/*Norway*/ "c_2068"  :  "NO",<br>/*Oman*/ "c_8193"  :  "OM",<br>/*Pakistan*/ "c_1056"  :  "PK",<br>/*Peru*/ "c_10250"  :  "PE",<br>/*Philippines*/ "c_13321"  :  "PH",<br>/*Philippines*/ "c_32777"  :  "PH",<br>/*Poland*/ "c_21"  :  "PL",<br>/*Portugal*/ "c_22"  :  "PT",<br>/*Portugal*/ "c_2070"  :  "PT",<br>/*Puerto Rico*/ "c_20490"  :  "PR",<br>/*Qatar*/ "c_16385"  :  "QA",<br>/*Romania*/ "c_24"  :  "RO",<br>/*Russian Federation*/ "c_25"  :  "RU",<br>/*Saudi Arabia*/ "c_1025"  :  "SA",<br>/*Serbia*/ "c_26"  :  "RS",<br>/*Serbia*/ "c_1050"  :  "RS",<br>/*Serbia*/ "c_3098"  :  "RS",<br>/*Serbia*/ "c_2074"  :  "RS",<br>/*Singapore*/ "c_4100"  :  "SG",<br>/*Slovakia*/ "c_27"  :  "SK",<br>/*Slovenia*/ "c_36"  :  "SI",<br>/*South Africa*/ "c_7177"  :  "ZA",<br>/*Spain*/ "c_10"  :  "ES",<br>/*Spain*/ "c_40970"  :  "ES",<br>/*Sweden*/ "c_29"  :  "SE",<br>/*Sweden*/ "c_1053"  :  "SE",<br>/*Switzerland*/ "c_4108"  :  "CH",<br>/*Switzerland*/ "c_2055"  :  "CH",<br>/*Switzerland*/ "c_10241"  :  "CH",<br>/*Syria*/ "c_2064"  :  "SY",<br>/*Taiwan*/ "c_1028"  :  "TW",<br>/*Thailand*/ "c_30"  :  "TH",<br>/*Thailand*/ "c_38942"  :  "TH",<br>/*Thailand*/ "c_1054"  :  "TH",<br>/*Tunisia*/ "c_7169"  :  "TN",<br>/*Turkey*/ "c_31"  :  "TR",<br>/*Ukraine*/ "c_34"  :  "UA",<br>/*United Arab Emirates*/ "c_14337"  :  "AE",<br>/*United Kingdom*/ "c_2057"  :  "GB",<br>/*United States*/ "c_1033"  :  "US",<br>/*Venezuela*/ "c_8202"  :  "VE",<br>/*Vietnam*/ "c_42"  :  "VN",<br>/*Yemen*/ "c_9217"  :  "YE",<br>/*blank*/ "c_" : ""<br>}

---

Function Name:
getTextHP

Function Definition:
function getTextHP() {<br>  return "{data: valid}

---

Function Name:
MaskS1

Function Definition:
function MaskS1() {<br><br>	var xSet = new Set();<br>	<br>		xSet = xSet.union(set('99'));<br>		<br>		if ( isFR() )<br>			xSet = xSet.union(nset('3'));<br><br>		if ( isIT() || isBR() || isUK() )<br>			xSet = xSet.union(set('1'));<br><br>		if ( isDE() )<br>			xSet = xSet.union(nset('2'));<br><br>	return xSet;<br><br>}

---

Function Name:
TermS4

Function Definition:
function TermS4() {<br><br>	var xCNT = 0;<br>	<br>		if ( isFR() )<br>		{<br>		<br>			if ( GetNum('S4_1') < 50 && f('S3aFR').any('1','2') )<br>				xCNT = xCNT + 1;<br>				<br>			if ( GetNum('S4_1') < 60 && f('S3aFR').none('1','2') )<br>				xCNT = xCNT + 1;				<br>		<br>		}

---

Function Name:
MaskColS6e1

Function Definition:
function MaskColS6e1() {<br><br>	var xSet = new Set();<br>	<br>		for ( var j=1;j<=3;j++ )<br>		{<br>			<br>			if ( Sum(f('S6e1x'+j).values()) > 0 )<br>				xSet = xSet.union(set(j));<br>		}

---

Function Name:
MaskColsB1b

Function Definition:
function MaskColsB1b() {<br><br>	var xSet = new Set();<br>	<br>		for ( var j=1;j<=3;j++ )<br>		{<br>			<br>			if ( Sum(f('B4x'+j).values()) > 0 )<br>				xSet = xSet.union(set(j));<br>		}

---

Function Name:
MaskAnsB1b

Function Definition:
function MaskAnsB1b() {<br><br>	var xSet = new Set();<br>	<br>		for ( var j=1;j<=2;j++ )<br>		{<br>			<br>			for ( var k=1;k<=3;k++ )<br>			{<br>			<br>				if ( GetNum("B4x"+k+"_"+j) > 0 )<br>					xSet = xSet.union(set(j));<br>					<br>			}

---

Function Name:
DisableB1b

Function Definition:
function DisableB1b(xQID1,xQID2) {<br><br>	 var txt = "";<br><br>	var xCodes = f(xQID2).domainValues();<br>	<br>		for ( var j=0;j<xCodes.length;j++ )<br>		{<br>		<br>			if ( GetNum(xQID1+"_"+xCodes[j]) == 0 )<br>			{<br>			<br>				txt = txt + '$("#desktop_'+xQID2+'_'+xCodes[j]+'").parent().html("");';<br>				txt = txt + '$("#mobile_'+xQID2+'_'+xCodes[j]+'").parent().html("");';<br>			<br>			}

---

Function Name:
validateB1b

Function Definition:
function validateB1b(xQID1,xQID2) {<br><br>	var xCodes = f(xQID2).domainValues();<br>	<br>	var xStr = "";<br>	<br>		if ( xQID2 == "B1bx1" )<br>			xStr = ""+f('qTitle')['B1h1'].label();<br><br>		if ( xQID2 == "B1bx2" )<br>			xStr = ""+f('qTitle')['B1h2'].label();<br><br>		if ( xQID2 == "B1bx3" )<br>			xStr = ""+f('qTitle')['B1h3'].label();			<br>	<br>		for ( var j=0;j<xCodes.length;j++ )<br>		{<br>		<br>			<br>		<br>			f('qErrNum')['3'].set(xStr);<br>			f('qErrNum')['1'].set(GetNum(xQID1+"_"+xCodes[j]));<br>		<br>			if ( GetNum(xQID1+"_"+xCodes[j]) > 0 && !f(xQID2)[xCodes[j]].toBoolean() )<br>				errorMsg(f('qErrors')['36'].label()+"("+f(xQID2)[xCodes[j]].label()+"): "+f('qErrors')['1'].label());<br>			else if ( GetNum(xQID2+"_"+xCodes[j]) > GetNum(xQID1+"_"+xCodes[j]) )<br>				errorMsg(f('qErrors')['36'].label()+"("+f(xQID2)[xCodes[j]].label()+"): "+f('qErrors')['29'].label());<br>		<br>			f('qErrNum')['3'].set(null);<br>			f('qErrNum')['1'].set(null);<br>		<br>		}

---

Function Name:
SetNullB1b

Function Definition:
function SetNullB1b(xQID1,xQID21,xQID22) { <br>	<br>	var xCodes = f(xQID22).domainValues();<br>	<br>		for ( var j=0;j<xCodes.length;j++ )<br>		{<br>		<br>			if ( GetNum(xQID1+"_"+xCodes[j]) == 0 )<br>			{<br>			<br>				f(xQID21)[xCodes[j]].set(null);<br>				f(xQID22)[xCodes[j]].set(null);<br>			<br>			}

---

Function Name:
MaskB10b2

Function Definition:
function MaskB10b2() {<br>    var xset = new Set();<br>    if(Sum(GetNum("B4x1_1"),GetNum("B4x2_1"),GetNum("B4x3_1")) < GetNum('HVAR6_1')){xset=xset.union(set('1'));}

---

Function Name:
MaskB10bloop

Function Definition:
function MaskB10bloop() {<br><br>    var xSet = new Set();<br><br>    if (GetNum("B4x1_1") > 0 || GetNum("B4x2_1") > 0 || GetNum("B4x3_1") > 0)<br>        xSet = xSet.union(set('1'));<br><br>    if (GetNum("B4x1_2") > 0 || GetNum("B4x2_2") > 0 || GetNum("B4x3_2") > 0)<br>        xSet = xSet.union(set('2'));<br><br>    return xSet;<br><br>}

---

Function Name:
MaskColsB10b

Function Definition:
function MaskColsB10b() {<br>    var xset = new Set();<br>    if( Sum(GetNum("B4x1_1"),GetNum("B4x2_1"),GetNum("B4x3_1")) > 0 ){xset=xset.union(set('1'));}

---

Function Name:
sameAs

Function Definition:
function sameAs(qid, code) {<br>    var dv = f(qid).domainValues();<br>    var startCode = 65;<br>    for (var i = 0; i < dv.length; i++) {<br>        if (dv[i] == code)<br>            return '<span style="display:none">' + String.fromCharCode(Number(startCode) + i) + '</span>';<br>        //return '<span>'+String.fromCharCode(Number(startCode)+i)+'</span>---';<br>    }

---

Function Name:
MaskC4

Function Definition:
function MaskC4() {<br>    var xset = new Set();<br>    xset = xset.union(nnset('1', '98'))<br>    if (isBR() || isUK()) { xset = xset.diff(set('3')); }

---

Function Name:
MaskC5a

Function Definition:
function MaskC5a() {<br>    var xset = new Set();<br>    xset = xset.union(nnset('1', '98'))<br>    if (isBR() || isUK()) { xset = xset.diff(set('3')); }

---

Function Name:
MaskC5

Function Definition:
function MaskC5() {<br>    var xset = new Set();<br>    xset=xset.union(nnset('1','98'))<br>    if (isBR() || isUK()) { xset = xset.diff(set('3')); }

---

Function Name:
MaskScaleC8

Function Definition:
function MaskScaleC8() {<br>    var xset = new Set();<br>    if (GetNum('B1bx1_1') > 0 || GetNum('B1bx2_1') > 0 || GetNum('B1bx3_1') > 0) { xset = xset.union(set('1')); }

---

Function Name:
MaskC11a

Function Definition:
function MaskC11a() {<br>    var xset = new Set();<br>    xset=xset.union(nnset('1','98'))<br>    if (isBR() ) { xset = xset.diff(set('11')); }

---

Function Name:
copyq

Function Definition:
function copyq(toQid,fromQid,qtype) {<br>ClearForm(toQid);<br>if(qtype == 'S' || qtype == 'M'){<br>	f(toQid).set(f(fromQid));<br>}

---

Function Name:
countInArray

Function Definition:
function countInArray(array, x) {<br>    var count = 0;<br>    for (var i = 0; i < array.length; i++) {<br>        if (array[i] == x) {<br>            count++;<br>        }

---

Function Name:
MaskD2

Function Definition:
function MaskD2() {<br>    var xset = new Set();<br>    xset=xset.union(set('4'));<br>    if(f('A2a')['6'].any('4','5','6','7','8','9')){xset=xset.union(set('1'));}

---

Function Name:
MaskD3

Function Definition:
function MaskD3() {<br>    var xset = new Set();<br>    xset=xset.union(set('4'));<br>    if( f('HA2a_6').any('2','3') ){xset=xset.union(set('1'));}

---

Function Name:
MaskD5

Function Definition:
function MaskD5() {<br>    var xset = new Set();<br>    xset=xset.union(set('4'));<br>    if(f('A2a')['6'].any('2','3','4','5','6','7','8','9')){xset=xset.union(set('1'));}

---

Function Name:
MaskPRF

Function Definition:
function MaskPRF() {<br><br>	var xSet = new Set();<br>	<br>		if ( f('HP0').any('2') )<br>			xSet = xSet.union(set('1'));<br>			<br>		if ( f('HP0').any('3') )<br>			xSet = xSet.union(set('1','2'));<br>			<br>		if ( f('HP0').any('4') )<br>			xSet = xSet.union(set('1','2','3'));<br>			<br>	return xSet;<br><br>}

---

Function Name:
MaskPRFHPTs

Function Definition:
function MaskPRFHPTs() {<br><br>	var xSet = new Set();<br>	<br>		if ( f('hPTs').any('1') )<br>			xSet = xSet.union(set('1'));<br>			<br>		if ( f('hPTs').any('2') )<br>			xSet = xSet.union(set('1','2'));<br>			<br>		if ( f('hPTs').any('3') )<br>			xSet = xSet.union(set('1','2','3'));<br>			<br>	return xSet;<br><br>}

---

Function Name:
getLoopItr

Function Definition:
function getLoopItr() {<br>   return f('loopPTs').toNumber();<br>}

---

Function Name:
MaskP16

Function Definition:
function MaskP16() {<br>    var xset = new Set();<br>    xset=xset.union(nnset('1','98'))<br>    if (isBR() || isUK()) { xset = xset.diff(set('3')); }

---

Function Name:
MaskP18

Function Definition:
function MaskP18() {<br>    var xset = new Set();<br>    xset=xset.union(nnset('1','99'));<br>    if(isUK() || isBR() ){xset=xset.diff(set('3'))}

---

Function Name:
MaskP19

Function Definition:
function MaskP19() {<br><br>	var xSet = new Set();<br>	<br>		xSet = xSet.union(nset('98'));<br>		<br>			if ( isUK() || isBR() )<br>				xSet = xSet.diff(set('3')); // Gemcitabine  + cisplatin + pembrolizumab (Keytruda®)<br>            if ( isUK() )<br>                xSet = xSet.diff(set('6')); // FOLFIRI (5-FU, folinic acid, irinotecan)<br>  <br>			if ( f('P16').any('10') )<br>				xSet = xSet.diff(set('10')); // Ivosidenib (Tibsovo®) <br>	<br>	return xSet;<br><br>}

---

Function Name:
maskP20a

Function Definition:
function maskP20a() {	<br>	var xSet= new Set();<br>  	xSet= xSet.union(nset('98'));<br>	<br>	if ( f('P3').any('99') )<br>		{ xSet= xSet.diff(set('2'));}

---

Function Name:
MaskF1

Function Definition:
function MaskF1() {<br>    var xset = new Set();<br>    if (GreaterThan('A2a',1).isect(set('6')).size() > 0 ) { xset = xset.add(set('1')); }

---

Function Name:
maskF3a

Function Definition:
function maskF3a() {	<br>	var xSet= new Set();<br>	<br>	if ( f('F1',1).any('1') || f('F1',2).any('1') || f('F1',3).any('1'))<br>		{ xSet= xSet.union(set('1'));}

---

Function Name:
maskF3aCodes

Function Definition:
function maskF3aCodes() {	<br>	var xcode= new Set();<br>	xcode=xcode.union(set('1','2'))<br>	if(isUK()){xcode = xcode.union(set('4'))}

---

Function Name:
maskF4bN

Function Definition:
function maskF4bN() {	<br>	var xSet= new Set();<br>	<br>	if ( GreaterThan('A2a',1).isect(set('6')).size() > 0)<br>		{ xSet= xSet.union(set('1'));}

---

Function Name:
maskF4b

Function Definition:
function maskF4b() {	<br>	var xSet= new Set();<br>	<br>	if ( f('F1',1).any('1') )<br>		{ xSet= xSet.union(set('1'));}

---

Function Name:
getQSloopInfo

Function Definition:
function getQSloopInfo() {<br>  var loops=CurrentLoops()<br>  var info=""<br>  for( var i=0; i<loops.length; i++ ){<br>     info+=loops[i]+"_"+f(loops[i]).get()<br>  }

---

Function Name:
setRAflag

Function Definition:
function setRAflag(flag, code) {<br>   var rawResultArr=f("hRAResult").get().toString().split("||")//.replace(/ /gi, "").replace(/"/gi, "")<br>   //var oeArr=rawResult.split("QuestionID:")<br>   for( var i=0; i<rawResultArr.length; i++ ){<br>      if( rawResultArr[i]!="" && rawResultArr[i].split("QuestionID:").length>1 ){   <br>        var tempID=rawResultArr[i].split(",")[0].split(":")[1]<br>        tempID=tempID.split("__")[1]<br>        tempID=tempID.replace("_input","")<br>          if( flag=="DetectedLanguageCode" ){<br>           if( getLangCode()!="N/A" ){<br>            //check answer language - only if survey language is supported<br>             if( rawResultArr[i].toString().split(flag+":").length>1 && rawResultArr[i].toString().split(flag+":")[1].split(",")[0]!=getLangCode() ){<br>                f("RAflags")[code].set("1")<br>                if( !f("RAflags_"+code+"_other").toBoolean() || f("RAflags_"+code+"_other").get().toString().split(tempID).length<2 ){<br>                    if( !f("RAflags_"+code+"_other").toBoolean() ) f("RAflags_"+code+"_other").set(tempID+":"+rawResultArr[i].split(flag+":")[1].split(",")[0])<br>                    else  f("RAflags_"+code+"_other").set( f("RAflags_"+code+"_other").get()+","+tempID+":"+rawResultArr[i].split(flag+":")[1].split(",")[0])<br>                }

---

Function Name:
updateLOI

Function Definition:
function updateLOI(section,update) {<br>var maxIdle=45 //idle time in seconds when LOI caclulation is paused<br>if( !isDynTerm()  ){<br><br>var qLOI=Request.Form("qLOI")<br>if( qLOI!=undefined && qLOI.split(":").length==2 && f("hLOIupdated").none("1")){<br>      var screenerLOI=GetNum("respLOI_1")<br>      var qID=qLOI.split(":")[0]<br>      var infoLOI=parseFloat(qLOI.split(":")[1])<br>      f("respLOI_3").set(GetNum("respLOI_3")+infoLOI);<br>      if( section=="screener" ) f("respLOI_1").set(GetNum("respLOI_3") );<br>      if( section==undefined || section!="screener" ){<br>          if( f("respLOI_1").toBoolean() && !f("respLOI_2").toBoolean() ) f("respLOI_1").set(GetNum("respLOI_3") );  //this means it is first question in the main part, still need to update screener LOI from here<br>          f("respLOI_2").set(GetNum("respLOI_3") - GetNum("respLOI_1") );<br>      }

---

Function Name:
updateLOIvar

Function Definition:
function updateLOIvar(qID, timeSpent) {<br>     //records LOI of each individual question/screen***<br><br>     var sameQ=false<br><br>    if( f("hQLOI").toBoolean()  ){<br>        var curAnsw=f("hQLOI").get().toString().split(";")<br>       for( var i=0; i<curAnsw.length; i++ ){<br>	    var foundID=curAnsw[i].split(":")[0]<br>	    var foundLOI=curAnsw[i].split(":")[1]<br>	    var updatedLOI=parseFloat(foundLOI)+parseFloat(timeSpent)<br>        updatedLOI=Math.round(updatedLOI*100)/100<br>       if( foundID==qID ){<br>           sameQ=true;<br>           curAnsw[i]=foundID+":"+updatedLOI<br>       }

---

Function Name:
sectionLOI

Function Definition:
function sectionLOI(qID,action) {<br>  updateLOI("",true)<br>  f("hLOIupdated").set("1")<br>  if( action=='start' ) f(qID)['1'].set( GetNum("respLOI_3") )<br>  if( action=='end' ){<br>        f(qID)['2'].set( GetNum("respLOI_3") )<br>        f(qID)['3'].set( GetNum(qID+"_2")-GetNum(qID+"_1") )<br>  }

---

Function Name:
setInterviewTimeRegional

Function Definition:
function setInterviewTimeRegional(param) {<br>  var dtObj  = new  Date();<br>  var AESTTimezoneOffSet = 10; //UTC+10<br>  var yy = dtObj.getUTCFullYear();<br>  var mm = dtObj.getUTCMonth();<br>  var dd = dtObj.getUTCDate();<br>  var hr = dtObj.getUTCHours();<br>  var mn = dtObj.getUTCMinutes();<br>  var sc = dtObj.getUTCSeconds();<br>  var ms = dtObj.getUTCMilliseconds();<br><br>  //if (! isTimeInEST()) { AESTTimezoneOffSet++; }

---

Function Name:
isTimeInEST

Function Definition:
function isTimeInEST() {<br>  var flag = false;<br>  var firstSunApr;<br>  var firstSunOct;<br>  var dtObj  = new  Date();<br><br>  var yy = dtObj.getUTCFullYear();<br>  var mm = dtObj.getUTCMonth();<br>  var dd = dtObj.getUTCDate();<br>  var hr = dtObj.getUTCHours();<br>  var mn = dtObj.getUTCMinutes();<br>  var sc = dtObj.getUTCSeconds();<br>  var ms = dtObj.getUTCMilliseconds();<br><br>  var dtObjAEST = new Date(yy,mm,dd,hr+10,mn,sc,ms); //UTC+10<br>  //var dtObjAEST = new Date(yy,9,1,2,59,0,0); //UTC+11<br><br><br>  //find first Sunday of April/Oct<br>  var dtObjTempApr = new Date(yy,3,dd); //Date with April month<br>  var dtObjTempOct = new Date(yy,9,dd); //Date with October month<br>  for (var d=1;d<=30;d++) {<br>    dtObjTempApr.setDate(d); dtObjTempOct.setDate(d);<br>    if (dtObjTempApr.getDay() == 0 && firstSunApr == undefined) { firstSunApr = dtObjTempApr.getDate(); }

---

Function Name:
captchaInstr

Function Definition:
function captchaInstr() {<br>  return "<!-- ------------------ CAPTCHA HTML -------------------- --> <div class='container'> <div style='width:100%; display: flex; justify-content: space-between;'> <div id='captcha'> </div> <button class='regenerateCaptchaBtn' id='btnCreateCaptcha' style='width: 5rem;' > <img src='/isa/CVBPNBJTLMHDHKHTEDFXPXAOGFGIMPMK/icons/redo.png' > </button> </div> <span id='cpatchaTextBox'></span> <button id='btnSubmit' class='cf-navigation__button cf-navigation-next'>>></button> </div> <!-- -------------------- CSS --------------------------- --> <style> .cf-page__navigation { display: none; }

---

Function Name:
CheckReentryQuotas

Function Definition:
function CheckReentryQuotas() {<br>  if(GetStatus() != 'complete') {<br>    if( isQuotaFull() && f('screenStatus').any('SURVEY_QUIT') )<br>		return true;<br>	<br>    return false;<br>  }

---

Function Name:
setDayMonthWeekYear

Function Definition:
function setDayMonthWeekYear() {<br>var today = new Date();<br>var day  = today.getDay()+1;<br>var dd   = today.getDate();<br>var mm   = today.getMonth()+1;<br>var yyyy = today.getFullYear();<br><br>f("hYear").set(yyyy);<br>f("hMonth").set(mm);<br>f("hDay").set(day);<br><br><br>var date = new Date();<br>date.setHours(0, 0, 0, 0);<br><br>// Thursday in current week decides the year.<br>date.setDate(date.getDate() + 3 - (date.getDay() + 6) % 7);<br><br>// January 4 is always in week 1.<br>var week1 = new Date(date.getFullYear(), 0, 4);<br><br>// Adjust to Thursday in week 1 and count number of weeks from date to week1.<br>var finweekISO = 1 + Math.round(((date.getTime() - week1.getTime()) / 86400000 - 3 + (week1.getDay() + 6) % 7) / 7);<br>f("hWeek").set(finweekISO);<br>}

---
